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ABSTRACT
AN AUTISM-CAUSING VARIANT MISREGULATES SELECTIVE AUTOPHAGY TO
ALTER AXON TARGETING AND BEHAVIOR
by
Tyler Buddell

The University of Wisconsin-Milwaukee, 2019
Under the Supervision of Professor Christopher C Quinn
Neurodevelopmental disorders cause debilitating disruptions to the cellular mechanisms
that underlie development of the brain. Unfortunately, the complexities of neurodevelopmental
disorders make them difficult to study, and the molecular mechanisms perturbed by these
disorders remain elusive. Better understanding of neurodevelopmental mechanisms, and the
related genes involved, will likely yield new insight into neurodevelopmental disorders. A gene
that has been associated with a number of neurodevelopmental disorders is the calcium voltagegated channel subunit alpha1 C (CACNA1C) gene. Common and rare variants of the CACNA1C
gene have been associated with autism and other neurodevelopmental disorders including
schizophrenia, bipolar disorder and ADHD. However, little is known about how CACNA1C
variants affect cellular processes to alter neurodevelopment. The Timothy syndrome mutation is
a rare, gain-of-function variant in CACNA1C that causes autism with high penetrance, providing
a powerful avenue into investigating the role of CACNA1C variants in neurodevelopmental
disorders. A gain-of-function (gof) mutation in the C. elegans CACNA1C homolog known as
egl-19 causes an equivalent amino acid change to the Timothy syndrome mutation in humans.
This work shows that this egl-19(gof) mutation can alter axon targeting and affect behavior in C.
elegans. Wildtype egl-19 functions independently of Regulator of Presynaptic Morphology-1
(rpm-1) to negatively regulate axon termination. The egl-19(gof) mutation represses axon
ii

termination to cause axon targeting defects that lead to the misplacement of electrical synapses
and alterations in habituation to light touch. Moreover, genetic analysis indicates that selective
autophagy acts downstream of the egl-19(gof) mutation to mediate its effects on both axon
termination and behavior. These results reveal a novel mechanism whereby an autism-causing
variant of CACNA1C misregulates selective autophagy to alter circuit formation and affect
behavior.
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Chapter 1 – Human Autism and Autism Genetics

1.1 Autism Overview
Autism spectrum disorder (ASD) is defined as a pervasive disorder that affects the
development of the brain. In the United States, it is estimated that around 1 in 59 children are
diagnosed with some form of ASD (Baio et al., 2018). People with ASD can exhibit severe
neurological symptoms such as difficulties learning to speak, as well as problems with repetitive
behavior, impaired social interaction, and general cognition deficiencies ("Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)," 2000;
Fombonne, 2009). While some forms of ASD can be mild, the more severe forms of ASD can
lead to heavy financial and emotional costs. It is estimated to cost about 60 million USD
annually for the lifelong care of people with ASD (Lavelle et al., 2014). Human and financial
costs make understanding the causes of ASD paramount.
While ASD is a neurodevelopmental disorder, the exact mechanisms affected in the
development of the disorder are not clear. The first portion of this chapter will focus on
neurodevelopment, specifically the mechanisms governing the development of the long neurite
projection known as the axon. The relationship between axon development and ASD will then be
discussed. The remainder of the chapter will then discuss the genetics of ASD, and how we can
use those genetics to better understand the disorder.
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1.2 Neurodevelopment Background
1.2.1 Basics of axon outgrowth
During the formation of neuronal networks, neurons undergo many developmental
changes that culminate in the elongation of the axon in order to reach and selectively form
synapses with its proper targets. New neuronal cells differentiate from their progenitors based
on the concentration of specific proteins, which direct proper polarization of the neuron
(Prehoda, 2009; Gallaud et al., 2017). For instance, the localization of aPKC directs the
development of the basal domain of the neuron (Atwood & Prehoda, 2009; Prehoda, 2009). The
further differentiation of the neuron gives rise to the polarized outgrowth of axons and dendrites
(Polleux & Snider, 2010). Axon outgrowth has a number of key factors that govern how the axon
develops, the directions it moves, and the point at which the axon stops growing and forms
synapses with its intended targets.
In neurons, the enlarged tip of the elongating axon is known as the growth cone. The
physical outgrowth of the axon is governed by many of the same mechanisms that govern cell
migration in other cell types. Cell migration starts with the polarized protrusion of cytoplasm in
the form of lamellipodia, filopodia, or membrane ruffles from the cell body (Small et al., 2002;
Lämmermann & Sixt, 2009). There are high levels of actin in the peripheral region of the growth
cone (Letourneau, 1983; Challacombe et al., 1996). The actin in the growth cone is a dynamic
structure that is constantly reforming and expanding in precise directions, allowing for the
elongating axon to move and change as needed during outgrowth. Growth cones promote neuron
elongation through the expansion of cytoplasmic space (Letourneau, 1979; Challacombe et al.,
1996). This expansion is generated by tensile force created by the polymerization of acting
filaments (Symons & Mitchison, 1991; Carlier & Pantaloni, 2007; Kerstein et al., 2015). The
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regulation of how the growth cone expands is controlled by actin mediator proteins. Actin
nucleation is mediated by the Arp2/3 complex (Figure 1). Arp2/3 is made up of highly conserved
proteins that, when active, bind to actin and induce the formation of short actin filaments
(Svitkina & Borisy, 1999). The Arp2/3 complex is recruited to the leading edge of the growth
cone by the Rac activated SCAR/WAVE complex, which is made of up five different proteins
(Xu & Quinn, 2012; Vehlow et al., 2013). Furthermore, the Arp2/3 complex is activated by
members of the WASP family (Higgs & Pollard, 2001). In addition to growing actin filaments at
the leading edge of the growth cone, the force at the membrane is regulated by contracting
myosin (Craig et al., 2012) Myosin is also integral in the turnover of actin for later use (Wilson
et al., 2010; Craig et al., 2012). All of these proteins serve as precise regulatory machinery to
control the actin dynamics at the growth cone, thus insuring the proper outgrowth of the axon to
its intended targets.
Continued axon outgrowth, and the overall function of the neuron, is maintained by axon
transport. Actin at the distal tip of the axon is eventually replaced by microtubules as the axon
continues to grow (Letourneau, 1979; Challacombe et al., 1996). These microtubules are a more
permanent structure for the neuron, and also allow for the shuttling of proteins, cargo, and
organelles up and down the axons. Proteins and organelles are transported by motor proteins like
dyneins and kinesins (Hirokawa et al., 2010; Maday et al., 2014). The importance of functional
axon transportation mechanisms is highlighted by the fact that disruption of axon transport has
been linked to neurodegenerative diseases such as ALS (Chevalier-Larsen & Holzbaur, 2006).
Some examples of the cargo and organelles transported up and down the axon includes vesicles
(Okada et al., 1995; Kamal et al., 2000), endosomes (Delcroix et al., 2003), autophagosomes
(Maday et al., 2012) and mitochondria (Pilling et al., 2006; Misgeld et al., 2007). Cargo and
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organelles having proper spatial and temporal localization is vital for the continued outgrowth
and survival of the neuron. Understanding how two of these cargo/organelles play their roles in
axon outgrowth and neuronal homeostasis will be of particular importance: autophagosomes and
mitochondria. We will discuss the movement of autophagosomes up and down the axon in a later
chapter, and instead focus on mitochondria’s role in the developing neuron.
Mitochondria move bidirectionally in the axon, and their movements are closely tied to
the outgrowth of the axon (Morris & Hollenbeck, 1993; Kiryu-Seo & Kiyama, 2019).
Additionally, mitochondrial function in neurons is closely connected to the development and
regeneration of axons (Han et al., 2016; Smith & Gallo, 2018). As an illustration of the
importance of mitochondria in axon development, mitochondrial depletion at or before the
initiation of axon outgrowth totally prevents the formation of the axon (Mattson & Partin, 1999).
Indeed, proper mitochondrial numbers at the synaptic terminal is vital for the proper
transportation of other vesicles and cargo along the axon. A lack of mitochondrial transport can
lead to dysfunctional synapses (Verstreken et al., 2005; Lee & Peng, 2008). Therefore,
mitochondrial function and localization are important for the proper development and function of
neurons. These examples of cellular migration mediators are only some of the axon outgrowth
regulators. On top of general outgrowth, there are also a multitude of regulators of axon
pathfinding and the eventual termination of outgrowth, both of which are discussed below.

1.2.2 Axon guidance and termination
Now that we have outlined the proteins and mechanisms involved in the physical
outgrowth of axons, we will shift focus to the regulators of axon guidance. Axon guidance is the
process by which axons navigate to their intended targets. This is primarily done by utilizing
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axon guidance cues. Within axons, guidance receptors function at the leading edge of the growth
cone. These receptors are used by the axon to detect either attractive or repulsive cues that act
either over long distances or locally (Figure 2; Berzat & Hall, 2010; Stoeckli, 2018). These
guidance receptors can be regulated by the neuron so that the makeup of the types of guidance
receptors at the surface of the growth cone are in sync with the direction the axon needs to grow.
As one example, mRNA transported from the cell body to the growth cone leads to the
translation of the necessary guidance receptors locally in the growth cone. This results in
alterations in receptor composition at the growth cone (Campbell & Holt, 2001; Brittis et al.,
2002). Axon guidance receptors, when acting correctly, are what allow the axon to navigate to
their final target.
Axon guidance cues can act as both attractants and repellents (Figure 2B,C). Some
examples of proteins that have evidence showing they act as attractive cues are FGF and SFRP,
which bind to the FGFR1 and frizzled guidance receptors, respectively (Shirasaki et al., 2006;
Marcos et al., 2015). Some well-known examples of proteins that act as repulsive cues are SLIT,
which binds to ROBO (Ypsilanti et al., 2010), and RGM which binds to neogenin (Monnier et
al., 2002). There are also examples of proteins that can act as both attractive and repulsive cues,
the function of which is dependent on a number of factors. Another well studied example are
netrins, which are attractive cues when binding to the neurogenin receptor, but can also act as
repulsive cues when they bind to the UNC5A netrin receptor (Sun et al., 2011). Then there is the
axon guidance roles of the pervasive developmental proteins WNT and SHH. WNT will bind
only to frizzled, while SHH binds only to BOC, and their chemotrophic effect is dependent on
the subsequent signaling cascade that is triggered by the binding of the cue to the receptor
(Charron & Tessier-Lavigne; Salinas, 2012). Finally, EPHA binds to the ephrinA receptor, but
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depending on which co-receptor is also present during EPHA binding, will either act as an
attractive or repulsive cue (Knoll, 2004; Suetterlin & Drescher, 2014). Guidance cue behavior
can depend on the receptor it binds to and/or additional modifications, and can provide an
incredible amount of complexity to the regulatory mechanisms governing axon path finding.
Axon guidance is further complicated by additional factors outside of the aforementioned
guidance cues. There are many extracellular matrix components that can affect the outgrowth of
an axon, as well as neuronal process self-avoidance, which is the neuron’s tendency to grow
axons or other branch-like structures away from one another (Kolodkin & Pasterkamp, 2013). In
addition, the proteins that mediate axon cytoskeletal restructuring are also thought to play a role
in regulating axon outgrowth. For example, in the growth cone of neurons, the Arp2/3 complex
has been shown to negatively regulate axon outgrowth, despite being a positive regulator of axon
guidance (Strasser et al., 2004). There are also axon outgrowth links to the cellular degradation
and recycling during autophagy. Autophagy is a regulator of various forms of axon outgrowth,
with some evidence of negative regulation of axon outgrowth by autophagy (Ban et al., 2013).
Other findings show that autophagy is vital for proper microtubule stabilization and it is
therefore key for axon regeneration (He et al., 2016). There will be more discussion of autophagy
and neurodevelopment in a later chapter.
Axon termination is simply the growing axon’s ability to stop its growth at a specified
place and time (Figure 2D). Defects in axon termination are marked by overextended axons and
are often coupled with weakened synaptic function (Wan et al., 2000; Wu et al., 2005; Grill et
al., 2007; Borgen, M. et al., 2017). While the regulators of axon outgrowth are relatively well
characterized, there is far less known about the ability of neurons to stop their axon outgrowth at
the appropriate location. Axon termination has its own mechanisms and regulators to consider,
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but many of these mechanisms and regulators remain to be identified. PAM/Highwire/RPM-1
(PHR) is one of the most studied axon termination regulators and is highly conserved in multiple
organisms (Zhen et al., 2000; Borgen, M. et al., 2017). Most other known regulators of axon
termination function in conjunction with or on the same targets of PHR (Tulgren et al., 2011;
Tulgren et al., 2014). In C. elegans, RPM-1 has established a signaling pathway made up of well
conserved proteins. RPM-1 acts upstream of two parallel pathways: the GLO-4 pathway (Grill et
al., 2007) and the FSN-1 pathway (Liao et al., 2004). The RPM-1+FSN-1 ubiquitin ligase
activity targets DLK-1, which activates a MAP kinase pathway that leads to the activation of P38
(Liao et al., 2004; Nakata et al., 2005). The parallel GLO-4 pathway is downstream of RPM-1
and works to activate the Rab GTPase GLO-1, which then promotes vesicular trafficking via late
endosomes (Grill et al., 2007). These pathways govern the axon’s ability to terminate its growth,
and subsequently undergo synaptogenesis with its appropriate targets (Figure 3; Grill et al.,
2007). These studies provide substantial evidence that axon termination is indeed governed by
unique regulators that are separate from those controlling axon guidance or synaptogenesis.
However, cross talk between the signaling pathways show how these axon termination
mechanisms can influence and be influenced by other mechanisms.
Axon termination and its regulators have influence on and are influenced by neuron
function and circuit formation. In zebrafish, the PHR homolog Esrom has roles in the proper
organization of the visual system (D'Souza et al., 2005), and in mice, PHR-1 functions to
regulate synapse formation for the neuromuscular junction and sensory neurons (Burgess et al.,
2004). Axon termination also has close ties to axon guidance and repulsive cues, as well as the
regulation of cargo transport up and down the axon, as is evidenced by RPM-1 being involved in
growth cone integrity and microtubule stability (Borgen, M.A. et al., 2017). Further research will
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need to be performed in order to identify additional mechanistic intricacies and specific targets of
the axon termination regulators. Since there are limited findings regarding the regulators of axon
termination, we also do not fully understand what role dysfunctional axon termination may play
in neurodevelopmental disorders. As we learn more about the mechanisms governing axon
development and termination, we will gain a better understanding of how disruptions of these
mechanisms can lead to neurodevelopmental disorders. We will now shift our focus to one
particular component of functional neurons; voltage gated calcium channels.

1.3 Voltage gated calcium channels and neurodevelopment
1.3.1 General function of calcium channels
Voltage gated calcium channels (VGCC) function to control the amount of calcium that
is allowed to enter the neuron. Like other neuronal ion channels that exist on neurons, VGCCs
respond to action potentials, as well as contribute to the membrane potential that triggers action
potentials of the neuron (Catterall, 2000; Bender et al., 2010). Calcium ions are not only
important for the regulation of membrane potentials, but also play roles as important signaling
molecules (Clapham, 2007). The opening of VGCCs results in an influx of calcium, which
ultimately leads to elevated intracellular calcium (Wadel et al., 2007). The tight regulation of the
activation of VGCCs thus results in specific spatial-temporal intracellular calcium transients that
trigger a wide range of calcium-dependent processes. These processes include neurotransmitter
release, neurite outgrowth, gene transcription, and the activation of signaling enzymes such as
calmodulin-dependent protein kinase II (CaMKII) and protein kinase C (PKC) (Wheeler et al.,
1994; Wheeler et al., 2008; Wheeler et al., 2012). When a VGCC protein is mutated in a way
that increases its permeability to calcium transients to lower the threshold for activation, or
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increase the rate of inactivation of the channel, it is considered a gain of function mutation
(Splawski et al., 2005; Laine et al., 2014). When the opposite occurs, and a mutation results in a
constitutively inactive or difficult to activate channel, then it is considered a loss-of-function
mutation (Templin et al., 2011).
There are three general families of VGCCs that share conserved functions across many
organisms, each differentiated by their pharmacological and biophysical properties. They are Ltype, P/Q type, and T-type channels (Catterall, 2011). In humans, the P/Q type channel can be
further divided into R-type and N-type calcium channels (Catterall, 2011). The L-type calcium
channels are characterized by their long-lasting activation (Catterall, 2000). The L-type calcium
channels are important for muscle contraction, endocrine secretion, gene transcription, synaptic
activity, neuronal function, and neuronal development (Catterall, 2000; Felizola et al., 2014;
Kamijo et al., 2018). T-type calcium channels are known for their low voltage threshold for
activation, as well as their fast voltage-dependent inactivation allowing for repetitive firing of
action potentials (Catterall, 2011). The rhythmic action potentials generated by T-type calcium
channels make them essential in the proper function of cardiac muscles, as well as dopaminergic
neurons (Catterall, 2011). The P/Q-type calcium channel is a high-voltage-gated calcium channel
important for neuronal excitation and the release of neurotransmitters (Bourinet et al., 1999;
Ishikawa et al., 2005). The P/Q-type calcium channels are primarily expressed in the neurons of
the central nervous system (Bourinet et al., 1999). The similar R-type and N-type calcium
channels are also high-voltage-activated channels (Williams et al., 1992; Soong et al., 1993). The
R-type calcium channels have roles in the cortex, hippocampus, striatum, and amygdala (Parajuli
et al., 2012). The N-type calcium channels are also important in the nervous system, but also
have known roles in the kidney and the heart (Adams & Berecki, 2013).
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VGCCs differ in physical organization and number of subunits depending on their type
and function, but each subunit of the VGCC are organized in a similar manner. The subunits
consist of the alpha-1 subunit, the alpha-2-delta subunit, the beta subunit, and sometimes the
gamma subunit (Figure 4; Catterall, 2011). The alpha-1 subunit is the pore forming subunit that
spans across the membrane of the neuron and physically allows for the influx of calcium into the
cell (Catterall, 2000). The alpha-1 subunit is composed of four domains that are made up of six
transmembrane segments linked to each other by cytoplasmic loops (Catterall, 2011). L-type and
P/Q-type VGCCs are also made up of extracellular alpha-2-delta subunit and cytosolic beta
subunit, which are considered auxiliary subunits (Buraei & Yang, 2013; Dolphin, 2013). Alpha2-delta subunits are vital for the proper localization of VGCC, in addition to affecting the
biophysical properties of the channels, such as influencing the voltage sensing capabilities and
inactivation rates of the channels (Felix et al., 1997; Qin et al., 1998; Sipos et al., 2000; Davies et
al., 2006; Davies et al., 2010; Dolphin, 2013). Interestingly, there are likely additional roles for
the alpha-2-delta subunits independent from the calcium channel complex, such as influencing
synaptic morphogenesis (Eroglu et al., 2009; Kurshan et al., 2009; Dolphin, 2012). These listed
functions of the alpha-2-delta likely vary depending on the type of VGCC and location in the
organism (Dolphin, 2013). The beta subunit is important for delaying VGCCs from being
flagged for degradation by the proteasome (Altier et al., 2011; Waithe et al., 2011). Beta subunits
also function to promote proper trafficking of the VGCC to the plasma membrane (Pragnell et
al., 1994). Finally, there are gamma subunits which are inconsistently present in the VGCC
complex (Dolphin, 2013). The gamma subunit plays a role in the activation and inactivation
properties of the VGCC, as well as influencing cellular trafficking (Wei et al., 1991; Chen et al.,
2000; Burgess et al., 2001).
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1.3.2 Calcium channels in neurodevelopment
VGCCs play a vitally important role in the development of neurons. As previously
mentioned, VGCCs have roles beyond regulating membrane potential, including the activation of
a variety of signaling cascades (Clapham, 2007). Specifically, calcium signaling has been shown
to modulate the length of neurites in a variety of neuron types (Gomez & Spitzer, 1999; Wayman
et al., 2008; Takemoto-Kimura et al., 2010). Likely related, calcium signaling also has roles in
growth cone motility (Zheng, 2000; Henley & Poo, 2004). Additionally, VGCCs give rise to
spontaneous fluctuation in intracellular calcium concentration during development (Tang et al.,
2003), although the specific molecular details of this phenomenon remain elusive. One way to
study the specifics in spontaneous regenerative calcium transients (SRCaTs) during neuronal
development is to test VGCC mutations. Indeed, Mutations in VGCC genes have been associated
with various neurodevelopmental disorders such as autism and schizophrenia (Ripke et al., 2011;
Lee, S.H. et al., 2013; De Rubeis et al., 2014; Purcell et al., 2014). Such mutations have been
recently shown to have observable effects on the SRCaTs as well as the overall development of
individual neurons. In the developing neurons of mice, knocking out L-type VGCCs result in
shorter axons and dendrites (Kamijo et al., 2018). Moreover, inducing gain-of-function
mutations in L-type calcium channels during perinatal development in mice impaired cortical
radial migration, and reversing the gain-of-function postnatally rescued this phenotype (Kamijo
et al., 2018). The role of the spontaneous opening of VGCCs in neural development remains an
important area of study. Mutations in VGCC genes is a logical place to continue investigating the
neurodevelopmental roles of VGCCs. In the next section, we will shift focus back to ASD and
how the many regulators of neuronal development have been tied to ASD.
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1.4 Axon development as it relates to ASD, relevant genes and mechanisms
ASD is primarily a neurodevelopmental disorder with symptoms deriving from changes
in brain function. It is pertinent to look at how the development of neurons in the brains of
patients with ASD are different, and what mechanisms might be involved. Excess neurogenesis
has been observed in patients with ASD, with 67% more neurons detected in the prefrontal
cortex (Courchesne et al., 2011). Recent studies utilizing functional MRIs (fMRIs) to view the
structures of the brains of those with ASD and those without have shed light on the
morphological changes in the brain (Just et al., 2004; Just et al., 2007; Schipul et al., 2011). In
addition, regions of abnormal neuronal positioning of cortical projection neurons have been
observed in patients with ASD (Wegiel et al., 2014). Abnormal lamination of neurons has been
detected in the cortex of brains in patients with ASD (Stoner et al., 2014). These are examples of
concrete ties to neurodevelopmental defects that are observable in the brains of individuals with
ASD. Besides ties to the physical changes in the brains and neurons of ASD patients, there are
plenty of genetic ties to neurodevelopmental regulators.
There are a few examples of genes identified in higher frequencies in patients with ASD
that also have ties to proper neuronal migration. RELN, a large secreted glycoprotein, is a
mediator of axon termination and is vital for proper neuronal layering and the morphology of
neurons (Falconer, 1951; D'Arcangelo et al., 1995; Hong et al., 2000). Studies have found
abnormal RELN in brain samples of individuals with ASD (Persico et al., 2001; Bonora et al.,
2003; Fatemi et al., 2005). There are also studies that show mutations within the AUTS2 gene
occurring in patients with ASD (Liu et al., 2015). The AUTS2 gene encodes a protein that is part
of a protein complex that maintains the repressed state of certain genes during brain development
(Bedogni et al., 2010; Gao et al., 2014), and has been shown to regulate cortical neuronal
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migration during axon outgrowth (Hori et al., 2014). CNTNAP2, which encodes a cell adhesion
glycoprotein, is another such gene identified in a population of patients with ASD that also has
potential roles in the proper migration of neurons (Strauss et al., 2006). There are also
connections between ASD and genes that are associated with specific symptoms or neurological
changes. This includes genes such as PTEN, encoding an enzyme vital for cell migration and
apoptosis, and has been associated with macrocephaly in ASD (Orloff et al., 2013; Weston et al.,
2014). There is also CHD8, encoding a calcium dependent cell adhesion protein, and has been
associated with macrocephaly (Bernier et al., 2014). Finally, patients with mutations in the
transcription factor encoding ARX gene display ASD-like symptoms along with epilepsy
(Stromme et al., 2002; Turner et al., 2002). While these genetic connections exist, the affected
mechanisms that lead to the development of ASD are unknown. Based on the statistical evidence
alone, the mechanisms that are likely affected by mutations that lead to the development of ASD
are numerous. It is also likely, due to the polygenic nature of ASD, that the development of ASD
is the result of a combination of mutations and thereby multiple neurodevelopmental mechanism
could be affected. Unfortunately, because of these genetic complexities, hard evidence linking
specific mechanisms to ASD is difficult to establish.
As was the case in identifying many of the above genes, one way that we can determine
the specific mechanisms affected by ASD is through the examination of the genetic data
regarding ASD. An example of this is the recent connection of various missense mutations of the
WDFY-3 gene being associated with ASD (Iossifov et al., 2012; Iossifov et al., 2014). WDFY-3
encodes WD repeat and FYVE domain containing protein 3 (WDFY-3), which is also known as
autophagy linked FYVE protein (ALFY). WDFY-3 is a selective autophagy related protein, and
thus gives us an additional clue as to which specific mechanisms are being affected in ASD.
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WDFY-3 also has known roles in regulating axon outgrowth (Iossifov et al., 2012; Orosco et al.,
2014; Dragich et al., 2016; Napoli et al., 2018). This selective autophagy connection with ASD
and neurodevelopment will be further explored in a later section. The next section covers the
many genetic connections to ASD that have recently been uncovered. The understanding of these
genetic associations with ASD will be incredibly useful in uncovering the many mysteries still
surrounding the development of ASD.

1.4 Autism Genetics Background
The identification of genetic markers has become a heavy focus in ASD research, and the
importance of genetics in the development of ASD cannot be overstated. Since the first
characterization of ASD, diagnosis has relied on the identification of specific symptoms. These
symptoms may be detectable as early as 18 months of age, but the most common age of an ASD
diagnosis is at 2 years or older (Lord et al., 2006). With the development of large-scale genomewide analysis, as well as more advanced tools for individual gene analysis, the rate of discovery
and characterization of key genetic markers for ASD has accelerated (De Rubeis et al., 2014;
Iossifov et al., 2014; RK et al., 2017; Grove et al., 2019). There is still much to uncover
regarding the genetic contributions and polygenic nature of ASD (Chaste et al., 2017). Moreover,
the exact nature of the mechanisms involved in the development of ASD remain unknown.
However, the thorough identification and characterization of the genetic causes of ASD would
not only improve the efficiency of diagnosis and subsequent treatment outcomes, but would also
shed light on the cellular mechanisms that underlie ASD. This would greatly increase our
understanding and ability to treat the disorder.
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Depending on the metrics utilized, ASD is estimated to be caused by genetic factors in
56% - 95% of the cases (Colvert et al., 2015). Twin studies place the heritability of ASD to be on
the higher side, with older studies indicating heritability around 90% (Steffenburg et al., 1989;
Bailey et al., 1995), and newer studies place heritability at 83% (Sandin et al., 2017). Regardless
of the exact percentage, the genetic association to ASD is very high, suggesting that disruptions
in a neurodevelopmental mechanism due to genetic changes is a certain contributor. Therefore,
elucidating the genetic interactions and variations that lead to ASD is of great importance if we
are to have any hope in understanding ASD. In this literature review, the different types of
genetic data available on ASD will be discussed, while outlining the existing gaps in the
literature. The three major categories of autism heritability are 1) common variants identified by
genome wide association studies (GWAS), 2) rare de novo likely gene disrupting (LGD)
mutations, and 3) missense mutations that are found in higher frequency in ASD patients. It is
important to note that a causative role of missense mutations in ASD is difficult to establish, and
therefore the role of these mutations remain poorly understood. This will establish a pretext for a
discussion of the polygenic component of ASD inheritance, and the difficulties these genetic
interactions create.

1.5 Common Variants
Common variants account for most of the heritability of ASD (Gaugler et al., 2014).
These common variants are identified through the utilization of GWAS studies. GWAS studies
provide extremely useful analyses of the entire genome across a large population of people.
When using GWAS to study ASD related loci, the general approach is to take a population of
individuals with ASD and scan their genome to find the genetic variations that they share. These
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genetic variations are compared to those in a random control population of the same general
traits without ASD. Researchers can compare variants between different types and severities of
ASD, such as severe ASD compared to high functioning ASD. Additionally, GWAS can be used
to compare the common variants identified in ASD to those identified in other
neurodevelopmental disorders. Indeed, many of the genetic variants identified as indicators of
ASD are shared with other neurodevelopmental disorders. For example, schizophrenia and major
depression have shared loci identified through GWAS (Li et al., 2015; Grove et al., 2019). These
shared loci might be comprised of conserved regions of genes important for the proper
development of neurons or are indirectly related to a mechanism governing the development of
the brain. However, it is important to note that without a large enough population or the use of
proper statistical methodology, narrowing down the significant loci can be difficult, and make it
almost impossible to identify individual genes of significance.
One difficulty in using GWAS to study polygenic disorders is that the original models
used to analyze the genomic data did not take into consideration the effect of many heterozygous
genes or other small genetic variants that create polygenicity. The use of polygenic scoring
systems and analyses, such as linkage disequilibrium (LD) score regression analysis (BulikSullivan et al., 2015) and polygenic risk score (PRS) analysis (Dudbridge, 2016), allow for
comparison of gene variants in a population while distinguishing true polygenic signals from
inflated distribution of test statistics. Utilizing these systems, the genetic variant candidates can
be further narrowed down, which has led to a number of new discoveries that were otherwise
buried beneath background noise (Grove et al., 2019). Once these significant “risk variants” for
ASD have been established, they can be used for clinical screening, proper genetic counseling,
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and treatments. These common risk variants must then be further studied to better understand
ASD and the mechanisms involved in the rise of the disorder.
When common genetic variants are identified, further research is needed in order to
elucidate the true mechanism behind the gene’s role in the development of ASD. The type of
mutation that is typically identified by GWAS are intergenic, which are non-coding regions of
DNA that do not encode for proteins. Most of the intergenic regions of DNA have no known
function, but these regions can contain sequences of DNA that have a regulatory function for
other genes (Dunham et al., 2012). Some specific risk variants in genes that have been identified
through GWAS studies and then examined for their association to ASD include variants in
calcium voltage-gated channel subunit alpha1 C (CACNA1C), which encodes the alpha-1
subunit of the L-type calcium channels in mammals (Lu et al., 2012; Li et al., 2015). Many of
these variants of CACNA1C incur risk of schizophrenia, (Li et al., 2015), as well as bipolar
disorder (Ferreira et al., 2008). Intergenic regions of DNA that regulate CACNA1C have been
identified as risk factors for other neurodevelopmental disorders such as schizophrenia (Roussos
et al., 2014), so it is likely that the intergenic variants identified via GWAS may regulate genes
with well-established connections to ASD. Another example of a gene identified via GWAS that
is a well-known common variant for ASD is the CNTNAP2 gene, which encodes the cell
adhesion glycoprotein CASPR2 (Canali et al., 2018). Further studies into CASPR2 show that it
plays a role in axon development and is thought to contribute to autism through selective
mechanisms (Canali et al., 2018). These studies show the value of GWAS studies in identifying
genes that are key contributors to the development of ASD.
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1.6 De novo likely gene disrupting mutations
While there is a plethora of evidence regarding the contribution of common variants as a
major cause of ASD, severe de novo mutations are a large factor in the development of ASD.
Rare, likely gene disrupting (LGD) mutations that contribute to ASD are those expected to
completely remove gene function, and can be frameshift, nonsense, or deletion mutations
(Iossifov et al., 2012). Often these LGD variants exist in one allele in individuals, supported by
the evidence of high levels of heterogeneity in individuals with such mutations (Iossifov et al.,
2014). The percentage of cases of ASD that are attributed to de novo LGD mutations are
estimated to be around 15-20% (Iossifov et al., 2012). While these rare variants can be passed
down from a parent (Gaugler et al., 2014), they most often appear de novo in the individual
without the mutation being in the genomes of the parents. Unlike the common variants discussed
above, many of which actually follow a pattern of positive selection (Polimanti & Gelernter,
2017), the more severe phenotypes caused by LGD mutations are less likely to be passed down
and are therefore more likely to occur de novo within the germline. Indeed, the categorization of
rare de novo LGD mutations as heritable has been a point of inconsistency within the scientific
community. While the nomenclature of de novo mutations makes it clear that these mutations in
individuals are not truly inherited from the parent, but instead arise in the germline as a new
mutation, these mutations can still be passed down from an individual to their progeny.
Regardless, the de novo mutations that are discussed below are, at their most basic level, altered
genes in an individual that arose independent from the parents, and have been shown to
contribute to the development of ASD. Therefore, these rare de novo LGD mutations are vital to
study and understand. In fact, rare genetic variation leads to a higher individual risk to develop
ASD than common variants (Gaugler et al., 2014; Alonso-Gonzalez et al., 2018), despite only
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making up around 15-20% of the cases of ASD (Iossifov et al., 2012). The significant
contribution of de novo LGD mutations to the pathogenesis of ASD exemplifies the complex
nature of its development. One of the examples of de novo LGD mutations that has been
associated with ASD is CACNA1C (Lu et al., 2012), where a severe form of ASD known as
Timothy syndrome is known to be caused by a rare mutation in the CACNA1C gene (Boczek et
al., 2015). Some de novo mutations in the WDFY-3 gene are also associated with the
development of various forms of ASD (Iossifov et al., 2012). These de novo LGD mutations are
powerful contributors to ASD, but are just a piece of a complex disorder associated with multiple
genetic variants, including the more subtle missense mutations.

1.7 Missense mutations
In contrast to LGD mutations, individual missense mutations tend to have smaller effects.
However, when missense mutations exist in multiple ASD related genes, or when they occur
simultaneously with LGD mutations, then the effects can cause dramatic phenotypes (Stein et al.,
2013; Guo et al., 2018). Not all missense mutations are the same, as some (including the
CACNA1C mutation resulting in Timothy syndrome) can lead to gain-of-function effects that can
cause severe ASD all on their own (Splawski et al., 2004; Napolitano & Antzelevitch, 2011;
Diep & Seaver, 2015). For the sake of differentiating the missense mutations from other
previously discussed genetic variants, the focus will be on less potent mutations that are still
associated with ASD. It is important to note that missense mutations associated with ASD were
identified because they were more prevalent in affected individuals than in controls. Therefore, it
is difficult to know if these ASD associated missense mutations actually contribute to ASD. The
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Timothy syndrome mutation is one of the few missense mutations where there is strong evidence
that it causes ASD (Boczek et al., 2015).
There are a few missense mutations that have strong connections to ASD. One family of
proteins that has been strongly associated with ASD is the SHANK proteins. The SHANK
family of proteins are scaffolding proteins that regulate the development and organization of
synapses (Naisbitt et al., 1999; Grabrucker et al., 2011). Various missense mutations in SHANK1
have been found in individuals with ASD (Sato et al., 2012; Gong & Wang, 2015). SHANK3 has
more recently been implicated in the development of ASD, with missense mutations being the
focus of a number of studies (Wang et al., 2019). As another example, a NLGN-4 missense
mutation has been associated with ASD (Zhang et al., 2009). NLGN-4 is a postsynaptic adhesion
protein that controls the development and function of synapses (Varoqueaux et al., 2006; Hoon et
al., 2011). While missense mutations of these families of proteins have been shown to be
associated with the development of ASD, it is the collective effect of all the genetic variants that
contribute to the symptoms of ASD.

1.8 Polygenic and gene interactions in autism
As established in the previous sections, research has shown that the clinical presentation
of ASD is the result of polygenic factors, meaning it is the result of the combined action of
multiple genetic variations (Niemi et al., 2018). There are many examples of polygenic
inheritance influencing the risk of developing ASD. For example, de novo single nucleotide
variants combined with nonsense mutation can confer five times the individual risk relative to
carrying a single copy number variant (Stein et al., 2013). Epigenetic factors contributing to
ASD have also been identified and add an additional layer of complexity to studying the disease
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(Siu & Weksberg, 2017; Hannon et al., 2018). Indeed, differential methylation of genes increases
the polygenic burden of ASD (Hannon et al., 2018). Additionally, GWAS studies are difficult in
part due to the original models used to analyze the genomic data not taking into consideration the
effect of many heterozygous or other small genetic effects that create polygenicity (Grove et al.,
2019). As mentioned above, novel statistical models have been helpful in elucidating the less
significant genetic variants (Grove et al., 2019). This will prove vital, as understanding the
additive effects of small genetic changes are equally important in understanding the various
individual variants that cause more severe symptoms on their own. Even though a few gene
variants have stood out as primary contributors to certain forms of ASD (Splawski et al., 2004;
Bader et al., 2011), it is clear that factors outside of these gene variants influence the severity of
the symptoms. All of these examples demonstrate how difficult it is to pinpoint specific
contributors to the development of ASD.
One of the most difficult parts of studying ASD is the fact that it is a polygenic disorder.
The genetic component of ASD is complex and diverse. The disorder could be caused by a
combination of mutations inherited by a parent or that arise de novo, and the number of genetic
variations is staggering (De Rubeis & Buxbaum, 2015; Sanders et al., 2015). There are many
genes that have been associated with ASD, with the number increasing depending on the criteria
used to implicate a gene, but we still do not know how they interact with each other. This makes
ASD difficult to study, as direct links between the genetic mutations and specific effects that lead
to ASD are difficult to discern. Ultimately, the complexities of the disorder make the specific
molecular mechanisms that underlie ASD elusive.
Another factor causing yet more complications in understanding ASD is the wide
spectrum of symptom severity due to polygenic factors and the large number of gene variants
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that likely contribute to ASD. Where one person can have mild symptoms that may go
undetected for a long period of time, others are severe enough to warrant lifelong care and cause
non-neural complications (Splawski et al., 2005; Jacquemont et al., 2014). This can make
reaching broad conclusions about ASD difficult. This differing symptom severity is likely a
result of the polygenicity of ASD, the large multitude of genetic variants, and complexity of the
genetic interactions that contribute to the disorder. Monogenic causes of ASD are few and far
between, making monogenic models for study hard to develop. It would be incredibly useful to
have a model that utilizes the more severe genetic variants, preferably a monogenic variant, in
order to understand the mechanisms underlying ASD.
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Chapter 1 Figures:

Figure 1: Diagram of how Arp2/3 complex nucleates a branched network of actin filaments
that produce a tension force at the growth cone membrane.
Actin nucleation is mediated by the Arp2/3 complex. ATP globular (G)-actin monomers are then
recruited to polymerize into long filamentous (F)-actin structures. Further nucleation of F-actin
can occur along growing F-actin strands that polymerize perpendicular to the original strand,
resulting in a branched like structure. These polymerizing F-actin strands push against the
membrane produce the force that drives cell elongation and migration.
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Figure 2: Diagram of axon outgrowth and guidance.
(A) Axon outgrowth is the process by which the axon extends away from the cell body, with the
dynamic capabilities lying within the growth cone. (B) Repulsive cues will bind to receptors at
the growth cone in order to direct the growth of the axon away from the repulsive cue. (C)
Attractive cues can also bind to receptors at the growth cone, but instead instruct the axon to
grow towards the attractive cues. (D) The final step in the axon outgrowth process is axon
termination, where the axon extension stops, and connections are formed with the neuron’s
intended targets.
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Figure 3: Model of the RPM-1 pathway.
RPM-1 is an E3 ubiquitin ligase containing an N-terminal RCC1-like GEF. It forms a complex
with the FSN-1 f-box protein in order to promote the ubiquitination of the MAPKKK known as
DLK-1. The DLK-1 pathway ultimately regulates the p38 MAPK which is involved in cell
differentiation. Overall, the FSN-1 pathway leads to the regulation of endosomal and activity
necessary for synaptogenesis. RPM-1 also interacts with GLO-4 to regulate the GLO-4 pathway,
which runs in parallel to the FSN-1 pathway. GLO-4 is a guanine nucleotide exchange factor
(GEF) which activates its downstream target GLO-1, a rab GTPase responsible for proper vesicle
formation. The GLO-4 pathway ultimately regulates AP-3, which is predicted to be involved in
the formation of vesicles and the biogenesis of lysosomes (Grill et al., 2007). Overall, the GLO-4
pathway leads to the regulation of vesicular transport and late endosomal/lysosomal activity
25

necessary for axon termination. Mammalian homologs to the C. elegans RPM-1 pathway are
reported adjacent to the RPM-1 pathway members in parentheses.
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Figure 4: Diagram of a voltage gated calcium channel with alpha-1, alpha-2-delta, beta,
and gamma subunits.
Example of a voltage gated calcium channel with all common subunits. The apha-1 subunit is the
pore forming subunit that physically allows for calcium to enter the intracellular space when the
channel is active. The alpha-2-delta subunit is responsible for the proper localization of the
alpha-1 subunit, as well as a regulator of various biophysical properties of the channel such as
the voltage sensing capabilities. The beta subunit is important for preventing VGCCs from being
flagged for degradation by the proteasome. Beta subunits also function to promote proper
trafficking of the VGCC to the plasma membrane. Finally, there are gamma subunits which are
inconsistently present in the VGCC complex. The gamma subunit plays a role in the activation
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and inactivation properties of the VGCC, as well as influencing cellular trafficking (Dolphin,
2013).
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Chapter 2 – Autophagy and Neurodevelopmental Disorders

2.1 Autophagy overview
Autophagy deals with the destruction of aged, damaged, misfolded, or otherwise
unwanted cellular components within the cell. Autophagy maintains the homeostasis and normal
functioning of a cell through the degradation and subsequent turnover of these old, aggregated,
or simply non-functional proteins and cell organelles. The digested proteins and organelles are
then recycled to create new intracellular components (Levine & Kroemer, 2008; Mizushima &
Komatsu, 2011; Levine & Kroemer, 2019). The basic molecular mechanisms of autophagy have
been well characterized. However, current research continues to identify proteins with previously
unknown functions related to the different forms of autophagy. Moreover, while the existence of
autophagy has been known for decades, its importance in the functioning cell and the
overarching mechanisms affected by autophagy remain poorly understood. Studies of various
diseases, developmental disorders, and degenerative disorders have implicated autophagy as a
key part of their pathogeneses, and the results help uncover cellular processes and mechanisms
where autophagy plays a role (Cushman et al., 2010; Iossifov et al., 2012; Lee, K.-M. et al.,
2013). Indeed, the number of recent findings on malfunctioning autophagy leading to such
detrimental disorders underscores the incredible importance of autophagy in organismal
development, health, and physiology.
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2.2 The molecular mechanisms of general autophagy
2.2.1 Autophagy Basics
There are two major forms of autophagy that will be discussed: general autophagy and
selective autophagy. Among the forms of general autophagy are macroautophagy and
microautophagy. Macroautophagy is a bulk degradative pathway that generally occurs in the
cytosol (Levine & Kroemer, 2008). Most research on autophagy focuses on this form of
autophagy.
The process of general macroautophagy starts with the formation and elongation of a
membrane known as the phagophore. The phagophore will continue to elongate around
cytoplasmic material until the ends meet and fuse. This results in a sealed, large double
membrane bound vesicle, known as the autophagosome, which at this stage has fully formed
around the material to be degraded. The pathway ends with the autophagosome fusing with a
lysosome, which creates the autolysosome, where the contents are finally degraded via lysosomal
enzymes (Figure 5; Levine & Kroemer, 2008).
Microautophagy, although less understood, involves direct uptake of cargo into
lysosomes for degradation. Microautophagy typically occurs in order to degrade soluble
components. This uptake of the soluble components occurs through direct invagination of cargo
into the lysosomal lumen (Figure 6; Kunz et al., 2004; Uttenweiler & Mayer, 2008).

2.2.2 Mediators of General Autophagy
Autophagy is mediated by a group of highly conserved proteins, many of which are
encoded by ATG (autophagy related) genes (Klionsky et al., 2003). In yeast, a structure known as
the pre-autophagosomal structure (PAS) is where nearly all the ATG proteins co-localize (Suzuki
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et al., 2001). There are likely similar structures in mammals (Itakura & Mizushima, 2010),
although none have been concretely identified. The core proteins responsible for autophagosome
formation are as follows, using the human versions of these proteins. The initial creation of the
membranes that subsequently form the autophagosome requires activation of the ULK1/2-ATG13 complex and the PIK3C3-BECLIN1 complex (Mizushima et al., 1998). ATG9A and VMP1
localize to the phagophore membrane and are thought to add membrane to the growing
autophagosome (He et al., 2008; Yamamoto & Yue). The bulk of the elongation of the
membranes is then attained by two conjugation steps, which are the formation of an ATG-12–
ATG-5 conjugate and the formation of the LC3- PE conjugate (Mizushima et al., 1998; Ichimura
et al., 2000; Kirisako et al., 2000). Finally, the accumulation of LC3-PE conjugate on the
membrane is vital for the proper closure of the membrane (Figure 7; Nair et al., 2010).
The fusion of autophagosomes to the lysosome is also tightly regulated. One well
characterized component of the autophagosome-lysosome fusion is the SNARE complex.
Among the SNARE proteins are STX17 and SNAP-29, both of which are localized to the
autophagosome and form a complex with VAMP8, which is localized to the lysosome (Itakura et
al., 2012). The trans-SNARE protein complex forms, which drives the membrane fusion and
subsequent creation of the autolysosome. Another layer of regulation at this step in the
autophagy pathway has been recently discovered. cac, a Drosophila homolog of the CACNA1A
P/Q alpha subunit gene, is required for the normal progression of autophagy in neurons (Tian et
al., 2015; Wang, Y. et al., 2016). Moreover, it was found in mouse neurons that CACNA1A
localizes to lysosomes and promotes fusion of lysosomes and autophagosomes (Tian et al.,
2015). It is thought that this calcium channel-dependent mediation of autolysosome formation is
tied to the calcium activation of the SNARE complex. Studies have indicated that calcium
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activation of the SNARE complex can promote fusion of autophagosomes and lysosomes (Figure
7; Wang, Y. et al., 2016). This pathway of autophagic regulation has yet to be fully understood,
but the evidence demonstrates the existence of an intricate system of regulators to control where
and when autophagy takes place, showcasing that macro-autophagy may be more selective than
previously thought.

2.3 The molecular mechanisms of selective autophagy
2.3.1 Selective autophagy overview
The molecular mechanisms governing macroautophagy described above focus on the
creation of autophagosomes around cytoplasmic cargo to be degraded by a subsequent fusion of
the autophagosome with a lysosome. For a long time, it was thought that this relatively
indiscriminate form of autophagy (often referred to as bulk autophagy) was the primary form of
autophagy, with selective forms of substrate degradation being left to the likes of proteasomes.
However, evidence of autophagy in maintaining cellular homeostasis begged the question of how
autophagic pathways would selectively degrade unwanted substrates, while disregarding new
and functional substrates, in order to maintain a homeostatic balance within the cell. The second
category of autophagy that will be discussed is selective autophagy. Selective autophagy
introduces a component to the autophagy pathway that allows the cell to choose specific cellular
components to be degraded. In more recent years, research focused on selective autophagy has
uncovered multiple pathways for autophagy to precisely target and degrade specific cellular
materials.
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2.3.2 Chaperone mediated autophagy
One of the most well-known forms of selective autophagy is chaperone-mediated
autophagy (CMA). CMA can be described as the direct targeting and degradation of soluble
cytoplasmic proteins that have a specific target sequence that is recognized by a chaperone
protein (Cuervo, 2011; Kaushik & Cuervo, 2012). Chaperone proteins recognize specific
pentapeptide motifs, known as the KFERQ-motif, on target proteins that allow for binding
between the chaperone protein and the target protein (Fred Dice, 1990). These pentapeptide
motifs are recognized based on their physical properties rather than their individual amino acid
sequence (Fred Dice, 1990). The ability of the CMA pathway to select for old or misfolded
proteins lies in the fact that, when properly folded, the KFERQ-motif is located inside the protein
core, and it only becomes exposed to chaperone proteins if the protein undergoes some sort of
unfolding or modification. Moreover, if the KFERQ-motif is located at the linker region between
subunits, excess unassembled proteins can be eliminated via CMA (Wang et al., 2015). It has
also been shown that the overall number of KFERQ-motifs on a protein does not influence the
rate at which CMA selects and degrades such proteins (Massey et al., 2006; Dice, 2007). In
summary, it is the specific condition of the substrate that allows for the selection of the substrate
by CMA, not simply the presence or number of KFERQ-motifs located on the substrate.
It has been stated that HSC70 is the only chaperone protein known to function in
substrate targeting for CMA (Chiang et al., 1989). However, co-chaperones such as BAG1,
HSC40, HSC90, and HSC70-HSP90 organizing protein have been shown to interact with the
substrate-chaperone complex, and could recognize the KFERQ-motif, or at least assist HSC70 in
the CMA process (Agarraberes & Dice, 2001; Dice, 2007; Wang et al., 2015). The most basic
breakdown of the CMA system is that the KFERQ-motif of the substrate protein is recognized by
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the HSC70 which delivers the substrate protein to LAMP2A for degradation (Cuervo & Dice,
1996). LAMP2A is a transmembrane protein localized to the lysosome that delivers the substrate
into the lysosome lumen for degradation (Bejarano & Cuervo, 2010). The substrate is then
unfolded by HSC70-HSP90 and translocated across the lysosomal membrane with the assistance
of lysosomal lumen HSC70 (Bejarano & Cuervo, 2010; Kaushik & Cuervo, 2012). The substrate
is then degraded in the lysosome (Figure 8). Interestingly, LAMP2A is limiting for CMA,
meaning cells can regulate the levels of LAMP2A to upregulate or downregulate CMA, thus
assisting in the autophagy mediated homeostasis of the cell (Cuervo & Dice, 2000).

2.3.3 Selective microautophagy
It is important to note that there exist forms of microautophagy that are considered
selective autophagy. Microautophagy can lead to the selective uptake and subsequent
degradation of specific proteins and organelles (Kunz et al., 2004). If the substrate in question
contains the KFERQ motif, they can be selectively targeted to this autophagy pathway by
HSC70 (Sahu et al., 2011). Unlike CMA, selective microautophagy is not reliant on LAMP2A.
HSC70 instead binds to endosomal membrane phosphatidylserines to carry out the selective
microautophagy (Sahu et al., 2011). Moreover, the starvation-stress response has been shown to
increase selective endosomal microautophagy in Drosophila melanogaster (Mukherjee et al.,
2016). While these methods of selective autophagy do select for specific substrates for
degradation while excluding other substrates from the autophagosome, they do not take
advantage of the macroautophagic machinery available in the cell.
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2.3.4 Selective macroautophagy
Recent studies and interpretation of macroautophagy has suggested what was previously
thought to be “bulk-autophagy” is instead far more selective for its cargo. In yeast, the selective
form of macroautophagy is known as the cytoplasm-to-vacuole targeting (Cvt) pathway. Cargo
receptor proteins (CRPs) are one of the facilitators of selective macroautophagy. CRPs function
by binding specific cargo to core autophagic machinery (Figure 9; Zaffagnini & Martens, 2016).
One core autophagic component in this selective process is LC3. LC3 and its family members
are localized to the early autophagosome components, as discussed above. In the yeast Cvt,
ATG-19 acts as a cargo receptor, binding to various cargo and to LC3 (ATG-8 in yeast), thereby
facilitating the recruitment of core autophagic machinery to the bound cargo (Shintani et al.,
2002; Sawa-Makarska et al., 2014). In mammals, some cargo receptors bind to their cargos
directly, while others recognize poly-ubiquitin chains attached to the surface of cargos
(Khaminets et al., 2016). An example of a cargo receptor is SQSTM1, which mediates the
autophagic degradation of ubiquitinated aggregated protein and cytosolic bacteria (Figure 10;
Pankiv et al., 2007; Zheng et al., 2009; Seto et al., 2013). However, SQSTM1 only functions to
tag aggregated proteins at a high affinity when they are oligomerized and when there is a high
amount of ubiquitination present on the cargo, thereby increasing the selectivity of the cargo
receptor (Long et al., 2010; Wurzer et al., 2015; Zaffagnini & Martens, 2016). Another such
cargo receptor protein is NCOA4, which works to degrade intracellular iron sequestered by
ferritin (Dowdle et al., 2014; Mancias et al., 2015). Once again, only high amounts of ferritin
will be successfully bound to NCOA4 (Dowdle et al., 2014; Mancias et al., 2015), insuring that
NCOA4 is only acting on excess iron. While cargo receptor proteins are responsible for directly

35

interacting with core autophagic components and the cargo, a number of other proteins are
integral for the selection process to be successful for selective macroautophagy.
Cargo receptors are aided by adaptor proteins in order to facilitate the proper selection of
cargo. One adaptor protein of current research interest is WDFY-3. WDFY-3 is a membrane
associated selective autophagy adaptor that functions by acting as a scaffold between a CRP,
core autophagic machinery (namely SQSTM1 and ATG-5), and insoluble protein aggregates to
be degraded by autophagy (Figure 11; Simonsen et al., 2004; Filimonenko et al., 2010; Lystad et
al., 2014). WDFY-3 has been specifically associated with mitophagy, which is the selective
degradation via autophagy of old and unwanted mitochondria in the cell (Napoli et al., 2018). To
underscore the importance of WDFY-3 in cell homeostasis, WDFY-3 has been recently identified
as a genetic risk factor for multiple neurodevelopmental disorders (Iossifov et al., 2012; Orosco
et al., 2014; Kadir et al., 2016; Napoli et al., 2018). One way WDFY-3 acts in neurons to
regulate outgrowth is through the selective degradation of aggregated DVL3, a protein involved
in the WNT signaling pathway (Kadir et al., 2016). ATG-11 is another such adaptor protein that
works as a scaffold to recruit ATG proteins to cargo destined to be degraded (Delorme-Axford &
Klionsky, 2015). ATG-11 is primarily known for its role in selective degradation of
mitochondria during starvation through BCL2L13 (Kanki et al., 2009; Mao et al., 2013). The
general trend in the literature is that macroautophagy is far more selective than previously
believed, suggesting that the regulatory functions mediated by autophagy are more numerous and
more important than previously thought.
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2.4 Autophagy and cellular function
Autophagy is conserved in all eukaryotic organisms and is vital for overall cell and tissue
structure and function, as well as for maintaining organismal physiology. Indeed, there are many
diseases and disorders attributed to the malfunction of general autophagy. These include
cardiovascular disorders, neurodegeneration, and cancer (Mizushima & Komatsu, 2011). For
example, the pathology of Parkinson’s disease has several links to malfunctioning autophagy
(Levy et al., 2009; Lynch-Day et al., 2012). Autophagy also plays a crucial role in defending
against intracellular pathogens (Seto et al., 2013; Wileman, 2013). Beyond these links to tissue
health and physiology, there is evidence that autophagy has highly conserved roles in cellular
adaptation to various stressors. Autophagy is important for the mitigation of damage caused by
metabolic stress, and therefore has a role in counteracting aging (Madeo et al., 2010). Moreover,
autophagy plays a crucial role in the starvation response in cells. When starvation occurs,
autophagy in cells is induced by calcium activated ULK1/2 in order to digest unneeded cellular
substrates and provide the cells with much needed nutrients (Scott et al., 2004; Shang & Wang,
2011). While these examples of autophagic processes are focused on how the cell utilizes
autophagy during the life of the cell, there are many important roles for autophagy during the
development and differentiation of cells.
Autophagy has conserved roles in the proper development of an organism. The
developmental roles of autophagy are just beginning to be understood, but the importance and
ubiquitous nature of autophagy in development cannot be understated (Mizushima & Komatsu,
2011). There is much evidence of autophagy playing key roles in the differentiation of cells from
stem cells to differentiated cells (Boya et al., 2018). The roles of autophagy in a variety of cell
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types could be discussed, however the primary focus of the next section will be on the role that
autophagy plays in the proper development of highly specialized neurons.

2.5 Autophagy and neuronal function
Autophagy has many roles in proper neuronal function. The most obvious function of
autophagy is maintaining homeostasis and cell survival (Yamamoto & Yue, 2014; Kulkarni et
al., 2018). Autophagy in neurons is highly compartmentalized, which is important for the large
length and specialized nature of neurons (Kulkarni & Maday, 2018). The vast majority of
autophagosomes originate in the distal end of the axon and move towards the cell body
throughout the life of the cell (Maday et al., 2012). The core machinery for autophagosome
formation is similar in neurons to that in other cells, with the exception of a few neuron-specific
proteins that regulate the rate of autophagosome biogenesis (Murdoch et al., 2016; Soukup et al.,
2016; Okerlund et al., 2017; Vanhauwaert et al., 2017). One feature of autophagy that is unique
in neurons is that autophagosomes fuse to late endosomes in order to initiate the migration of the
autophagosomes toward the cell body (Maday et al., 2012; Cheng et al., 2015). Once the
autophagosomes are moving along the axon, they can fuse with lysosomes to become
autolysosomes, starting the degradative process of the cargo (Maday et al., 2012). Once the
autophagosomes are in the cell body, they are sequestered to the somato-dendritic region, where
further fusion with lysosomes can occur in order to finish degrading any cargo remaining in the
autophagosomes (Maday & Holzbaur, 2016). The majority of autophagosomes originate at the
distal end of neurons, but they can also be generated within the cell body (Maday & Holzbaur,
2016), and along the axon to perform mitophagy and other specific, local needs (Ashrafi et al.,
2014). Maintaining homeostasis of the brain also involves coordination between neurons and
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other types of cells nearby, such as glia. There is evidence that neurons will shuttle cellular cargo
to neighboring glia, consisting of cellular garbage to be degraded by the glia’s autophagic
systems (Kulkarni et al., 2018). While this intercellular coordination between neurons and glia
are outside the scope of this review, it does outline further complexities regarding autophagy
regulated cellular homeostasis within the brain. Autophagy is indisputably important for the
survival of neurons, however its importance in the proper development and function of neurons
have also been well documented.

2.6 Autophagy and neurodevelopment
Autophagy has key roles in the proper development of neurons and neuronal networks
(Shen & Ganetzky, 2009; Shen et al., 2015). One way this is demonstrated is by the axonal
outgrowth defects caused by the loss of autophagic proteins (Ban et al., 2013; Stavoe et al., 2016;
Kannan et al., 2017). Furthermore, autophagy is important in neuroregeneration (Huang et al.,
2016). One way autophagy works in neurons to facilitate proper growth and maintenance is to
stabilize microtubules through the degradation of a microtubule destabilizing protein SCG10,
which helps promote axon growth and regeneration (He et al., 2016).
Autophagy is also vital for proper neuronal signaling and synaptic function.
Autophagosomes can act as signaling conduits from the axon tip to the cell body in order to
promote specific neuronal functions, as well as prevent neurodegeneration (Kononenko et al.,
2017). This signaling is facilitated by transport of BDNF-activated TrkB receptors (Kononenko
et al., 2017). One of the ways synaptic function is reliant on autophagy is through the turnover of
synaptic cargoes, including synaptic scaffold proteins and synaptic vesicles (Wang et al., 2017;
Liang & Sigrist, 2018). These synaptic proteins include WASP and NSF (Uytterhoeven et al.,
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2015). There are additional synaptic proteins that act in the opposite manner, utilizing autophagy
to regulate synaptic function. A protein known as bassoon has a role in controlling the activity
levels of presynaptic autophagy, adding a new layer to the molecular mechanisms for synaptic
regulation by autophagy (Okerlund et al., 2017). ATG-9, endophilin-A, and SYNJ1-1 also have
roles in the regulation of synaptic function through autophagy (Soukup et al., 2016; Stavoe et al.,
2016; Vanhauwaert et al., 2017).
There are additional proteins that act through autophagy in order to facilitate other forms
of proper neuronal development and function. As mentioned previously, voltage gated calcium
channels (VGCCs) have been shown to regulate autophagosomes in promoting homeostasis in
the neurons of drosophila (Tian et al., 2015; Wang, Y. et al., 2016). These same studies placed
the localization of the VGCC proteins on the membrane of lysosomes, implicating VGCCs as a
mediator of autophagosome-lysosome fusion (Tian et al., 2015; Wang, Y. et al., 2016). The
downstream targets of autophagy are still being elucidated, and the pathways that are uncovered
will help us understand the complex mechanisms regulating the development and function of
neurons and neuronal networks. Full understanding of these autophagic mechanisms will also
help us find the elusive causes of neurodevelopmental disorders.

2.7 Autophagy and neurodevelopmental disorders
Defects in general autophagic machinery have been associated with various
neurodevelopmental disorders (Lee, 2012; Lee, K.-M. et al., 2013). Moreover, impaired
lysosomal function, which indirectly causes autophagic malfunction, have also been implicated
in a variety of neurological disorders (Kang et al., 2010; Nixon, 2013; Ebrahimi-Fakhari et al.,
2016). The primary role of autophagy is to clear away misfolded or unneeded proteins or
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organelles. Accumulation of misfolded proteins is a hallmark of various neurodegenerative
diseases such as Amyotrophic Lateral Sclerosis (ALS), Parkinson’s, Huntington’s and
Alzheimer’s disease (Cushman et al., 2010). The accumulation of misfolded and malfunctioning
proteins plays one and perhaps more roles in autophagy during normal and abnormal neural
development. Autophagy’s role in polygenic neurodevelopmental disorders such as ASD and
schizophrenia have been investigated (Sragovich et al., 2017; Napoli et al., 2018). Indeed, the
mechanisms and downstream targets are unclear in any of the few identified autophagy related
links to ASD. However, these studies focused on general macroautophagy and its role in
neurodevelopmental disorders, and we have much to learn about the roles of selective autophagy
in the development of neurodevelopmental disorders.

2.8 Selective Autophagy in neurodevelopmental disorders
Studies have identified selective autophagy genes as potential candidates for ASD (Iossifov
et al., 2012). However, biological evidence for a role for selective autophagy in ASD has not
been established. One selective autophagy related gene that has been associated numerous times
to neurodevelopmental disorders is the cargo adaptor encoding WDFY-3 discussed earlier
(Iossifov et al., 2012; Orosco et al., 2014; Dragich et al., 2016; Kadir et al., 2016; Napoli et al.,
2018). Selective autophagy has been implicated in having an axon guidance role through the
degradation of ubiquitin proteins (Dragich et al., 2016). Widespread axonal wiring defects were
observed in mouse brains, where the mice were carrying different alleles of WDFY-3 mutants
(Dragich et al., 2016). The homozygous null WDFY-3 mutants caused major forebrain
commissure defects, further demonstrating the importance of WDFY-3 in the proper
development of the brain (Dragich et al., 2016). Additional screens of mice that had brains with
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severe neuronal defects found a hypomorphic WDFY-3 allele as a contributor (Orosco et al.,
2014). Some of the possible mechanisms for WDFY-3 and selective autophagy in neurons is
through the degradation of outgrowth signaling molecules like DVL3 (Kadir et al., 2016) or via
mitophagy (Napoli et al., 2018). Defects in mitochondrial quality control in neurons affects the
function of axon guidance proteins semaphorin, ROBO, L1CAM and EPH-EPHRIN signaling
(Napoli et al., 2018). Overall, research supports a key role for WDFY-3 in neurodevelopment,
possibly through mitochondrial homeostasis. These are the overall trends regarding the link
between selective autophagy and neurodevelopmental disorders. However, a direct link between
the key regulators of axon outgrowth machinery and selective autophagy have not been
established. There is a great deal more we need to understand about the roles of selective
autophagy and the various neurodevelopmental disorders to which they have been genetically
associated.
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Chapter 2 Figures:

Figure 5: General autophagy diagram.
The process of general autophagy starts with the formation and elongation of a membrane known
as the phagophore. The phagophore will continue to elongate around cytoplasmic material until
the ends meet and fuse. This results in a sealed, large double membrane bound vesicle, known as
the autophagosome, which at this stage has fully formed around the material to be degraded. The
pathway ends with the autophagosome fusing with a lysosome, which creates the autolysosome,
where the contents are finally degraded via lysosomal enzymes.
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Figure 6: Microautophagy diagram.
Microautophagy involves direct uptake of cardo directly into lysosomes for degradation. This
uptake of the soluble components occurs through endocytosis into the lysosomal lumen.
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Figure 7: Core autophagic machinery diagram.
The initial creation of the membranes that subsequently form the autophagosome requires
activation of the ULK1/2-ATG-13 complex and the PIK3C3-BECLIN1 complex (Mizushima et
al., 1998). ATG9A and VMP1 localize to the phagophore membrane and are thought to add
membrane to the growing autophagosome. The bulk of the elongation of the membranes is then
attained by two conjugation steps, which are the formation of an ATG-12–ATG-5 conjugate and
the formation of the LC3- PE conjugate. Finally, the accumulation of LC3-PE conjugate on the
membrane is vital for the proper closure of the membrane. SNARE proteins are responsible for
the fusion of the autophagosome with the lysosome. SNARE proteins localized to the
autophagosome form a complex with vesicle-associated membrane protein 8 VAMP8, which is
localized to the lysosome. CACNA1A localizes to lysosomes and promotes fusion of lysosomes
and autophagosomes, likely through calcium activation of the SNARE complex.
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Figure 8: Chaperone mediated autophagy diagram.
The KFERQ-motif of the substrate protein is recognized by the HSC70 which delivers the
substrate protein to the LAMP2A for degradation. The LAMP2A is a transmembrane protein
localized to the lysosome that delivers the substrate into the lysosome for degradation. The
substrate is then unfolded by HSC70-HSP90 and translocated across the lysosomal membrane
with the assistance of lysosomal lumen HSC70. The protein is then degraded in the lysosome.
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Figure 9: Selective autophagy diagram.
Cargo receptor proteins (CRPs) are one of the facilitators of the selective macroautophagy. These
CRPs can be further assisted by adaptor proteins acting as a scaffold between the cargo, the CRP,
and the core autophagic machinery. The remainder of the autophagy pathway proceeds the same
way as general autophagy. The autophagosome forms around the cargo, then fuses to the
lysosome to create the autolysosome and degrade the cargo.
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Figure 10: Selective autophagy with cargo binding protein diagram.
An example of a cargo receptor is SQSTM1, which mediates the autophagic degradation of
ubiquitinated aggregated protein.
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Figure 11: WDFY-3 in selective autophagy diagram.
WDFY-3 is an adaptor protein that acts as a scaffold between the cargo, the CRP, and the core
autophagic machinery. As one specific example, WDFY-3 has been shown to act as a scaffolding
for SQSTM-1, helping to maintain a connection between the cargo and the CRP protein
SQSTM-1. Both WDFY-3 and SQSTM-1 are bound to ATG-5, a member of the core autophagic
machinery. Once a cargo is successfully bound, the regular autophagy pathway is induced, and
the cargo is eventually degraded.
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2.9 Thesis statement

What are the mechanisms that function downstream of autism-causing gene variants to
disrupt neuronal development? This fundamental question is the basis for this dissertation work.
By answering this question, we can contribute to a biological explanation for the development of
autism spectrum disorder (ASD). Additionally, we would be likely to uncover important
pathways involved in critical steps of neurodevelopment.
Autism is a disorder that affects neuronal development, leading to alterations in cognition
and behavior. Imaging studies have revealed alterations in axonal connectivity as a key feature of
autism. However, the underlying perturbations in cell biology that drive these alterations remain
largely unknown. To address this issue, we have taken advantage of the Timothy syndrome
mutation, a variant in a voltage gated calcium channel that has the unusual property of causing
ASD with high penetrance. We identify a role for wild-type voltage gated calcium channels in
regulating axon termination in C. elegans. The C. elegans PLM axons are an ideal candidate for
studying axon termination because they terminate outgrowth in a consistent and easily
identifiable manner. The C. elegans PLM neurons start development in the posterior end of the
worm and extend their axons anteriorly until reaching the midpoint of the worm, just posterior to
the ALM cell body where the axons terminate their growth. C. elegans is also useful for genetic
experimentation due to its rapid life cycle, compact genome, and two sexes: self-fertilizing
hermaphrodite and male. For these reasons, C. elegans is an excellent model to study the
complex basis of ASD.
We found that the Timothy syndrome mutation disrupts axon termination and alters
behavior. We report that the effects of the Timothy syndrome mutation on both axon
development and behavior are mediated by selective autophagy, the process through which
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cellular components are selected for degradation. These results reveal a mechanism through
which variants in voltage gated calcium channels can cause the disruptions in axonal
connectivity that underlie autism.
The monogenic model we established is an important step towards understanding the
mechanisms that are disrupted in the development of ASD. Continued study of autism-causing
variants will lead to better understanding of ASD genetics. Our findings can be applied to ASD
diagnostic procedures in order to improve treatment outlook. Additionally, molecular
mechanistic discoveries derived from our findings can be used to develop new treatments that
can be applied to ASD and other neurodevelopmental disorders.
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Chapter 3 – An autism-causing variant misregulates selective autophagy to alter axon
targeting and behavior.

This chapter is a modified version of the paper published in the Journal Plos Genetics (Buddell et
al., 2019).

3.1 Abstract
Common and rare variants of the CACNA1C gene have been associated with autism and
other neurodevelopmental disorders including schizophrenia, bipolar disorder and ADHD.
However, little is known about how CACNA1C variants affect cellular processes to alter
neurodevelopment. The Timothy syndrome mutation is a rare de novo gain-of-function variant in
CACNA1C that causes autism with high penetrance, providing a powerful avenue into
investigating the role of CACNA1C variants in neurodevelopmental disorders. Here, we show
that an egl-19(gof) mutation that is equivalent to the Timothy syndrome mutation can alter axon
targeting and affect behavior in C. elegans. We find that wildtype egl-19 negatively regulates
axon termination. The egl-19(gof) mutation represses axon termination to cause axon targeting
defects that lead to the misplacement of electrical synapses and alterations in habituation to light
touch. Moreover, genetic interactions indicate that the egl-19(gof) mutation functions with genes
that promote selective autophagy to cause defects in axon termination and behavior. These
results reveal a novel genetic mechanism whereby a de novo mutation in CACNA1C can drive
alterations in circuit formation and behavior.
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3.2 Introduction
Variants in the CACNA1C voltage gated calcium channel (VGCC) gene are common risk
factors for autism and other neurodevelopmental disorders including schizophrenia, bipolar
disorder and attention deficit hyperactivity disorder (ADHD). For example, genome wide
association studies (GWAS) have associated common variants in CACNA1C to autism (Lu et al.,
2012; Li et al., 2015). Moreover, statistical analysis of whole genome sequencing data indicates
that rare variants in CACNA1C are also associated with autism (Splawski et al., 2004; Schaaf et
al., 2011; Jiang et al., 2013; Brett et al., 2014; Iossifov et al., 2014; D'Gama et al., 2015;
Alvarez-Mora et al., 2016; RK et al., 2017). Whereas the evidence is strongest for CACNA1C,
variants in other VGCC subunit genes are also associated with autism (Strom et al., 2010; Lu et
al., 2012; Breitenkamp et al., 2014; RK et al., 2017). Despite these insights from statistical
analysis, little is currently known about how variants in VGCC genes affect cellular processes to
disrupt neurodevelopment.
A major impediment to understanding how autism-associated variants affect cellular
processes is that most variants have a small effect size. Because each variant only has a small
effect, it is thought that multiple variants engage in genetic interactions that give rise to the
neurodevelopmental defects underlying autism (Robinson et al., 2016; Turner et al., 2017).
Therefore, a key goal in understanding the biological basis for autism is to understand genetic
interactions between autism-associated variants. However, currently little is known about how
autism-associated variants interact with each other. Moreover, in most cases the cellular
mechanisms perturbed by each variant are also unknown.
Morphological abnormalities in axon development are associated with autism and other
neurodevelopmental disorders (Travers et al., 2012; Wolff et al., 2012; Koldewyn et al., 2014;
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Lazar et al., 2014; Farias et al., 2017). Most mechanistic studies of autism-associated genes have
focused on dendrite and synapse structure. However, imaging studies have suggested that
alterations in axon targeting are a key feature of autism. For example, diffusion tensor imaging
has revealed alterations in the Inferior Longitudinal Fasciculus in autistic individuals relative to
healthy controls (Travers et al., 2012; Wolff et al., 2012; Koldewyn et al., 2014; Lazar et al.,
2014; Farias et al., 2017). Moreover, functional MRI has revealed alterations in long range
connectivity that can predict autism in individuals before the onset of symptoms (Just et al.,
2004; Just et al., 2007; Schipul et al., 2011). These observations suggest that alterations in axon
targeting are likely to underlie autism. However, little is currently known about how autismassociated variants can alter axon targeting.
In this work, we use the Timothy syndrome mutation as a platform to discover how
autism-associated variants interact with each other to alter cellular processes and disrupt axon
development. The Timothy syndrome mutation is a rare de novo mutation in CACNA1C that
causes autism with high penetrance (Splawski et al., 2004; Bader et al., 2011). Although this is a
rare mutation with a large effect, common variants with a small effect in CACNA1C are also
associated with autism (Lu et al., 2012; Li et al., 2015). As the mechanisms by which
CACNA1C affects axon development are unknown, studies of the Timothy Syndrome variant
may uncover genetic mechanisms that also apply to the more common CACNA1C risk variants.
Here, we identify an egl-19(gof) mutation in C. elegans that is equivalent to the Timothy
syndrome mutation. Using the mechanosensory nervous system (Figure 12), we find that this
egl-19(gof) mutation causes overextension of the PLM axon, leading to the misplacement of
electrical synapses. Moreover, we find that this egl-19(gof) mutation interacts genetically with a
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homolog of the autism-associated WDFY3 selective autophagy gene to disrupt axon development
and alter behavior.

3.3 Results
3.3.1 A VGCC mutation that causes autism in humans and disrupts axon termination in C.
elegans
The egl-19(n2368) mutation is equivalent to the autism-causing Timothy syndrome
mutation in CACNA1C. Both common and rare variants in the human CACNA1C gene have been
associated with autism and other neurodevelopmental disorders (Strom et al., 2010; Schaaf et al.,
2011; Lu et al., 2012; Li et al., 2015; Yuen et al., 2015; Al-Mubarak et al., 2017; RK et al., 2017;
Stessman et al., 2017). The Timothy syndrome mutations, G402R, G402S and G406R in human
CACNA1C, are of particular interest because each causes autism with high penetrance (Splawski
et al., 2004; Napolitano & Antzelevitch, 2011; Diep & Seaver, 2015). To establish a model for
investigating how the Timothy syndrome mutation affects neurodevelopment, we searched for an
equivalent mutation in egl-19, the C. elegans orthologue of CACNA1C. We found that the egl19(n2368) mutation (hereafter referred to as egl-19(gof)) encodes a G365R variant of EGL-19
that is equivalent to the G402R Timothy syndrome variant in human CACNA1C (Figure 13A). In
both human CACNA1C and C. elegans EGL-19, this Timothy syndrome mutation is a gain-offunction variant: it disrupts slow inactivation of the voltage gated channel, thereby increasing
calcium permeation (Splawski et al., 2004). Specifically in the egl-19(n2368) mutation, the EGL19 VGCC opens at a lower threshold compared to wild-type, and their activation times were
about twice as long as wild-type worms (Laine et al., 2014).
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To determine how the Timothy syndrome mutation affects neurodevelopment, we
observed the PLM touch receptor neuron in egl-19(gof) mutants. The PLM cell body is located in
the tail, with an axon extending along the lateral body wall (Figure 12). For this experiment we
used two independently isolated egl-19(gof) alleles, egl-19(n2368) and egl-19(tr134). Both of
these alleles produce a G365R mutation in EGL-19, which is equivalent to the G402R Timothy
syndrome mutation in humans (Figure 13A; Lee et al., 1997; Kwok et al., 2008). In wild-type
animals, nearly all of the PLM axons terminate posterior to the ALM cell body (Figure 12A;
Figure 13B,D). However, in the egl-19(n2368) and egl-19(tr134) G365R gain-of-function
mutants, around 52% of the PLM axons terminate anterior to the ALM cell body (Figure 12B;
Figure 13C,D). By contrast, egl-19(lof) mutants exhibit normal PLM axon termination (Figure
13D), with nearly all PLM axons terminating posterior to the ALM cell body. We also tested the
egl-19(ad695) gain-of function mutation, which has previously been characterized as a weaker
gain-of-function relative to egl-19(n2368) (Lee et al., 1997). Consistent with these prior
observations, we found that the egl-19(ad695) gain-of-function mutation causes axon
termination defects with a lower penetrance relative to egl-19(n2368) and egl-19(tr134) (Figure
13D).
In humans, Timothy syndrome is also caused by a G406R mutation in CACNA1C
(Splawski et al., 2004). Therefore, we tested egl-19(syb1243), a mutation that produces a G369R
mutation in EGL-19, which is equivalent to G406R in human CACNA1C (Figure 13A). We
found that the egl-19(syb1243) mutation is homozygous lethal, with no maternal rescue.
However, we observed the PLM axon in egl-19(syb1243) heterozygotes and found that around
18% of the PLM axons had axon termination defects (Figure 13D). Together, these observations
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indicate that mutations equivalent to the Timothy syndrome mutations can cause defects in axon
targeting.
To determine if the Timothy syndrome mutation functions cell autonomously to disrupt
axon termination, we used Pmec-7::egl-19(gof) transgenes to express the EGL-19 G365R mutant
protein specifically within touch receptor neurons (PLM, ALM, AVM and PVM) (Figure 13E).
We tested one transgene that was created by injecting Pmec-7::egl-19(gof) at a concentration of
5 ng/ul and another at 25 ng/ul. We found that both of these transgenes caused axon termination
defects. These results suggest that EGL-19(GOF) functions cell autonomously in the PLM
neuron to disrupt axon termination.
Finally, we repeated these experiments in the ALM in order to determine if the disrupted
axon termination machinery was observed in additional mechanosensory neurons in egl-19(gof)
mutants (Figure 14). In wild type animals, the ALM axon terminates its growth past the nerve
ring and posterior to the mouth of the worm (Figure 14A,C). In egl-19(gof) mutants, we observed
overextended ALM axons, which were scored when the axon terminated at the mouth of the
worm (Figure 14 B,C). This result suggests that the axon termination mechanism regulated by
EGL-19 functions in multiple axons.
It is important to note that an additional defect was observed in the ALM cell body of
egl-19(gof) mutants. In wild type animals, the ALM cell body extends a singular axon in the
anterior direction of the worm, and no large neurites are visible growing in a different direction
(Figure 15A). However, in egl-19(gof) mutants, there is visible neurite growth extending from
the posterior side of the ALM cell body (Figure 15B). We observed a 24% penetrance of
posterior process defects in egl-19(gof) mutants (Figure 15C). These types of defects are often
seen in animals with mutated genes important for regulating axon development (Kirszenblat et
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al., 2013), or genes that govern cell orientation and polarity (Hilliard & Bargmann, 2006). This
result further suggests that axon development mechanisms are perturbed in egl-19(gof) Timothy
syndrome mutants.

3.3.2 Wild-type EGL-19 and other VGCC subunits negatively regulate axon termination
To determine if and how wild-type EGL-19 regulates axon termination, we conducted
genetic analysis with mutations in the genes that encode the RPM-1 (PAM, Highwire) signaling
pathway. RPM-1 is an E3 ubiquitin ligase that promotes axon termination by ubiquitinating
DLK-1 (MAP3K12), thereby marking it for proteasomal degradation (Schaefer et al., 2000; Zhen
et al., 2000; Nakata et al., 2005). This function of RPM-1 is mediated through an interaction
between RPM-1 and a SCF (Skp/Cullin/F-box) complex that includes the FSN-1 (FBXO45) Fbox protein. In addition, RPM-1 also promotes axon termination by functioning with GLO-4
(RCBTB1), a guanine nucleotide exchange factor (GEF) for the GLO-1 (RAB38) Rab GTPase
(Grill et al., 2007). GLO-4 functions with RPM-1, but in parallel to FSN-1, to promote axon
termination (Figure 3).
Since the egl-19(gof) mutation disrupts axon termination, it is possible that wild-type
EGL-19 also negatively regulates axon termination. Alternatively, it is possible that egl-19(gof)
acts in a neomorphic role not normally controlled by wild-type EGL-19. To determine the
function of wild-type EGL-19, we conducted genetic analysis with a loss-of-function allele of
egl-19. For this experiment, we used a null allele of fsn-1 that causes axon termination defects
(Liao et al., 2004; Grill et al., 2007). In fsn-1(null) mutants, 53% of the PLM axons are
overextended (Figure 16A). However, in fsn-1(null); egl-19(lof) double mutants, the phenotype
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is suppressed to only 33% of PLM axons overextended. These observations suggest that wildtype EGL-19 acts to negatively regulate axon termination.
EGL-19 is the pore forming subunit of the L-type VGCC. To further explore the role of
voltage gated calcium channels, we tested loss-of-function mutations in other genes that encode
VGCC components. The unc-2 gene encodes the pore-forming subunit of the P/Q-type VGCC
(Schafer & Kenyon, 1995). The human homolog of unc-2, CACNA1A, has also been associated
with autism (Damaj et al., 2015; Li et al., 2015; Lelieveld et al., 2016). We found that a null
allele of unc-2 could also suppress axon termination defects caused by a fsn-1(null) mutation
(Figure 16A). We also tested a null mutation in unc-36, which encodes the alpha2-delta3 subunit
that works with both the EGL-19 and UNC-2 pore-forming subunits to modulate voltage
dependence, activation kinetics, and calcium conductance (Frokjaer-Jensen et al., 2006; Saheki
& Bargmann, 2009; Laine et al., 2011). The human homolog of UNC-36, CACNA2D3 has also
been associated with autism (De Rubeis et al., 2014; Iossifov et al., 2014; RK et al., 2017). We
found that a null allele of unc-36 could also suppress axon termination defects caused by a fsn1(null) mutation (Figure162A). Together, these observations suggest that both L-type and P/Qtype voltage gated calcium channels can negatively regulate axon termination. We note that the
different levels of suppression observed between unc-36(null), unc-2(null) and egl-19(lof)
mutations are likely the result of differing roles played by each VGCC subunit or could reflect
different strengths of the alleles that we used.
To determine if VGCCs function cell-autonomously to regulate axon termination, we
constructed a Pmec-7::unc-36::rfp transgene, which uses the mec-7 promoter to drive expression
of UNC-36::RFP within the touch receptor neurons. If UNC-36 functions cell autonomously, we
expect that the Pmec-7::unc-36::rfp transgene will reverse the suppression of axon termination
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defects observed in fsn-1(null);unc-36(null) double mutants relative to fsn-1(null) single mutants.
Indeed, we found that fsn-1(null);unc-36(null) double mutants with the Pmec-7::unc-36::rfp
transgene had a higher penetrance of axon termination defects relative to fsn-1(null);unc-36(null)
double mutants without the Pmec-7::unc-36::rfp transgene (Figure 16A). These observations
suggest that UNC-36 functions cell-autonomously to negatively regulate axon termination.

3.3.3 VGCC regulation of axon termination is specific to the FSN-1 pathway
FSN-1 functions in parallel to GLO-4 to promote PLM axon termination (Hermann et al.,
2005; Grill et al., 2007). Although both pathways promote axon termination, they do so through
distinct molecular mechanisms. Whereas FSN-1 is an F-box protein that regulates a MAP Kinase
cascade (Liao et al., 2004), GLO-4 is a guanine nucleotide exchange factor for the GLO-1 Rab
GTPase (Hermann et al., 2005). To determine if VGCCs regulate the GLO-4 pathway, we
constructed glo-4(null);unc-2(null) and glo-4(null);unc-36(null) double mutants. We found that
neither loss of unc-2 nor loss of unc-36 function suppresses the axon termination defects caused
by loss of glo-4 function, suggesting that VGCCs do not regulate the GLO-4 pathway (Figure
16B). To further explore the role of VGCCs within the context of the parallel FSN-1 and GLO-4
pathways, we constructed an fsn-1(null);glo-4(null);unc-36(null) triple mutant and a fsn1(null);glo-4(null) double mutant (Figure 16C). Consistent with prior studies, we found that fsn1(null);glo-4(null) double mutants had termination defects in 86% of PLM axons (Grill et al.,
2007). In the triple mutant, loss of unc-36 function reduced this penetrance to 46%, which is
similar to the glo-4 single mutants. Together, these observations suggest that VGCCs can
negatively regulate axon termination in response to the FSN-1 pathway, but not GLO-4 pathway.
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The RPM-1 ubiquitin ligase functions with the FSN-1 F-box protein to negatively
regulate downstream proteins (Liao et al., 2004; Grill et al., 2007). Loss-of-function mutations in
these downstream proteins suppress the phenotype of loss-of-function mutations in FSN-1 and
RPM-1. For example, FSN-1 and RPM-1 function together to negatively regulate the DLK-1
MAP Kinase (Nakata et al., 2005). Loss of DLK-1 function suppresses the phenotype that is
caused by either loss of RPM-1 function or loss of FSN-1 function. Since loss of VGCC function
can suppress the axon termination phenotype caused by loss of FSN-1 function, we considered
the possibility that FSN-1 might function with RPM-1 to negatively regulate VGCCs. If this is
true, loss of VGCC function should suppress the axon termination defect caused by loss of RPM1 function. However, we found that axon termination defects caused by loss of RPM-1 function
could not be suppressed by loss of function mutations in unc-36, unc-2 or egl-19 (Figure 16B).
These observations suggest that VGCCs are not downstream targets of RPM-1 and FSN-1.

3.3.4 The egl-19(gof) mutation alters PLM axon connectivity
To determine if the egl-19(gof) mutation affects connectivity of the PLM axon, we
examined its chemical and electrical synapses. In wild-type animals, the PLM axon extends a
synaptic branch that forms a cluster of chemical synapses on axons in the ventral nerve cord
(Schaefer et al., 2000). We used a mec-7::rfp transgene (Bounoutas et al., 2009) to visualize the
PLM synaptic branch and found that it appears normal in egl-19(gof) mutants (Figure 17A,D).
We also used a mec-7::gfp::rab-3 transgene (Marcette et al., 2014) to visualize synaptic vesicles
and found that these also appear normal in egl-19(gof) mutants (Figure 17B,E). We measured the
length of the synaptic vesicle clusters in wildtype and egl-19(gof) mutants and found no
significant difference (Figure 17C,F,G). Moreover, consistent with prior findings (Grill et al.,
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2007), we found that about 15% of fsn-1 null mutants were missing the PLM branch (Figure
17H). However, this missing branch phenotype was not suppressed in fsn-1(null); egl-19(lof)
double mutants (Figure 17H). These observations suggest that the EGL-19(GOF) mutation does
not affect the PLM synaptic branch or its chemical synapses. Moreover, wildtype EGL-19 does
not affect the PLM branch. However, we cannot rule out the possibility that the synaptic branch
and chemical synapses are affected in more subtle ways.
We next asked if the egl-19(gof) mutation affects electrical synapses. In wild-type PLM
axons, electrical synapses are clustered in two distinct zones (Meng et al., 2016). Zone 1
electrical synapses are located close to the PLM cell body, whereas zone 2 electrical synapses are
located at the PLM axon tip, which is posterior to the ALM cell body (Figure 18A). Since the
egl-19(gof) mutation causes overextension of the PLM axon, it is possible that it could also cause
misplacement of zone 2 electrical synapses to a location anterior to the ALM cell body.
Alternatively, it is possible that egl-19(gof) causes axon overextension, but leaves the zone 2
synapses in their normal location posterior to the ALM cell body. To differentiate between these
two possibilities, we used a mec-7::unc-9::gfp transgene (Meng et al., 2016) to visualize the
UNC-9 Innexin, a marker for electrical synapses (Meng et al., 2016). We found that the egl19(gof) mutation caused misplacement of the zone 2 electrical synapses to a point anterior to the
ALM cell body (Figure 18B). Misplacement of the electrical synapse occurred in approximately
53% of egl-19(gof) PLM axons, but only in 7% of wildtype PLM axons (Figure 18C) Therefore,
the PLM axon overextension caused by egl-19(gof) is also associated with misplacement of zone
2 electrical synapses.
The zone 2 electrical synapses are formed between the PLM mechanosensory neuron and
the BDU interneuron. The BDU interneuron begins its axon extension in the nerve ring of C.
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elegans, which grows in a posterior direction until it approaches the PLM. The BDU axon then
maneuvers towards the PLM and continues to grow until it reaches the PLM axon tip where the
connection is formed (White et al., 1986). Despite not being a true mechanosensory neuron, the
BDU interneuron is vitally important for the touch response (Li et al., 2011). Therefore, we
wanted to know whether or not the BDU interneuron was disturbed in the egl-19(gof) mutants. In
order to examine the integrity of the PLM-BDU connection, we used a Pmec-7::gfp to observe
the PLM axon (Figure 19A,C), and a Punc-86::myr gfp to visualize the BDU axon (Figure
19B,D). In wild-type animals, the BDU axon maneuvers towards the PLM and forms a
connection at the PLM axon tip (Figure 19B). Despite the overextension of the PLM, in the egl19(gof) mutants the PLM-BDU connection appears undisturbed, and the BDU maneuvers
towards the PLM axon tip before making a connection in the same manner as the wild-type
animal (Figure 19D). This result suggests that the zone 2 electrical synapses are mislocalized in
the egl-19(gof) mutant worm, but the overall PLM-BDU connection remains intact. It is
important to note that, although the overall structure of the BDU neuron appears normal, we
cannot say for certain that the BDU neuron is unaffected by the egl-19(gof) mutation.

3.3.5 The egl-19(gof) mutation interacts with selective autophagy genes to disrupt axon
termination
As part of an ongoing effort to test autism-associated genes for roles in axon
development, we identified a genetic interaction between egl-19(gof) and wdfy-3, a homolog of
the autism-associated WDFY3 selective autophagy gene. For this experiment, we used the wdfy3(ok912) deletion allele, hereafter called wdfy-3(lof). This allele is likely to be a null or strong
loss of function because it creates a frameshift that disrupts the FYVE domain, WD repeat
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domain and nearly all of the beach domain. We found that the PLM axon was normal in wdfy3(lof) single mutants. In egl-19(gof); wdfy-3(lof) double mutants, the axon termination defects
observed in egl-19(gof) single mutants were almost completely suppressed (Figure 20A).
Moreover, PLM axon termination defects caused by transgenic expression of EGL-19(GOF) in
touch receptor neurons were also suppressed by wdfy-3(lof). The PLM neurons are likely to
express WDFY-3 because RNAseq on purified touch receptor neurons identified wdfy-3 mRNA
transcripts (Kaletsky et al., 2016). The wdfy-3 gene is an orthologue of the human autismassociated WDFY3 gene that encodes a protein required for cargo selection during selective
autophagy (Clausen et al., 2010; Filimonenko et al., 2010). Therefore, these observations
establish a genetic pathway between two autism-associated genes that regulates axon
termination.
To further explore a potential interaction between selective autophagy and EGL19(GOF), we constructed double mutants between egl-19(gof) and mutations in two other genes
that are expected to disrupt selective autophagy: epg-7 (RB1CC1, FIP200) and cup-5
(Mucolipin-3). The epg-7 gene encodes an additional component required for selection of cargo
for autophagy (Lin et al., 2013), and the cup-5 gene encodes a scaffold protein that promotes
lysosome biogenesis (Hersh et al., 2002; Treusch et al., 2004). We found that axon termination
defects caused by the egl-19(gof) mutation could be suppressed by either a likely null mutation
in epg-7 or a hypomorphic mutation in cup-5 (Figure 20A). These observations suggest that the
egl-19(gof) mutation causes axon termination through a mechanism that requires selective
autophagy.
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3.3.6 WDFY-3 negatively regulates PLM axon termination
Having found that wdfy-3 can negatively regulate axon termination in the egl-19(gof)
mutant, we wanted to ask if wdfy-3 could also regulate axon termination independently of the
gain-of-function egl-19 mutation. For this experiment, we used a fsn-1(null) mutation to induce
axon termination defects. We found that loss of wdfy-3 function completely suppresses the axon
termination defects caused by the fsn-1(null) mutation (Figure 20B). Like the VGCC loss-offunction mutants, we also found that the wdfy-3(lof) mutant does not suppress axon termination
defects caused by rpm-1(lof). Together, these observations suggest that WDFY-3, like VGCCs,
can regulate axon termination signaling downstream of FSN-1, but is not a downstream target of
FSN-1 and RPM-1.
We next wanted to narrow down the possible selective autophagic mechanism involved
in axon termination. One likely candidate is the cargo receptor protein SQSTM-1, as it has been
shown to function with WDFY-3 in selective autophagy (Figure 11; Clausen et al., 2010)). The
homolog of mammalian SQSTM-1 in C. elegans is encoded by the sqst-1 gene. In order to
determine if SQST-1 mediated selective autophagy functions as a regulator of axon termination,
we used a fsn-1(null) mutation to induce axon termination defects. We found that the sqst-1(lof)
mutation does not suppress axon termination defects caused by the fsn-1(null) mutation (Figure
20C). This is in contrast to both wdfy-3 and VGCC loss-of-function mutations, which result in
the suppression of fsn-1(null) induced axon termination defects (Figure 16A; Figure 20A). These
results taken together suggest that WDFY-3 mediated selective autophagy functions with EGL19 to regulate axon termination. Although we did not see an effect from the loss-of-function of
sqst-1, its important to note that there are many sqst genes in C. elegans. Therefore, the lack of
observed effect is likely due to redundant function of other sqst genes.
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As an additional experiment, we wanted to see if other proteins that have been associated
with ASD would act as regulators of axon termination. One family of proteins that have
statistical association with the development of ASD are the SHANK proteins (Gong & Wang,
2015; Wang et al.). In order to test this relationship, we utilized the C. elegans homolog to
human SHANK2, encoded by the gene shn-1. These experiments used the fsn-1(null) mutation to
induce axon termination defects. We found that two different shn-1(lof) alleles caused
suppression of axon termination defects caused by the fsn-1(null) mutation (Figure 21).
However, the axon termination defect suppression induced by the shn-1(lof) mutations was
weaker than that of the wdfy-3 and VGCC loss-of-function mutations (Figure 16A; Figure 20A;
Figure 21). This weaker affect by the shn-1(lof) as compared to wdfy-3(lof) does imply
specificity in selective autophagy as a regulator of axon termination. Additionally, due to the
preliminary nature of these results, we cannot rule out pleiotropic effects as a possible cause for
the shn-1(lof) induced changes in axon termination defects. Additional experiments using shn-1
mutations will be required before any inferences can be made.

3.3.7 The egl-19(gof) mutation interacts with the wdfy-3 selective autophagy gene to regulate
habituation to light touch
The PLM neuron is a mechanosensory neuron that is responsible for sensing light touch
in the posterior of C. elegans (Chalfie et al., 1985). When light touch is applied to the tail, the
animal responds by moving forward (Rankin et al., 1990; Hobert et al., 1999; Zhang & Chalfie,
2002). However, after repeated touches, the animal habituates and becomes less likely to respond
to each touch. Since we observed that the egl-19(gof) mutation alters the morphology of the PLM
neuron, we wanted to determine if this mutation also alters the response to light touch.
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We conducted a touch assay to determine if the egl-19(gof) mutation affects the response
to light touch. Each animal was subjected to ten eyelash touches alternating between the head
and tail . For the initial touch, there was no significant difference in the response rate between
egl-19(gof) mutants and wild-type animals. However, for each subsequent touch, the egl-19(gof)
mutants had a significantly lower response rate relative to wild-type animals (Figure 22). These
observations suggest that the egl-19(gof) mutation enhances habituation to light touch.
Because we found that the egl-19(gof) mutation interacts with wdfy-3 to disrupt axon
termination, we next asked if this genetic interaction can also affect habituation to light touch. If
the egl-19(gof) mutation functions with wdfy-3 to alter habituation, we expect that loss of wdfy-3
function will reduce the effect of the egl-19(gof) mutation on habituation. Indeed, we found that
in egl-19(gof);wdfy-3(lof) mutants, the habituation to light touch was not significantly different
relative to wild-type animals (Figure 22). Together, these observations suggest that the egl19(gof) mutation acts through wdfy-3 to affect both axon termination and habituation to light
touch.

3.3.8 WDFY-3 as it fits in the RPM-1 pathway
A question we wanted to answer regarding WDFY-3 and its role in axon termination was
where the protein existed in the context of the RPM-1 pathway. We previously determined that
wdfy-3(lof) mutations suppress fsn-1(null) induced axon termination defects, and that wdfy-3(lof)
mutations do not suppress rpm-1(lof) induced axon termination defects (Figure 20B). However,
we did not yet examine how WDFY-3 relates to GLO-4. In order to answer this question, we
examined the effect wdfy-3(lof) mutations have on axon termination defects induced by glo4(null) mutations (Figure 23). In contrast to the VGCC(lof) mutants (Figure 16B), wdfy-3(lof) did
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appear to suppress the axon termination defects caused by the glo-4(null) mutation (Figure 23).
However, there were additional defects observed in the glo-4(null);wdfy-3(lof) double mutants,
including some shortening of the PLM axon, instances of more severe than glo-4(null) single
mutants, and the occasional missing PLM axon. These defects are not observable in any other
mutation discussed in this research and are therefore indicative of pleiotropic affects. Additional
experiments will be necessary to rule out this affect as the reason for a lower penetrance in the
glo-4(null);wdfy-3(lof) double mutants.

3.3.9 Determining how UNC-36 acts to severely suppress the fsn-1(null) induced axon
termination defects
We further tested the enhanced suppression of fsn-1(null) caused axon termination
defects by unc-36(null) mutations. UNC-36 is important for the proper localization of the UNC-2
alpha-1 subunit and the proper function of the EGL-19 calcium channel in C. elegans (Laine et
al., 2011; Caylor et al., 2013). We therefore wanted to test if the enhanced unc-36(null)
suppression of axon termination defects was due to the additive effects caused by the disrupted
UNC-2 and EGL-19 calcium channels. In order to test this, we used axon termination defects
caused by the fsn-1(null) mutation. We found that loss-of-function of both egl-19 and unc-2 did
not suppress axon termination defects, and instead increased the penetrance of the axon
termination defects (Figure 24). This is in contrast to the suppression effect of unc-36(null)
mutations (Figure 16A), and therefore suggests that UNC-36 does not regulate axon termination
via UNC-2 and EGL-19. The results are also opposite of what was observed in the single mutant
unc-2(null) and egl-19(lof), both of which suppressed axon termination defects caused by the fsn1(null) mutation (Figure 24). This suggests that the loss of both unc-2 and egl-19 function caused
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additional developmental mechanisms to fail, possibly due to pleiotropic effects. More
experiments will be needed to further understand these mechanisms.

3.3.10 VGCCs co-localize with mitochondria in the PLM cell body
In order to determine the target of the mechanism by which VGCCs regulate axon
termination, we utilized transgenic expression of unc-36::RFP in the PLM cell body. We
expressed the unc-36::RFP in conjunction with markers for organelles associated with selective
autophagy and neuronal outgrowth. These include lysosomes, autophagosomes, golgi, and
mitochondria. We found that UNC-36::RFP co-localized with mitochondria (Figure 25F), but not
with any of the other organelles (Figure 25A,D,E). This result is interesting in regards to
neuronal development, given that mitochondria have important roles in axon outgrowth and
neuronal health (Han et al., 2016; Smith & Gallo, 2018). However, we cannot say with certainty
if and how UNC-36 and mitochondria interact, and which mechanisms are being regulated. In
addition, the co-localization of mitochondria and UNC-36 is seen in the cell body but not in the
axon. These locations in the cell body may be sites of mitophagy, but could also be aggregated
proteins trapped in the cell body. The latter option is less likely considering that co-localization
seems to be specific to the mitochondria marker and UNC-36, and not the other markers tested.
Eventually we will also want to know if selective autophagy is involved, as mitophagy is a vital
part of maintaining functional and homeostatic levels of mitochondria in neurons (Kanki et al.,
2009; Mao et al., 2013). It will also be important to follow up with additional experiments to
identify the exact nature of the connection between UNC-36 and mitochondria.
We also tested UNC-36::RFP co-localization with GLO-1::GFP, which is a downstream
target of RPM-1 in the GLO-4 pathway (Figure 3; Grill et al., 2007). We found that UNC-
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36::RFP and GLO-1::GFP did not co-localize in the PLM cell body (Figure 25B). This result
suggests that UNC-36 and GLO-1 do not directly interact in the cell body of the PLM. However,
they both could act on an intermediate protein or organelle. Finally, due to the role of the GLO-4
pathway as regulators of late endosomes/lysosomes (Grill et al., 2007), we tested the localization
of GLO-1::RFP relative to lysosomes, and found that GLO-1::RFP did not co-localize with
lysosomes (Figure 25C). Therefore, GLO-1 does not appear to directly interact with lysosomes
in the PLM cell body.

3.4 Discussion
The Timothy syndrome mutation in CACNA1C has the unusual property of being
causative for autism with high penetrance, providing an opportunity to discover the downstream
cellular processes that are perturbed to cause autism. However, the cellular processes that
interact with this mutation to give rise to autism have remained unknown. To address this
question, we created a disease model in C. elegans that utilizes a mutation equivalent to the
Timothy syndrome mutation in humans. Our results reveal that selective autophagy genes
interact with the Timothy syndrome mutation to disrupt axon termination and alter behavior.
Because common variants of CACNA1C are associated with autism, it is likely that this
mechanism will be broadly applicable to autism in humans.

3.4.1 An understanding of genetic interactions between variants is key to understanding autism
Only a small fraction of autism cases are thought to be caused by a single variant. Rather,
most cases of autism are thought to be caused by genetic interactions between variants (Schaaf et
al., 2011; Grice et al., 2015; Turner et al., 2017). For example, likely gene-disrupting (LGD)
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mutations have been associated with 15-20% of autism cases. In addition, autistic individuals
carry more missense mutations in autism-associated genes relative to healthy controls (Schaaf et
al., 2011; Geisheker et al., 2017).
However, both LGD and missense mutations are rare and therefore almost always
heterozygous. Therefore, in most cases, it is thought that each of these mutations have little or no
effect on their own. Thus, it is likely that the disorder arises from genetic interactions between
autism-associated variants. Indeed, statistical analysis of sequencing data suggests that autism
arises from the combined action of multiple variants (Schaaf et al., 2011; Turner et al., 2017;
Chen et al., 2018).
Although the heritability of autism has been estimated at 83% (Sandin et al., 2017), the
complexity of the genetic interactions that give rise to autism make it difficult to predict and
diagnose autism from whole genome sequencing data. In fact, with current knowledge, no
genetic cause can be found from whole genome sequencing data for most cases of autism. The
solution to this challenge could come from genetic analysis. For example, in most cases, single
heterozygous null mutations have no phenotype. However, many cases exist to show that an
animal carrying two heterozygous null mutations can exhibit a phenotype when each of the
mutated genes function in the same genetic pathway (Yook et al., 2001; Xu & Quinn, 2012).
Thus, if an individual is heterozygous for two LGD variants in each of two autism-associated
genes that function in a pathway, this individual would carry a higher risk for autism. Therefore,
knowledge of the pathways that link autism-associated genes will help promote our
understanding of the genetic basis of autism.
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3.4.2 Selective autophagy functions with EGL-19(gof) to alter axon development and behavior
A key finding of our study is the identification of a genetic interaction between the
homologs of two autism-associated genes, egl-19 and wdfy-3. Our genetic analysis indicates that
wdfy-3 and other selective autophagy genes are required for the egl-19(gof) mutation to disrupt
axon termination. Moreover, we also find that wdfy-3 can negatively regulate axon termination
independently of the egl-19(gof) mutation. These observations suggest that wdfy-3 functions with
egl-19 to negatively regulate axon termination. Based on these genetic interactions, we propose a
model where the Timothy syndrome mutation induces excessive selective autophagy that causes
a disruption of axon termination. As an alternative, it is also possible that selective autophagy
could function upstream of the EGL-19(GOF) mutant protein. In this scenario, selective
autophagy could promote the function of the EGL-19(GOF) protein by affecting its turnover,
stability or localization.
The genetic interaction between egl-19 and wdfy-3 also regulates habituation to light
touch. It is possible that this genetic interaction affects behavior by functioning in the developing
nervous system to regulate connectivity. Alternatively, it is possible that the genetic interaction
between egl-19 and wdfy-3 functions in the mature nervous system to regulate neural function.
Although our data cannot distinguish between these two possibilities, recent work on mice favor
the former possibility (Dedic et al., 2018). Conditional knockout of CACNA1C in forebrain
neurons during development results in anxiety in adult mice, whereas knockout of CACNA1C
during adulthood does not. These observations lend support to the possibility that CACNA1C
acts during development to alter circuit formation, which in turn affects behavior in the adult.
The interaction between the Timothy syndrome mutation and wdfy-3 provides biological
evidence for a role of selective autophagy in autism. A major challenge in autism genetics is to
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confirm and characterize the roles of autism candidate genes. For example, WDFY3 is a
candidate gene for autism because whole genome sequencing has found that 3 out of 6707
sequenced autism genomes contain a heterozygous de novo likely-gene-disrupting mutation in
WDFY3 (De Rubeis et al., 2014; Iossifov et al., 2014; Wang, T. et al., 2016; RK et al., 2017).
However, despite this association, it is not possible to determine if WDFY3 variants contribute to
the cause of autism. Our results place genes that promote selective autophagy in a pathway with
a mutation that is causative for autism in humans, thereby providing the first biological evidence
for a role of selective autophagy in autism.
Selective autophagy is also required for normal axon development. Aside from its
function with EGL-19(GOF) in inducing axon defects, our results suggest that WDFY-3 also
functions independently of EGL-19(GOF) to regulate axon development. Consistent with this
idea, loss of WDFY3 causes the disorganization and loss of many commissural axon tracts in
mice (Dragich et al., 2016). Loss of WDFY3 in mice also attenuates the response to guidance
cues in vitro, suggesting that selective autophagy could regulate the response to guidance cues.
Despite these insights, the mechanism through which selective autophagy regulates axon
targeting is currently unknown. Based on our genetic analysis, we propose a mechanism whereby
selective autophagy functions with voltage gated calcium channels to regulate the response to
axon targeting cues.
Selective autophagy and bulk autophagy may have distinct functions in
neurodevelopment. Whereas our results suggest a mechanism for selective autophagy in the
negative regulation of axon termination, prior studies have reported a role for bulk autophagy in
promoting synapse development and inhibiting axon growth. In cultured mouse neurons,
knockdown of an autophagy gene promotes axon growth, whereas induction of autophagy
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inhibits axon growth (Ban et al., 2013). In Drosophila, autophagy promotes development of the
neuromuscular junction (Shen & Ganetzky, 2009). In C. elegans, autophagosomes form at
synaptic sites and are required for presynaptic assembly (Stavoe et al., 2016; Hill et al., 2019).
This role for autophagy in synaptogenesis is specific to bulk autophagy, since mutations in
selective autophagy genes do not affect synaptogenesis (Stavoe et al., 2016). Interestingly, our
results suggest that selective autophagy may regulate axon termination without affecting
synaptogenesis.
Selective autophagy could function with VGCCs to regulate other aspects of autismrelated pathology. Whereas our study focuses on the role of the Timothy syndrome mutation in
misregulating axon termination and behavior, previous work has found that the Timothy
syndrome mutation can promote activity-dependent dendrite retraction in cultured mouse
neurons and can inhibit the elaboration of mouse dendrites in vivo (Krey et al., 2013). The
downstream cellular mechanisms for this effect on dendrites are not yet known, but it is possible
that selective autophagy could also be involved in this process. Alternatively, it is possible that
the Timothy syndrome mutation functions through distinct mechanisms to affect dendrite
development and axon development.

3.4.3 Potential role for VGCCs in regulating the RPM-1 pathway.
Our results identify specific genetic interactions between VGCC genes and RPM-1
pathway genes. These genetic interactions indicate that loss of VGCC function suppresses axon
termination events that are caused by loss of fsn-1 function, but not loss of glo-4 function.
Moreover, we find that loss of VGCC function does not suppress defects caused by loss of rpm-1
function, but can partially suppress defects caused by the double loss of fsn-1 and glo-4. Taken
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together, these observations suggest that VGCCs specifically regulate axon termination signaling
downstream of FSN-1, but are not themselves downstream targets of RPM-1 and FSN-1.
The genetic interactions between the VGCC genes and RPM-1 pathway genes could be
explained by a model where VGCCs negatively regulate an unknown protein that functions with
RPM-1 to enhance signaling events that promote axon termination downstream of FSN-1, but
not GLO-4 (Figure 26). In fact, prior work has found that FSN-1 binds to RPM-1 and promotes
axon termination by negatively regulating the DLK-1 MAP kinase signaling pathway (Liao et
al., 2004; Nakata et al., 2005). Moreover, the PPM-1 phosphatase also binds to RPM-1 and
promotes axon termination by negatively regulating DLK-1 MAPK signaling (Tulgren et al.,
2011). Thus, it is possible that EGL-19 might repress axon termination by negatively regulating
PPM-1, or another protein that plays a similar role (Figure 27).

3.4.4 Role for VGCC-mediated calcium transients in axon growth.
Our study focuses on the genetic mechanisms that mediate the role of VGCC genes in
axon termination, but does not address how alterations in calcium permeation might be involved
in this process. Interestingly, a recent study of cultured prenatal mouse neurons has revealed that
VGCCs function during axon outgrowth to produce calcium transients that have very different
properties compared to those produced during synaptic transmission (Kamijo et al., 2018). These
transients have been named Spontaneous Regenerative Calcium Transients (SRCaTs) and are
mediated by CaV1.2, which includes the homolog of EGl-19, CACNA1C. Unlike its function in
adult neurons, CaV1.2 appears to open near resting potential, suggesting that the CaV1.2 channel
may open spontaneously in developing axons. Knockout of CACNA1C in these cultured neurons
causes a decrease in axon growth. Thus, CaV1.2 functions in axons to regulate axon growth,
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using a mechanism that is very different than how it functions in synaptic transmission. The role
of SRCaTs in regulating axon growth are unknown. However, our results suggest the possibility
that these SRCaTs may regulate signaling downstream of FSN-1 (FBXO45), utilizing a
mechanism that involves selective autophagy.

3.4.5 Potential role for common CACNA1C variants in affecting selective autophagy and axon
development in autism
We propose that the effect of CACNA1C variation in altering axon development is not
limited to the Timothy syndrome mutation, but rather extends to the other autism-associated
CACNA1C variants. This idea is supported by our genetic analysis suggesting that the effect of
the egl-19(gof) Timothy syndrome mutation on axon termination is not neomorphic, but rather
reflects an increase in the normal function of egl-19. Therefore, other gain-of-function and lossof-function variants in CACNA1C could contribute to autism by altering axon development.
Consistent with this idea, statistical analysis has identified some candidate variants in VGCC
genes that are likely to be gain-of-function and others that are likely to be loss-of-function
(Splawski et al., 2004; Breitenkamp et al., 2014; De Rubeis et al., 2014; Iossifov et al., 2014;
Limpitikul et al., 2016). Therefore, we speculate that both under-activation and over-activation
of the signaling pathways that promote axon termination could contribute to autism.
The Timothy syndrome mutation is a very rare de novo mutation, and is therefore only
responsible for a very tiny fraction of autism cases. However, several common variants in
CACNA1C have also been associated with autism (Lu et al., 2012; Cross-Disorder Group of the
Psychiatric Genomics, 2013; Li et al., 2015). For example, the A genotype at the rs1006737
locus in CACNA1C confers risk for autism and is present in about 33% of the human population.
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This A genotype at rs1006737 is located within a large intron and is thought to cause CACNA1C
gain-of-function because neurons with the risk genotype have higher levels of CACNA1C mRNA
and increased L-type calcium currents relative to neurons with the non-risk genotype (Yoshimizu
et al., 2015). Therefore, this risk variant may be associated with a gain-of-function of CACNA1C
that could disrupt axon development in a way analogous to the Timothy syndrome mutation.
However, the small effect size of the rs1006737 locus suggests that this is a relatively weak
CACNA1C gain-of-function.
Although common alleles have a small effect size relative to the Timothy syndrome
mutation, they could interact with risk variants in other genes that function in a genetic pathway
with CACNA1C. For example, the rs1006737 risk variant could provide a weak gain-of-function
in CACNA1C that does not cause autism on its own. However, the rs1006737 risk variant could
synergize with a gain-of-function risk variant in WDFY3 to contribute to autism. Alternatively, a
weak loss of function in CACNA1C could synergize with a weak loss-of-function in WDFY3 to
give rise to autism.

3.5 Methods
C. elegans genetics C. elegans strains were cultured and maintained on nematode growth
medium (NGM)-agar plates using standard methods at 20°C (Brenner, 1974). The following
alleles were used in this study: wild-type N2, rpm-1(ok364), glo-4(ok362), fsn-1(gk429), unc2(e55), unc-36(e251), egl-19(n2368), egl-19(n582), egl-19(syb1243), cup-5(ar465), epg7(tm2508), wdfy-3(ok912), ric-7(nu447); egl-30(n686), cca-1(gk30); msi-1(os1). Unless
otherwise noted, double and triple mutants were constructed following standard procedures, and
were confirmed by the associated phenotypes and by PCR/sequence genotyping.
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Transgenic fluorescent markers The muIs32 transgene was obtained from the CGC and
encodes Pmec-7::gfp + lin-15(+) (Ch'ng et al., 2003) and was used to observe the PLM axon.
The jsls973 and jsls821 transgenes were obtained from Michael Nonet. The jsls973 transgene
encodes Pmec-7::rfp (Marcette et al., 2014) and was used to observe the PLM axon. The jsls821
transgene encodes Pmec-7::gfp::rab-3 (Bounoutas et al., 2009) and was used to observe the
localization of chemical synapses in the PLM axon. The yadIs12 transgene was obtained from
Dong Yan and encodes Pmec-4::GFP::unc-9 (Meng et al., 2016) and was used to observe
electrical synapses in the PLM axon. The kyIs262 transgene was obtained from the CGC and
encodes Punc-86::myr GFP + odr-1::rfp (Zhang et al., 2013) and was used to observe the BDU
neuron. The bzIs62 transgene was obtained from Monica Driscoll and encodes Pmec-7::lmp1::gfp (Melentijevic et al., 2017) and was used to observe lysosomes in the mechanosensory
neurons. The uIs145 transgene was obtained from Martin Chalfie and encodes Pmec-4::aman2::yfp (Chen et al., 2016) and was used to observe golgi in the mechanosensory neurons. The
sqIs24 transgene was obtained from the CGC and encodes Prgef-1::lgg-1::gfp (Palmisano et al.,
2016) and was used to observe autophagosomes in the mechanosensory neurons. The jsIs609
transgene was obtained from Ralf Baumeister and encodes Pmec-7::mito::gfp (Fatouros et al.,
2012) and was used to observe the mitochondria in the mechanosensory neurons. The egl19(syb1243) mutation was obtained from SunyBiotech. The cueEx17 and cueEx18 transgenes
were created by injecting Pmec-7::unc-36::rfp at 5 ng/ul + Pstr-1::gfp at 50 ng/ul. The cueEx19
and cueEx20 transgenes were created by injecting Pmec-7::egl-19(gof) at 5 ng/ul + Podr-1::rfp
at 50 ng/ul. The cueEx21 transgene was created by injecting Pmec-7::egl-19(gof) at 25 ng/ul +
Podr-1::rfp at 50 ng/ul. The cueEx22 transgene was created by injecting Pmec-7::glo-1::gfp at 5
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ng/ul + Podr-1::rfp at 50 ng/ul. The cueEx23 transgene was created by injecting Pmec-7::glo1::gfp at 5 ng/ul + Pstr-1::gfp at 50 ng/ul.

Microscopy Unless otherwise specified, the microscope used for imaging and phenotype
analysis was the Zeiss Axio Imager M2. Images were acquired using the AxioCam MRm
camera. Fluorescence was illuminated using the X-cite series 120Q. Images were taken under a
40x objective unless otherwise specified. All images acquired from the microscope were
analyzed using Axiovision 4 software. Images were edited into figures using Adobe Photoshop.

Analysis of phenotypes For analysis of axon termination phenotypes, animals were mounted on
a 5% agarose pad and observed with a 40x objective. For PLM axon termination, an axon was
scored as defective if it grew anterior to the ALM cell body. PLM neurons were visualized with
the muIs32 transgene which encodes Pmec-7::gfp and is expressed in all mechanosensory
neurons.

For analysis of the PLM chemical synapses, a Pmec-7::gfp::rab-3 transgene that expresses the
RAB-3 synaptic vesicle marker in the touch receptor neurons was used to visualize synaptic
vesicle clusters (Bounoutas et al., 2009). The size of each synaptic cluster was measured as
previously described (Xu & Quinn, 2016). For analysis of PLM electrical synapses, a Pmec4::gfp::unc-9 transgene was used to express the UNC-9 innexin fused to GFP in the touch
receptor neurons (Meng et al., 2016).
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For analysis of mechanosensation, we adopted an eyelash touch assay (Chalfie et al., 2014). We
assayed gentle touch responses by touching the lateral side of animals with an eyebrow hair.
Each animal was subjected to five touches alternating between the anterior and posterior ends
and scored by the number of responses elicited. Assays were performed blind to genotype. Three
independent samples of 20 animals each were collected by three independent observers and
reported as mean percentage scores.

C. elegans male creation using RNAi In order to create male C. elegans for performing genetic
crosses, we adopted a protocol originally established by Killian & Hubbard, described in Killian
and Hubbard (2001). 4 to 6 worms at the L3-L4 stage were placed on a plate freshly coated with
HT115(DE3) bacteria which produce him-14 dsRNA. The plates were incubated at 22 degrees
Celsius for 3-4 days. The F1 generation from these plates contained males. RNAi created males
were then used to mate with hermaphrodites of the same genotype in order to produce a second
generation of males. The F2 generation contained more fertile males that were one generation
separated from the RNAi treatment. The males were then used in genetic crosses.
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Chapter 3 Figures:

Figure 12: C. elegans mechanosensory neuronal network.
(A) A diagram of a wildtype mechanosensory neuronal network. The PLM axon terminates
growth near the midline, posterior to the ALM cell body. (B) A diagram of a mechanosensory
neuronal network with an overextended PLM. The PLM axon terminates growth anterior to the
ALM cell body. The black arrow indicates the PLM axon tip. The dotted arrow indicates the
ectopic branch formed between the PLM and the ventral nerve chord. The posterior end of the
worm is on the left, the anterior end of the worm is on the right.
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Figure 13: Mutations equivalent to the G402R and G406R Timothy syndrome mutations
cause PLM axon termination defects.
(A) The egl-19(n2368) and egl-19(tr134) mutations are equivalent to the G402R Timothy
Syndrome mutation in CACNA1C that causes autism in humans. The egl-19(syb1243) mutation
is equivalent to the CACNA1C G406R mutation that causes Timothy Syndrome in humans. (B)
Example of normal axon termination in a L4 stage wild-type PLM neuron, where the axon
terminates posterior to the ALM cell body. (C) Example of axon termination defect in a L4
stage egl-19(gof) mutant, where the axon terminates anterior to the ALM cell body. Axons are
visualized with the muIs32 transgene that encodes Pmec-7::gfp. Arrows point to the tip of the
PLM axon. Asterisk marks the ALM cell body. Scales bars are 10um. (D) Gain-of-function
mutations in egl-19 cause axon termination defects. The egl-19(lof) mutation does not affect
axon termination. (E) Transgenic expression of EGL-19(GOF) specifically within touch receptor
neurons causes axon termination defects. The Pmec-7::egl-19(gof) transgenes use the mec-7
promoter to drive expression of an egl-19 cDNA that includes a mutation identical to the egl19(n2368) mutation. For Pmec-7::egl-19(gof)-5 ng/ul, 2 independent transgenic strains were
analyzed and the results were averaged. For Pmec-7::egl-19(gof)-25 ng/ul, 1 transgenic strain
was analyzed.
Between 200 and 400 axons were observed in L4 stage hermaphrodites per genotype. Asterisks
indicate statistically significant difference, Z-test for proportions (*p<0.0001). Error bars
represent the standard error of the proportion.
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Figure 14: The egl-19(gof) Timothy syndrome mutation causes ALM axon termination
defects.
(A) Example of normal axon termination in a L4 stage wild-type ALM neuron, where the axon
terminates posterior to the mouth of the worm. (B) Example of axon termination defect in a L4
stage egl-19(gof) mutant, where the axon extends to the anterior most point of the worm. Axons
are visualized with the muIs32 transgene that encodes Pmec-7::gfp. Arrows point to the tip of the
ALM axon. Asterisk marks the anterior-most part of the worm. Scales bar is 10um. (C) Gain-offunction mutations in egl-19 cause axon termination defects.
Between 100 and 150 axons were observed in L4 stage hermaphrodites per genotype. Asterisks
indicate statistically significant difference, Z-test for proportions (***p<0.0001). Error bars
represent the standard error of the proportion.
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Figure 15: The egl-19(gof) Timothy syndrome mutation causes ALM posterior process
defects.
(A) Example of a normal cell body in a L4 stage wild-type ALM neuron, where there are no
visible processes extending from the posterior side of the ALM cell body. (B) Example of a
posterior process phenotype in a L4 stage egl-19(gof) mutant, where a visible process extends
from the posterior side of the ALM cell body. Axons are visualized with the muIs32 transgene
that encodes Pmec-7::gfp. Arrows point to the tip of the posterior process formed from the ALM
cell body. Asterisk marks the anterior most position on the worm. Scale bar is 10um. (C) Gainof-function mutations in egl-19 cause posterior process defects in the ALM.
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Between 100 and 150 axons were observed in L4 stage hermaphrodites per genotype. Asterisks
indicate statistically significant difference, Z-test for proportions (*p<0.0005). Error bars
represent the standard error of the proportion.
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Figure 16: VGCC genes negatively regulate axon termination.
(A) Loss-of-function mutations in VGCC genes suppress axon termination defects caused by the
fsn-1(null) mutation. The egl-19 gene encodes the pore-forming subunit of the L-type VGCC.
The unc-2 gene encodes the pore-forming subunit of the P/Q-type VGCC and the unc-36 gene
encodes the alpha2-delta3 subunit that works with both the L-type and P/Q-type VGCCs. (B)
Mutations in VGCC genes do not suppress axon termination defects caused by loss-of-function
mutations in glo-4 or rpm-1. (C) Loss of VGCC function can partially suppress axon termination
defects caused by the fsn-1(null); glo-4(null) double mutant background. Asterisks indicate
statistically significant difference, Z-test for proportions (*p<0.005, ***p<0.0001). Between 200
and 400 axons were observed in L4 stage hermaphrodites per genotype using the muIs32
transgene. Error bars represent the standard error of the proportion. For Pmec-7::unc-36::rfp, 2
independent transgenic strains were analyzed and the results were averaged. Alleles: fsn-1(null)
is fsn-1(gk429), egl-19(lof) is egl-19(n582), unc-2(null) is unc-2(e55), unc-36(null) is unc36(e251), glo-4(null) is glo-4(ok362), rpm-1(lof) is rpm-1(ok364)
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Figure 17: The egl-19(gof) Timothy syndrome mutation causes no visible change to PLM
chemical synapse and branch formation.
(A) Example of normal PLM chemical synapse in a wild-type animal. The PLM axon and branch
of a wild-type animal are shown here in the L4 stage. (B) The PLM chemical synapses of a wildtype animal are shown here in the L4 stage. (C) The merged image showing the PLM chemical
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synapse in a wild-type animal. (D) Example of chemical synapses in an egl-19(gof) mutant. The
PLM axon and branch appear morphologically unchanged by the egl-19(gof) mutation, shown
here in the L4 stage. (E) The PLM chemical synapses appear morphologically unchanged by the
egl-19(gof) mutation, shown here in the L4 stage.. (F) The merged image showing the PLM
chemical synapse in an egl-19(gof) animal. The axon and its synaptic branch are shown in red as
visualized with the jsls973 transgene that encodes Pmec-7::rfp. The chemical synapse is shown
in green as visualized by the jsls821 transgene that encodes Pmec-7::gfp::rab-3. The synaptic
vesicles appear yellow in merged images due to overlap with the red signal. (G) The PLM
chemical synapses are unaffected by changes in egl-19 function. The average width of the
chemical synapse cluster is not changed by the egl-19(gof) mutation. Between 50 and 100
chemical synapse clusters were observed in L4 stage hermaphrodites per genotype using the
jsls821 transgene. Error bars represent the standard error of the proportion. (H) The PLM
synaptic branch is unaffected by changes in egl-19 function. The egl-19(gof) mutation does not
cause defects in the PLM synaptic branch. The egl-19(lof) mutation does not suppress the PLM
synaptic branch defect caused by the fsn-1(null) mutation. Z-test for proportions. Between 200
and 400 synaptic branches were observed in L4 stage hermaphrodites per genotype using the
muIs32 transgene. Error bars represent the standard error of the proportion. Alleles: egl-19(gof)
is egl-19(n2368), fsn-1(null) is fsn-1(gk429), egl-19(lof) is egl-19(n582).
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Figure 18: The egl-19(gof) Timothy syndrome mutation causes mislocalization of PLM
electrical synapses.
(A) Example of zone 2 electrical synapses at the tip of the PLM axon in wildtype animals. (B)
Example of zone 2 electrical synapses at the tip of the PLM axon in egl-19(gof) mutants. The
zone 2 electrical synapses should be localized posterior to the ALM cell body. However, in egl19(gof) mutants, the zone 2 electrical synapses are aberrantly localized anterior to the ALM cell
body. Electrical synapses were visualized with the yadIs12 transgene that encodes Pmec4::gfp::unc-9 (Meng et al., 2016). Axons were observed under the Zeiss Axio Imager M2
microscope, and images were acquired using the Axiocam 702mono camera. Fluorescence
illumination was performed with an X-cite 120LED boost by Lumen Dynamics. Arrow marks
electrical synapses at the tip of the PLM axon. Asterisk marks the ALM cell body. Scalebars are
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10um. (C) The egl-19(gof) mutation causes mislocalization of PLM zone 2 electrical synapses.
Z-test for proportions (***p<0.0001). Between 200 and 400 zone 2 electrical synapses were
observed in L4 stage hermaphrodites per genotype using the yadIs12 transgene.. Alleles: egl19(gof) is egl-19(n2368).
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Figure 19: PLM-BDU connection is not disrupted by the egl-19(gof) Timothy syndrome
mutation.
(A) An example of normal axon termination in a L4 stage wild-type PLM neuron, where the
axon terminations posterior to the ALM cell body. (B) Example of a normal PLM-BDU
connection. The BDU migrates towards PLM to form a connection with the axon tip of the PLM.
(C) Example of axon termination defect in a L4 stage egl-19(gof) mutant, where the axon
terminates anterior to the ALM cell body.. (D)Example of PLM-BDU connection in egl-19(gof)
mutants. Despite the overextension of the PLM, the BDU migrates towards the PLM and forms a
connection with the axon tip of the PLM. ALM and PLM axons are visualized with the muIs32
transgene that encodes Pmec-7::gfp. BDU axons are visualized with the kyIs262 transgene that
encodes Punc-86::myr gfp + odr-1::rfp. Axons were observed under the Zeiss Axio Imager M2
microscope, and images were acquired using the Axiocam 702mono camera. Fluorescence
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illumination was performed with an X-cite 120LED boost by Lumen Dynamics. Arrows point to
the tip of the PLM axon. Asterisk marks the ALM cell body. Scales bar are 10um. Alleles: egl19(gof) is egl-19(n2368).

93

Figure 20: EGL-19(GOF) functions with selective autophagy to cause axon termination
defects.
(A) Axon termination defects caused by the egl-19(gof) mutation are suppressed by loss-offunction mutations in wdfy-3(lof), epg-7(null) and cup-5(lof). (B) Axon termination defects
caused by the fsn-1(null) mutation are suppressed by the wdfy-3(lof) mutation. However, axon
termination defects caused by rpm-1(lof) mutation are not suppressed by the wdfy-3(lof)
mutation. (C) Axon termination defects caused by the fsn-1(null) mutation are not suppressed by
the sqst-1(lof) mutation. The sqst-1 gene encodes a cargo receptor protein that functions with
WDFY-3 in selective autophagy. Axons are visualized with the muIs32 transgene that encodes
Pmec-7::gfp. Asterisks indicate statistically significant difference, Z-test for proportions
(*p<0.005, ***p<0.0001). Error bars represent the standard error of the proportion. n=200-400
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axons per genotype. Alleles: egl-19(gof) is egl-19(n2368), wdfy-3(lof) is wdfy-3(ok912), epg7(null) is epg-7(tm2508), cup-5(lof) is cup-5(ar465), fsn-1(null) is fsn-1(gk429), rpm-1(lof) is
rpm-1(ok364).
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Figure 21: Loss-of-function mutations in the autism associated gene shn-1 suppress the
axon termination defects caused by fsn-1(null) mutation.
Axon termination defects caused by the fsn-1(null) mutation are partially suppressed by loss-offunction mutations in shn-1. Z-test for proportions (*p<0.05). Between 200 and 400 synaptic
branches were observed in L4 stage hermaphrodites per genotype using the muIs32 transgene.
Error bars represent the standard error of the proportion. Alleles: fsn-1(null) is fsn-1(gk429).
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Figure 22: The wdfy-3 gene functions with the egl-19(gof) mutation to alter habituation to
light touch.
Animals were subjected to eyelash touches alternating between the head and tail and the
response rate was recorded after each touch. (A) Response rate for anterior touches. (B)
Response rate for posterior touches. For both anterior and posterior touches habituation was
significantly increased in egl-19(gof) mutants relative to wild-type. This change in habituation in
egl-19(gof) mutants was suppressed by wdfy-3(lof). Asterisks indicate statistically significant
difference compared to wild type worms, Z-test for proportions (*p<0.0001). Error bars
represent the standard error of the proportion. For each genotype, the assay was repeated 3 times
by 3 different observers who were blind to the genotype. Each experiment included 20 worms for
a total n of 60 for each genotype. Alleles: egl-19(gof) is egl-19(n2368), wdfy-3(lof) is wdfy3(ok912).
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Figure 23: loss-of-function of wdfy-3 partially suppresses overextension phenotype caused
by glo-4(null) mutation.
Axon termination defects caused by the glo-4(null) mutation are partially suppressed by the
wdfy-3(lof) mutation. The suppression appears to be a pleiotropic affect due to the many
additional and unique defects in the PLM axon in the wdfy-3(lof);glo-4(null) mutant. Asterisks
indicate statistically significant difference compared to wild type worms, Z-test for proportions
(*p<0.01). Error bars represent the standard error of the proportion. Between 200 and 400
synaptic branches were observed in L4 stage hermaphrodites per genotype using the muIs32
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transgene. Error bars represent the standard error of the proportion. Alleles: wdfy-3(lof) is wdfy3(ok912), glo-4(null) is glo-4(ok362).
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Figure 24: Loss-of-function of both egl-19 and unc-2 genes enhances the axon termination
defects caused by the fsn-1(null) mutation.
Axon termination defects caused by the fsn-1(null) mutation are suppressed by the egl-19(lof)
mutation. Axon termination defects caused by the fsn-1(null) mutation are suppressed by the
unc-2(null) mutation. Loss of egl-19 and unc-2 function enhance axon termination defects
caused by the fsn-1(null) mutation. Asterisks indicate statistically significant difference
compared to wild type worms, Z-test for proportions (*p<0.005, ***p<0.0001). Error bars
represent the standard error of the proportion. Between 200 and 400 synaptic branches were
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observed in L4 stage hermaphrodites per genotype using the muIs32 transgene. Error bars
represent the standard error of the proportion. Alleles: fsn-1(null) is fsn-1(gk429), egl-19(lof) is
egl-19(n582), unc-2(null) is unc-2(e55).
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Figure 25: UNC-36 co-localizes with mitochondria in the PLM cell body.
(A) Expression of mec-7p::unc-36::RFP was used to visualize the voltage gated calcium channel
UNC-36 localization in the PLM cell body. Expression of the transgene bzIs62 which encodes
Pmec-7::lmp-1::GFP was used to visualize lysosomes. No co-localization was detected. (B)
Expression of mec-7p::unc-36::RFP was used to visualize the voltage gated calcium channel
UNC-36 localization in the PLM cell body. Expression of mec-7p::glo-1::GFP was used to
visualize the endosomal related protein GLO-1. No co-localization was detected. (C) Expression
of mec-7p::glo-1::RFP was used to the endosomal related protein GLO-1 localization in the
PLM cell body. Expression of the transgene bzIs62 which encodes mec-7p::lmp-1::GFP was
used to visualize lysosomes. No co-localization was detected. (D) Expression of mec-7p::unc36::RFP was used to visualize UNC-36 localization in the PLM cell body. Expression of the
transgene uIs145 which encodes mec-4p::aman-2::GFP was used to visualize golgi bodies. No
co-localization was detected. (E) Expression of mec-7p::unc-36::RFP was used to visualize
UNC-36 localization in the PLM cell body. Expression of the transgene sqIs24 which encodes
rgef-1p::lgg-1::GFP was used to visualize autophagosomes. No co-localization was detected.
(F) Expression of mec-7p::unc-36::RFP was used to visualize UNC-36 localization in the PLM
cell body. Expression of the transgene jsIs609, which encodes mec-7p::mito::GFP was used to
visualize mitochondria. Co-localization was detected. Zeiss imaging software was used to
capture images and to test for co-localization. Scalebar is 5um.
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Figure 26: Model for function of VGCCs in relation to the RPM-1 pathway.
This hypothetical model could explain the genetic interactions observed between VGCC genes
and genes that encode members of the RPM-1 pathway. In this model, VGCCs function with
WDFY-3 to negatively regulate an unknown protein (labeled as X). Protein X functions with
RPM-1 to promote signaling events downstream of FSN-1 that promote axon termination. Loss
of VGCC function causes an increase in protein X function. The additional protein X function
works with RPM-1 to promote axon termination mechanism B, thereby compensating for loss of
FSN-1 function. Loss of VGCCs does not suppress loss of RPM-1 function because the function
of protein X requires RPM-1.
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Figure 27: Model for function of VGCCs relative to specific members of the RPM-1
pathway.
PPM-1 is a protein that functions with RPM-1 to promote signaling events downstream of FSN-1
that promote axon termination. It is possible that PPM-1, or another protein with a similar role,
could be protein X (see Figure 26). Both FSN-1 and PPM-1 promote axon termination by
functioning with RPM-1 to negatively regulate the DLK-1 MAP kinase pathway. Thus, it is
possible that VGCCs and WDFY-3 could negatively regulate PPM-1, or a protein with a similar
role. The extra PPM-1 function could enhance negative regulation of the DLK-1 pathway,
thereby compensating for loss of FSN-1 function.
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Table 1: List of mutations.
Gene
egl-19(n2368)

egl-19(tr134)

egl-19(syb1243)

egl-19(n582)

fsn-1(gk429)

unc-2(e55)
unc-36(e251)
glo-4(ok362)

rpm-1(ok364)

wdfy-3(ok912)

egl-19(syb4935)

egp-7(tm2508)
cup-5(ar465)

glo-1(zu391)

Description
Encodes L-type voltage gated calcium channel alpha-1 subunit,
homolog to human CACNA1C, contains gain-of-function point
mutation equivalent to G402R mutation that causes Timothy
syndrome in humans
Encodes L-type voltage gated calcium channel alpha-1 subunit,
homolog to human CACNA1C, contains gain-of-function point
mutation equivalent to G402R mutation that causes Timothy
syndrome in humans
Encodes L-type voltage gated calcium channel alpha-1 subunit,
homolog to human CACNA1C, contains gain-of-function point
mutation equivalent to G406R mutation that causes Timothy
syndrome in humans
Encodes L-type voltage gated calcium channel alpha-1 subunit,
homolog to human CACNA1C, contains loss-of-function mutation
Encodes an F-box protein that regulates a map kinase cascade,
important for axon termination, homolog to human FBXO45,
contains null mutation
Encodes P/Q-type voltage gated calcium channel alpha-1 subunit,
homolog to human CACNA1B, contains null mutation
Encodes P/Q-type voltage gated calcium channel alpha-2-delta
subunit, homolog to human CACNA2D3, contains null mutation
Encodes a guanine nucleotide exchange factor, important for axon
termination, homolog to human RCBTB1, contains null mutation
Encodes an E3 ubiquitin ligase, important for axon termination,
homolog to human/drosophila PAM/Highwire proteins, contains
loss-of-function mutation
Encodes a selective autophagy adaptor protein, variants statistically
associated with autism, homolog to human WDFY-3, contains lossof-function mutation
Encodes L-type voltage gated calcium channel alpha-1 subunit,
homolog to human CACNA1C, contains gain-of-function point
mutation equivalent to G402R mutation that causes Timothy
syndrome in humans
Encodes a selective autophagy adaptor protein, homolog to yeast
ATG-11, contains null mutation
Encodes a scaffold protein essential to lysosome formation,
homolog to MCOLN3, contains hypomorphic loss-of-function
mutation
Encodes a Rab GTPase downstream of GLO-4, important for axon
termination, homolog to human RAB38, contains a loss-of-function
mutation
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ric-7(nu447)
egl-30(n686)
cca-1(gk30)

msi-1(os1)

Encodes a protein important for proper mitochondrial localization
in the axon, contains loss-of-function mutation
Encodes a G protein subunit, important for learning and memory,
homolog to human GNAQ, contains a loss-of-function mutation
Encodes a T-type voltage gated calcium channel alpha-1 subunit,
homolog to human CACNA1G and CACNA1I, contains loss-offunction mutation
Encodes an RNA binding protein, involved in neurodevelopment,
homolog to human MSI1, contains loss-of-function mutation
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Table 2: List of transgenes.
Transgene
cueEx19 + cueEx20
cueEx21
cueEx17 + cueEx18
muIs32
jsls973
jsls821
yadIs12
kyIs262
cueEx22
cueEx23
bzIs62
uIs145
sqIs24
jsIs609

Description
Pmec-7::egl-19(gof) at 5 ng/ul + Podr-1::rfp at 50 ng/ul used to
observe Timothy syndrome mutation in mechanosensory neurons
Pmec-7::egl-19(gof) at 25 ng/ul + Podr-1::rfp at 50 ng/ul used to
observe Timothy syndrome mutation in mechanosensory neurons
Pmec-7::unc-36::rfp at 5 ng/ul + Pstr-1::gfp at 50 ng/ul used to
observe Timothy syndrome mutation in mechanosensory neurons
Pmec-7::gfp is expressed in all mechanosensory neurons, used to
observe defects in the mechanosensory neurons
Pmec-7::rfp is expressed in all mechanosensory neurons, used to
observe defects in the mechanosensory neurons
Pmec-7::gfp::rab-3 used to observe the localization of chemical
synapses in the PLM axon
Pmec-4::gfp::unc-9 used to observe electrical synapses in the
PLM axon
Punc-86::myr GFP + odr-1::RFP is expressed in touch neurons
and interneurons, used to observe the BDU neuron
Pmec-7::glo-1::gfp used to view glo-1 expression patterns in the
mechanosensory neurons
Pmec-7::glo-1::rfp used to view glo-1 expression patterns in the
mechanosensory neurons
Pmec-7::lmp-1::gfp used to view lysosomes in the
mechanosensory neurons
Pmec-4::aman-2::yfp used to view golgi in the mechanosensory
neurons
Prgef-1::lgg-1::gfp used to view autophagosomes in the
mechanosensory neurons
Pmec-7::mito::gfp used to view mitochondria in the
mechanosensory neurons
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Chapter 4 – General Discussion

4.1 Summary of key findings
The results of this dissertation research yield a novel model from which to continue
autism research in neurons. The model is a neuron morphology defect caused by a genetic
variant that is causative for autism. Moreover, this genetic variant also causes a related
behavioral defect. This autism model is incredibly useful for studying neuronal development. By
using the model system, we uncovered a number of primary findings.
The first finding was genetic evidence for a role for voltage gated calcium channels
(VGCC) as regulators of axon termination. We showed that loss of function of VGCC genes
suppress the axon overextension phenotype that is caused by loss of fsn-1 function. Moreover,
the autism-linked Timothy syndrome mutation known as egl-19(gof) caused an axon
overextension phenotype on its own. We also have evidence that synapse integrity remains
unaffected by the egl-19(gof) mutation, suggesting a synaptogenesis-independent mechanism. As
mentioned in the first chapter, the human homolog for egl-19 known as CACNA1C has been
associated with a number of different neurodevelopmental disorders (Ferreira et al., 2008; Li et
al., 2015), including ASD (Lu et al., 2012; Boczek et al., 2015; Li et al., 2015). The egl-19(gof)
mutation results in the exact same amino acid change that can occur in CACNA1C to cause
Timothy syndrome in humans. Therefore, we have uncovered a cellular/genetic mechanism by
which the calcium channel CACNA1C could act to influence neuronal development, and when
mutated leads to neurodevelopmental disorders. Indeed, the direct connection of the gain-offunction Timothy syndrome mutation in the CACNA1C homolog in C. elegans is a new piece of
evidence associating the ASD-causing mutation to a neurodevelopmental change in the form of
axon termination defects. The genetic interactions between the Timothy syndrome mutation and
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other known mechanisms governing axon termination only strengthens this link between the
ASD-causing mutation and neurodevelopmental changes. Moreover, the resulting axon
overextension in the mechanosensory network is a potential contributor to the behavioral defects
observed in the Timothy syndrome mutant worms, as the overextension displaces the electrical
synapses located at the tip of the PLM to the anterior portion of the worm. The aforementioned
electrical synapses located at the PLM axon tip and their role in the mechanosensation of C.
elegans is the subject of a future study in our lab, as the exact contribution of that synaptic
connection with the BDU neuron is not well understood. Regardless, the morphological and
behavioral defects induced by the monogenic Timothy syndrome mutation make our ASD model
one of great interest for future studies of ASD. However, this model has additional depth which
we also uncovered that could link CACNA1C and ASD to another mechanism; autophagy.
In addition to the link between an ASD-causing CACNA1C variant and axon
overextension, the second major finding was a connection between selective autophagy and
CACNA1C in the development of ASD. Autophagy has been statistically associated with ASD
(Krey et al., 2013; Tang et al., 2014; Sragovich et al., 2017; Napoli et al., 2018) and other
neurodevelopmental disorders (Lee, 2012; Lee, K.-M. et al., 2013). Selective autophagy is less
understood as a cellular mechanism compared to other forms of autophagy, and the evidence
linking selective autophagy to neurodevelopmental disorders is limited (Iossifov et al., 2012;
Iossifov et al., 2014). We have provided biological evidence for the suppression of egl-19 (gof)
Timothy syndrome mutation-induced overextension phenotypes by wdfy-3 selective autophagy
gene loss-of-function mutation. While the selective autophagy protein WDFY-3 has been shown
to be essential for the development of neurons (Iossifov et al., 2012; Orosco et al., 2014; Dragich
et al., 2016; Napoli et al., 2018), our evidence is the first that puts it in a pathway with a genetic
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variant that causes autism in humans. Considering that WDFY-3 is an adaptor protein and acts as
a scaffold for the targeting and degradation of a variety of different cargo (Simonsen et al., 2004;
Pohl & Jentsch, 2009; Filimonenko et al., 2010; Lystad et al., 2014; Napoli et al., 2018),
identification of the targets for selective autophagy in this process are likely to yield mechanistic
insights. Therefore, identification of the selective autophagy targets in the ASD model we have
developed is the subject of a current study.
The evidence we gathered from our research suggests a strong role for selective
autophagy as a regulator of axon termination during both normal and pathological development.
Indeed, selective autophagy appears to be both an important target for the Timothy syndrome
mutation, but also regulates normal axon development in the absence of the Timothy syndrome
mutation. As mentioned, we have demonstrated that loss of wdfy-3 function suppresses the
overextension caused by the egl-19(gof) Timothy syndrome mutation. Our evidence also shows
selective autophagy mutant genes wdfy-3 and epg-7 suppress the fsn-1(null) phenotype, similar
to the VGCC loss-of-function mutant suppression on the fsn-1 lof phenotype. This evidence
further strengthens the connection between selective autophagy and the regulation of axon
termination. In addition, similar suppression using lysosome hypomorphic lof mutations agree
that autophagy is a key regulator of axon termination, as lysosomal degradation of autophagic
cargo is the final step of the autophagy pathway (Levine & Kroemer, 2008). The connection
extends to the behavioral defects shown in the egl-19(gof) Timothy syndrome mutants, as the
defects can be suppressed by wdfy-3(lof), further strengthening our model. Overall, our findings
strengthen the connection between the CACNA1C and WDFY-3 genes and their role in
neurodevelopment.
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Finally, our model ties VGCCs and selective autophagy back to ASD. There is a strong
ASD connection to the EGL-19 and selective autophagy pathway that will help us understand the
development of ASD. Both CACNA1C and WDFY-3 have statistical connections to ASD (Lu et
al., 2012; Lee, S.H. et al., 2013; De Rubeis et al., 2014; Iossifov et al., 2014; Li et al., 2015;
Wang, T. et al., 2016; RK et al., 2017). Our genetic, mechanistic, and behavioral data further
connect these ASD risk variants. The morphological and behavioral changes make for a good
model to use for better understanding of ASD. Having a model such as this is vitally important
since most ASD linked variants have little effect on their own. Therefore, ASD is likely to arise
from interactions between variant genes, and this model can be a useful system to test such
interactions. Future research can continue to use this model to further elucidate the mechanistic
causes of ASD.

4.2 EGL-19 and WDFY-3

4.2.1 Selective autophagy and neurodevelopment
There is much evidence of autophagy influencing axon outgrowth, but not as much
concerning the importance of selective autophagy. In cultured mouse neurons, loss of autophagy
leads to axon growth, while inducing autophagy inhibits axon growth (Hara et al., 2006). In
Drosophila, autophagy has been shown to promote development of the neuro-muscular junction
(Shen & Ganetzky, 2009). In C. elegans, autophagosomes form at synaptic sites and are required
for presynaptic assembly (Stavoe et al., 2016; Hill et al., 2019). These studies each provide
insight into the importance of autophagy in neurodevelopment. However, the studies were
focused on autophagy in a general sense. What we have produced is evidence of selective
autophagy regulating axon outgrowth in a manner independent of general autophagy pathways.
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Our evidence shows selective autophagy mediates the specific axon outgrowth step of axon
termination. Unlike the work done to show that loss of autophagy leads to axon growth in mouse
neurons (Hara et al., 2006), we show loss of selective autophagy does not increase outgrowth in
C. elegans. The pathway we have established shows that loss of function of the selective
autophagy gene wdfy-3 can suppress axon termination defects created by both the egl-19(gof)
mutation and the fsn-1(null) mutation. This suppression of axon termination defects is done
without affecting synaptogenesis. This is consistent with the literature, as mutations in selective
autophagy genes do not affect the regulation of synaptogenesis (Stavoe et al., 2016). This also
suggests that selective autophagy regulation of axon termination is a separate pathway from
general autophagic activity at the synapses in C. elegans. Overall, this isolation of selective
autophagy as a mediator of axon termination is a specialized pathway and could help us further
elucidate how selective autophagy affects neurodevelopment.

4.2.2 Our findings and their connection with Selective Autophagy and Neurodevelopment
As outlined in the background, the selective autophagy gene WDFY-3 has been
statistically associated with ASD in multiple studies (Iossifov et al., 2012; Iossifov et al., 2014).
In addition, studies done in mice have shown that the loss of WDFY-3 function results in altered
neurogenesis and a reduction in neuronal connectivity (Orosco et al., 2014; Dragich et al., 2016).
These studies showcase the importance of WDFY-3 during neurodevelopment, and provide
examples of what can go wrong when WDFY-3 is not functioning properly. Our findings
provide the first biological evidence that associates WDFY-3 with ASD and uncover a
neurodevelopmental mechanism that WDFY-3 regulates. In addition, given the known links
between autophagy and neurodevelopmental disorders (Krey et al., 2013; Tang et al., 2014;
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Sragovich et al., 2017; Napoli et al., 2018), our findings are consistent and support a major role
for autophagy in neuronal development. However, the connection between selective autophagy
and neurodevelopmental disorders is lacking in terms of clear biological data. We provide novel
biological evidence that is consistent with the role of WDFY-3 in regulating neurodevelopment.
Moreover, our evidence linking selective autophagy and the ASD-causing Timothy syndrome
mutation adds one of the first pieces of biological evidence for selective autophagy playing a role
in ASD development

4.2.3 The role of CACNA1C in regulating selective autophagy
There are previously established roles for calcium channels in the regulation of
autophagy (Tian et al., 2015; Wang, Y. et al., 2016). Studies show that VGCCs can promote
autophagy in Drosophila and mice (Tian et al., 2015) and that CACNA1A has a direct
connection with autophagosome fusion with lysosomes (Wang, Y. et al., 2016). We have
provided biological evidence of a role for CACNA1C mediating selective autophagy for
neurodevelopment. Our evidence puts selective autophagy downstream of the EGL-19 calcium
channel, seen in the suppression of the overextension induced by the egl-19(gof) Timothy
syndrome mutation by the wdfy-3(lof) mutation. The interaction between CACNA1C and
selective autophagy is a novel connection. However, while we have provided a connection
between CACNA1C and selective autophagy, the exact way the calcium channel proteins are
interacting with the autophagy pathway are something we are still investigating. Because many
organelles are important in the autophagy pathway, it could be that VGCCs interact with the
lysosome related GLO-1, golgi bodies, late endosomes, or directly with lysosomes. Late
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endosomes are a strong candidate for a potential interactor with VGCCs, as there is already
evidence of interaction between the two (Tian et al., 2015).

4.3 Mechanisms for VGCCs as regulators of neurodevelopment
The novelty of our findings is that they place selective autophagy in a pathway with
voltage gated calcium channels in the regulation of axon outgrowth. Variants in CACNA1C have
been statistically shown to be an ASD risk factor and a risk factor for other neurodevelopmental
disorders (Ferreira et al., 2008; Lu et al., 2012; Li et al., 2015). However, the actual mechanisms
involved in CACNA1C mutation induced neurodevelopmental disorders are still unknown. Our
research further strengthens the connection between CACNA1C and ASD by tying CACNA1C
to the function of the selective autophagy gene WDFY-3, which has also been statistically
associated with ASD (Iossifov et al., 2012; Iossifov et al., 2014). Our evidence also adds a
possible mechanism for the regulation of axon termination by selective autophagy. Looking
beyond CACNA1C to the other VGCCs may allow us to find more context for interpreting our
evidence.
Axon termination was not previously recognized as a VGCC mediated step of axon
outgrowth. To underscore the importance of VGCCs in axon termination, our data show
enhanced suppression of fsn-1(null) overextension phenotype when coupled with unc-36(lof),
compared to fsn-1(null) double mutants with other VGCC loss-of-function mutations. This is
significant as UNC-36 regulates the function of EGL-19 and the localization of UNC-2 calcium
channels (Caylor et al., 2013), thus providing a possible explanation for the enhanced phenotype.
However our fsn-1(null);egl-19(lof);unc-2(null) showed an enhancement of axon termination
defects, suggesting unc-36 functions to regulate axon termination independent of EGL-19 and
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UNC-2. While our data is the first to suggest VGCCs are regulators of axon termination, we are
not the first to find that VGCCs affect the general outgrowth of axons. Many studies have linked
calcium signaling to the regulation of neurite outgrowth (Gomez & Spitzer, 1999; Zheng, 2000;
Henley & Poo, 2004; Wayman et al., 2008; Takemoto-Kimura et al., 2010). A recent study
showed that knocking down CACNA1C results in shorter axons in mice (Kamijo et al., 2018).
Although this study did not focus on axon termination, but instead found that overall neurite
length decreases in CACNA1C mutants, our findings are in line with these findings, and add
more evidence to the regulatory abilities of VGCCs during axon development.

4.4 RPM-1 pathway revelations
Our data suggest EGL-19 and WDFY-3 are acting outside of the RPM-1 pathway. While the
suppression of the fsn-1(null) axon overextension phenotype by both egl-19(lof) and wdfy-3(lof)
mutants means they could be downstream targets of FSN-1, our remaining data suggest they act
outside of the RPM-1 pathway. The triple mutant analysis of fsn-1(null);glo-4(null);unc36(null)
also suggest that EGL-19 and WDFY-3 suppression is specific to FSN-1 only. We also found
that wdfy-3(lof) caused pleiotropic affects to the PLM axon, which was not observed in any of
the VGCC and RPM-1 pathway double mutants. This could be indicative of the variety of roles
WDFY-3 plays in mechanosensory neurons, or an interaction between WDFY-3 and the RPM-1
pathway that requires further experimentation. Regardless, there is strong evidence suggesting
EGL-19 and WDFY-3 function outside of the RPM-1 pathway.
The primary evidence for the EGL-19 and WDFY-3 pathway being outside the RPM-1
pathway is that there is no VGCC(lof) or wdfy-3(lof)) suppression of the rpm-1(lof) severe
overextension phenotype. Moreover, in examining the localization of PLM-BDU electrical
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synapses in the overextended axon of egl-19(gof) mutants, we found that the synapses appear
anterior to the ALM cell body at the very tip of the overextended PLM axon. However, work on
the RPM-1 mutants examining the same synapses has demonstrated that the rpm-1(lof) mutants
have overextension of the PLM, but the PLM-BDU synapses are in their normal location and not
at the tip of the PLM axon (Borgen, M.A. et al., 2017). We also determined that the PLM-BDU
connection in the egl-19(gof) worms appeared to be intact. This difference between the egl19(gof) and rpm-1(lof) phenotypes, along with our genetic data, suggest that the mechanism of
axon termination affected by the egl-19(gof) mutation is separate from the RPM-1 pathway.
There are a few explanations for the data we have gathered regarding the RPM-1
pathway. For instance, FSN-1 could also be acting outside of its known function of working with
RPM-1 to ubiquitinate DLK-1 (Liao et al., 2004). Thus, FSN-1 could degrade a different target,
such as EGL-19, by partnering with a different E3 ubiquitin ligase domain containing protein. Or
it could be that EGL-19 and WDFY-3 act on a pathway adjacent to the FSN-1 pathway. There is
evidence of additional parallel pathways that regulate the downstream DLK-1 independently of
FSN-1 (Tulgren et al., 2011). While PHR proteins are known as axon termination regulators, it
could be that WDFY-3 and EGL-19 establish their own pathway, possibly incorporating separate
proteins to regulate axon termination.
Additionally, research on RPM-1 has opened up a possible mechanism by which the
WDFY-3 mediated selective autophagy functions to regulate axon termination. RPM-1 was
found to regulate the trafficking of the SAX-3 (homolog to human ROBO) and UNC-5 receptors
to the cell membrane (Li et al., 2008). This is thought to be a potential mechanism for axon
termination regulation via RPM-1; via the tight control of the localization of axon outgrowth
mediators SAX-3 and UNC-5. We would need to test if the selective autophagy mediated by
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WDFY-3 is somehow involved in the regulation of axon outgrowth receptors to determine if the
EGL-19 and WDFY-3 pathway is using a similar mechanism to regulate axon termination. That
is why determining the target of the WDFY-3 selective autophagy is paramount going forward.

4.5 Future Directions
4.5.1 AIM 1: Autophagy and Axon Development
The primary goal for future research is to determine how selective autophagy is
regulating axon outgrowth and axon termination. The GFP::LGG1 marker, a well-established
and stable marker for autophagosomes, had been used successfully to quantify autophagosome
formation (Stavoe et al., 2016; Hill & Colón-Ramos, 2018). We will utilize this marker to
examine changes in autophagosome numbers and trafficking in multiple VGCC mutant
backgrounds. Specifically, we will image GFP::LGG1 in egl-19(gof), egl-19(lof) and unc-36(lof)
mutant worms. If the Timothy Syndrome mutation promotes autophagy, we would expect to see
increased autophagosome clusters in the egl-19(gof) mutant background.
We will examine further evidence of a direct relationship between VGCCs and targets
related to selective autophagy. One way to address this is to continue examining the different
possible targets of selective autophagy in VGCC mutant backgrounds to see what is relevant.
These targets could be aggresomes, golgi, ER, lysosomes, lysosome related organelles, and
mitochondria. We will focus on the PLM neuron for these experiments, and will utilize the
following fluorescent markers: a-synuclein::YFP for aggresomes, AMAN-2::YFP for Golgi,
YFP::TRAM-1 for ER, LMP::1::GFP for lysosomes, GFP::GLO-1 for lysosome related
organelles, and mitochondria-targeted::GFP (mito::GFP) for mitochondria. These transgenes are
readily available and have been used in a number of studies (Hermann et al., 2005; van Ham et
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al., 2008; Chen et al., 2016; Melentijevic et al., 2017). We can also test each marker in the
following genetic backgrounds: egl-19(gof), egl-19(lof), and unc-36(lof). We can also utilize
wdfy-3(lof) and epg-7(lof) to test if any changes are dependent on selective autophagy. We can
use mitochondria, as we have already observed a possible connection between mitochondria and
VGCCs, and given the connection between mitochondria, axon outgrowth, and mitophagy
(Morris & Hollenbeck, 1993; Han et al., 2016; Napoli et al., 2018; Smith & Gallo, 2018). If
VGCCs are negatively regulating mitophagy, then we would expect loss-of-function mutations
of VGCC genes to result in increased mitophagy. A previous study suggests upregulated
mitophagy increases mitochondria numbers in the axon (Napoli et al., 2018). Therefore, we
would expect that the number of mitochondria clusters would increase in VGCC loss-of-function
backgrounds. Following these morphological experiments, we will do genetic experiments
utilizing mutant genes of the various targets of autophagy to support any connections we find.
For example, we can use ric-7(lof) and unc-116(lof) mutants, both of which are vital for the
proper localization of mitochondria in the axon (Rawson et al., 2014). If VGCCs promote
selective autophagy of mitochondria, we would expect the ric-7(lof) and unc-116(lof) mutants to
exhibit suppression of the overextension caused by the background egl-19(gof) Timothy
syndrome mutation in a similar way to wdfy-3(lof).
Finally, additional selective autophagy genes tested against the egl-19(gof) Timothy
syndrome mutation may narrow down which type of selective autophagy is downstream of EGL19. These include epg-2 and various sqst genes, both of which encode for adaptor proteins for
selective autophagy (Lamark et al., 2009; Tian et al., 2010; Lin et al., 2013). If any of these
selective autophagy adaptor proteins function downstream of EGL-19, then we expect to see a
suppression of the overextension caused by the egl-19(gof) Timothy syndrome mutation. These
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same sets of experiments would also be carried out in regard to the behavioral defects observed
in the egl-19(gof) Timothy syndrome mutants. We would expect the loss-of-function of selective
autophagy proteins functioning downstream of EGL-19 to suppress the increased
mechanosensory adaptation. Additional experiments can be done in reverse to test whether genes
responsible for axon termination are upstream of selective autophagy. We can use the wdfy-3(lof)
and epg-7(lof) mutations as backgrounds to see if they suppress the effects of the loss-of-function
mutant genes that cause overextension of the PLM, such as genes encoding members of the
RPM-1 pathway. Further experiments can be done to elucidate the role of the electrical synapses
formed between the PLM and the BDU, and whether or not the localization of these electrical
synapses play a role in the behavioral changes observed in the egl-19(gof) Timothy syndrome
mutants. Understanding the PLM-BDU connection would help us determine if the interaction
between EGL-19 and WDFY-3 acts during development to alter PLM-BDU connection, or
alternatively, if EGL-19 and WDFY-3 function elsewhere in the mature nervous system to affect
behavior. This particular line of experiments is not as imperative as those concerning selective
autophagy mechanisms, but still may run ancillary to primary studies to test additional cellular
mechanisms. Ultimately, all of these future experiments would aid in understanding the
specificity of the selective autophagy required for proper axon termination, and how these
mechanisms can go awry to lead to neurodevelopmental disorders such as ASD.

4.5.2 AIM 2: Human Variants
Studies have found that missense mutations in CACNA1C occur at a higher frequency in
individuals with ASD compared to control populations (Schaaf et al., 2011). In this study, a total
of 13 out of 376 control individuals carried missense mutations in CACNA1C, whereas 26 out of
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339 autistic individuals carried missense mutations in CACNA1C. Moreover, studies in both
humans and mice have associated both gain-of-function and loss-of-function VGCC variants to
ASD (Splawski et al., 2004; Bader et al., 2011; Bettt et al., 2012; Lee et al., 2012; RK et al.,
2017; Dedic et al., 2018). It is therefore important to test human variants of VGCC genes of
unknown significance in relation to neurodevelopmental disorders. This is especially true given
that the frequency of specific autism causing VGCC variants is low (Splawski et al., 2004; RK et
al., 2017), suggesting many other VGCC variants can also contribute to ASD. Since we found
that gain-of-function VGCC mutations cause axon termination defects, we can use that as an
indicator of gain-of-function mutations. The same can be done with loss-of-function variants, as
we found that loss-of-function VGCC mutations suppress axon termination defects in the fsn1(null) background. We can start by testing additional human variants associated with Timothy
syndrome by utilizing CRISPR mutations. An example of a Timothy syndrome variant that we
can induce with CRISPR is CACNA1C R240C (egl-19 R193C). We will also test unc36/CACNA2D3 variants and ccb-1/CACNB2 variants, as both genes have variants that have also
been associated with ASD (Breitenkamp et al., 2014; Iossifov et al., 2014; Yuen et al., 2015).
The findings can be strengthened through experiments showcasing enhanced phenotypes when
coupling multiple ASD risk factors. As human variant experiments in C. elegans are becoming
more efficient with improving genome editing technologies, these kinds of experiments will
provide a convincing means of linking human disorders with the evidence gathered through the
use of model organisms.
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4.5.3 AIM 3: RPM-1 pathway investigation
In regard to continued experimentation with the RPM-1 pathway, there are a number of
avenues we can consider. Genetic experiments utilizing additional RPM-1 pathway mutants,
such as DLK-1, can be useful in further specifying where EGL-19 and WDFY-3 are acting.
Rounding out the VGCC genetic testing with RPM-1 and GLO-4 would also be useful in that
regard, as we only tested unc-36(lof) and unc-2(lof) against the loss-of-function background of
the majority of the RPM-1 pathway. Another set of experiments we can do is to test the
involvement of WDFY-3 in other parts of the RPM-1 pathway. One experiment is to see if wdfy3(lof) suppresses the habituation defects also observed in fsn-1(null), glo-4(null), and rpm-1(lof)
mutant animals (Giles et al., 2015). However, these habituation defects are the opposite of what
we observed in the egl-19(lof) worms, whereby the rpm-1(lof) mutants show a lack of
habituation after repeated mechanosensory stimulations (Giles et al., 2015). Regardless, the
effect wdfy-3(lof) has in these in fsn-1(null), glo-4(null), and rpm-1(lof) mutant backgrounds will
give us another piece of evidence as to the role of the EGL-19 and WDFY-3 interaction in regard
to the RPM-1 pathway. Another is to see if wdfy-3(lof) suppresses the axon termination defects
of other RPM-1 pathway loss-of-function genes. If the results of these experiments show that
fsn-1(null) is the only mutant background to be suppressed by wdfy-3(lof) and egl-19(lof)
mutants, then we have further reason to suspect that the EGL-19 and WDFY-3 pathway is
outside of the RPM-1 pathway. However, if other members of the RPM-1 pathway are
influenced by wdfy-3(lof), then we will need to assess the function of selective autophagy as a
broad regulator of axon termination both within and apart from the RPM-1 pathway.
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4.6 Concluding remarks
In the case of ASD and similar polygenic disorders, uncovering the genetic variants that
contribute to the disorder will allow for early detection and preventative treatments long before
the development of severe symptoms. Moreover, understanding the genetics of
neurodevelopmental disorders will define the eventual therapeutic targets. The prevalent roles of
selective forms of autophagy in neurodevelopmental disorders is backed by genetic findings.
Additional cellular functions will likely be implicated in various human diseases by our
increased understanding of genetics. Determining the mechanisms that regulate the proper
development of the neuron is equally important in understanding the underlying causes of
neurodevelopmental disorders. Considering the many complexities of studying individual axons
in the developing brain, our monogenic ASD model, as well as the relatively simple nervous
system of C. elegans, will aid in overcoming some of the barriers of understanding
neurodevelopment. By progressing in our understanding of the molecular mechanisms that
govern neurodevelopment, future findings can extend to other human diseases involving the
brain and the rest of the nervous system.

123

References
Adams, D. J., & Berecki, G. (2013). Mechanisms of conotoxin inhibition of N-type (Ca(v)2.2)
calcium channels. Biochimica Et Biophysica Acta-Biomembranes, 1828(7), 1619-1628.
doi:10.1016/j.bbamem.2013.01.019
Agarraberes, F. A., & Dice, J. F. (2001). Protein translocation across membranes. Biochimica et
Biophysica Acta (BBA) - Biomembranes, 1513(1), 1-24. doi:10.1016/s03044157(01)00005-3
Al-Mubarak, B., Abouelhoda, M., Omar, A., AlDhalaan, H., Aldosari, M., Nester, M., . . . Al
Tassan, N. (2017). Whole exome sequencing reveals inherited and de novo variants in
autism spectrum disorder: a trio study from Saudi families. Sci Rep, 7(1), 5679.
doi:10.1038/s41598-017-06033-1
Alonso-Gonzalez, A., Rodriguez-Fontenla, C., & Carracedo, A. (2018). De novo Mutations
(DNMs) in Autism Spectrum Disorder (ASD): Pathway and Network Analysis. Frontiers
in Genetics, 9. doi:10.3389/fgene.2018.00406
Altier, C., Garcia-Caballero, A., Simms, B., You, H. T., Chen, L. N., Walcher, J., . . . Zamponi,
G. W. (2011). The Cav beta subunit prevents RFP2-mediated ubiquitination and
proteasomal degradation of L-type channels. Nature Neuroscience, 14(2), 173-U252.
doi:10.1038/nn.2712
Alvarez-Mora, M. I., Calvo Escalona, R., Puig Navarro, O., Madrigal, I., Quintela, I., Amigo, J.,
. . . Rodriguez-Revenga, L. (2016). Comprehensive molecular testing in patients with
high functioning autism spectrum disorder. Mutat Res, 784-785, 46-52.
doi:10.1016/j.mrfmmm.2015.12.006
Ashrafi, G., Schlehe, J. S., LaVoie, M. J., & Schwarz, T. L. (2014). Mitophagy of damaged
mitochondria occurs locally in distal neuronal axons and requires PINK1 and Parkin. The
Journal of Cell Biology, 206(5), 655-670. doi:10.1083/jcb.201401070
Atwood, S. X., & Prehoda, K. E. (2009). aPKC Phosphorylates Miranda to Polarize Fate
Determinants during Neuroblast Asymmetric Cell Division. Current Biology, 19(9), 723729. doi:10.1016/j.cub.2009.03.056
Bader, P. L., Faizi, M., Kim, L. H., Owen, S. F., Tadross, M. R., Alfa, R. W., . . . Shamloo, M.
(2011). Mouse model of Timothy syndrome recapitulates triad of autistic traits. Proc Natl
Acad Sci U S A, 108(37), 15432-15437. doi:10.1073/pnas.1112667108
Bailey, A., Le Couteur, A., Gottesman, I., Bolton, P., Simonoff, E., Yuzda, E., & Rutter, M.
(1995). Autism as a strongly genetic disorder: evidence from a British twin study.
Psychological Medicine, 25(1), 63-77. doi:10.1017/s0033291700028099
Baio, J., Wiggins, L., Christensen, D. L., Maenner, M. J., Daniels, J., Warren, Z., . . . Dowling,
N. F. (2018). Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States,
124

2014. Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C.
: 2002), 67(6), 1-23. doi:10.15585/mmwr.ss6706a1
Ban, B. K., Jun, M. H., Ryu, H. H., Jang, D. J., Ahmad, S. T., & Lee, J. A. (2013). Autophagy
Negatively Regulates Early Axon Growth in Cortical Neurons. Molecular and Cellular
Biology, 33(19), 3907-3919. doi:10.1128/mcb.00627-13
Bedogni, F., Hodge, R. D., Nelson, B. R., Frederick, E. A., Shiba, N., Daza, R. A., & Hevner, R.
F. (2010). Autism susceptibility candidate 2 (Auts2) encodes a nuclear protein expressed
in developing brain regions implicated in autism neuropathology. Gene Expression
Patterns, 10(1), 9-15. doi:10.1016/j.gep.2009.11.005
Bejarano, E., & Cuervo, A. M. (2010). Chaperone-Mediated Autophagy. Proceedings of the
American Thoracic Society, 7(1), 29-39. doi:10.1513/pats.200909-102js
Bender, K. J., Ford, C. P., & Trussell, L. O. (2010). Dopaminergic Modulation of Axon Initial
Segment Calcium Channels Regulates Action Potential Initiation. Neuron, 68(3), 500511. doi:10.1016/j.neuron.2010.09.026
Bernier, R., Golzio, C., Xiong, B., Stessman, Holly A., Coe, Bradley P., Penn, O., . . . Eichler,
Evan E. (2014). Disruptive CHD8 Mutations Define a Subtype of Autism Early in
Development. Cell, 158(2), 263-276. doi:10.1016/j.cell.2014.06.017
Berzat, A., & Hall, A. (2010). Cellular responses to extracellular guidance cues. The EMBO
Journal, 29(16), 2734-2745. doi:10.1038/emboj.2010.170
Bettt, G. C. L., Fernandez, S., Nayeri, A., Lis, A., Fallavollita, J. A., & Rasmusson, R. L. (2012).
A Cardiac Specific Inducible Mouse Model of Timothy Syndrome 2. Biophysical
Journal, 102(3), 542a. doi:10.1016/j.bpj.2011.11.2957
Boczek, N. J., Miller, E. M., Ye, D., Nesterenko, V. V., Tester, D. J., Antzelevitch, C., . . . Ware,
S. M. (2015). Novel Timothy syndrome mutation leading to increase in CACNA1C
window current. Heart Rhythm, 12(1), 211-219. doi:10.1016/j.hrthm.2014.09.051
Bonora, E., Beyer, K. S., Lamb, J. A., Parr, J. R., Klauck, S. M., Benner, A., . . . Monaco, A. P.
(2003). Analysis of reelin as a candidate gene for autism. Molecular Psychiatry, 8(10),
885-892. doi:10.1038/sj.mp.4001310
Borgen, M., Rowland, K., Boerner, J., Lloyd, B., Khan, A., & Murphey, R. (2017). Axon
Termination, Pruning, and Synaptogenesis in the Giant Fiber System of Drosophila
melanogaster Is Promoted by Highwire. Genetics, 205(3), 1229-1245.
doi:10.1534/genetics.116.197343
Borgen, M. A., Wang, D., & Grill, B. (2017). RPM-1 regulates axon termination by affecting
growth cone collapse and microtubule stability. Development, 144(24), 4658-4672.
doi:10.1242/dev.154187

125

Bounoutas, A., Zheng, Q., Nonet, M. L., & Chalfie, M. (2009). mec-15 encodes an F-box protein
required for touch receptor neuron mechanosensation, synapse formation and
development. Genetics, 183(2), 607-617, 601SI-604SI. doi:10.1534/genetics.109.105726
Bourinet, E., Soong, T. W., Sutton, K., Slaymaker, S., Mathews, E., Monteil, A., . . . Snutch, T.
P. (1999). Splicing of alpha(1A) subunit gene generates phenotypic variants of P- and Qtype calcium channels. Nature Neuroscience, 2(5), 407-415.
Boya, P., Codogno, P., & Rodriguez-Muela, N. (2018). Autophagy in stem cells: repair,
remodelling and metabolic reprogramming. Development, 145(4), dev146506.
doi:10.1242/dev.146506
Breitenkamp, A. F., Matthes, J., Nass, R. D., Sinzig, J., Lehmkuhl, G., Nurnberg, P., & Herzig,
S. (2014). Rare mutations of CACNB2 found in autism spectrum disease-affected
families alter calcium channel function. PLoS One, 9(4), e95579.
doi:10.1371/journal.pone.0095579
Brett, M., McPherson, J., Zang, Z. J., Lai, A., Tan, E. S., Ng, I., . . . Tan, E. C. (2014). Massively
parallel sequencing of patients with intellectual disability, congenital anomalies and/or
autism spectrum disorders with a targeted gene panel. PLoS One, 9(4), e93409.
doi:10.1371/journal.pone.0093409
Brittis, P. A., Lu, Q., & Flanagan, J. G. (2002). Axonal Protein Synthesis Provides a Mechanism
for Localized Regulation at an Intermediate Target. Cell, 110(2), 223-235.
doi:10.1016/s0092-8674(02)00813-9
Buddell, T., Friedman, V., Drozd, C. J., & Quinn, C. C. (2019). An autism-causing calcium
channel variant functions with selective autophagy to alter axon targeting and behavior.
PLoS Genet, 15(12), e1008488. doi:10.1371/journal.pgen.1008488
Bulik-Sullivan, B. K., Loh, P.-R., Finucane, H. K., Ripke, S., Yang, J., Patterson, N., . . . Neale,
B. M. (2015). LD Score regression distinguishes confounding from polygenicity in
genome-wide association studies. Nature Genetics, 47(3), 291-295. doi:10.1038/ng.3211
Buraei, Z., & Yang, J. (2013). Structure and function of the beta subunit of voltage-gated Ca2+
channels. Biochimica Et Biophysica Acta-Biomembranes, 1828(7), 1530-1540.
doi:10.1016/j.bbamem.2012.08.028
Burgess, D. L., Gefrides, L. A., Foreman, P. J., & Noebels, J. L. (2001). A cluster of three novel
Ca2+ channel gamma subunit genes on chromosome 19q13.43: Evolution and expression
profile of the gamma subunit gene family. Genomics, 71(3), 339-350.
doi:10.1006/geno.2000.6440
Burgess, R. W., Peterson, K. A., Johnson, M. J., Roix, J. J., Welsh, I. C., & O'Brien, T. P.
(2004). Evidence for a Conserved Function in Synapse Formation Reveals Phr1 as a
Candidate Gene for Respiratory Failure in Newborn Mice. Molecular and Cellular
Biology, 24(3), 1096-1105. doi:10.1128/mcb.24.3.1096-1105.2004
126

Campbell, D. S., & Holt, C. E. (2001). Chemotropic Responses of Retinal Growth Cones
Mediated by Rapid Local Protein Synthesis and Degradation. Neuron, 32(6), 1013-1026.
doi:10.1016/s0896-6273(01)00551-7
Canali, G., Garcia, M., Hivert, B., Pinatel, D., Goullancourt, A., Oguievetskaia, K., . . .
Goutebroze, L. (2018). Genetic variants in autism-related CNTNAP2 impair axonal
growth of cortical neurons. Human Molecular Genetics, 27(11), 1941-1954.
doi:10.1093/hmg/ddy102
Carlier, M. F., & Pantaloni, D. (2007). Control of actin assembly dynamics in cell motil. Journal
of Biological Chemistry, 282(32), 23005-23009. doi:10.1074/jbc.R700020200
Catterall, W. A. (2000). From ionic currents to molecular mechanisms: The structure and
function of voltage-gated sodium channels. Neuron, 26(1), 13-25. doi:Doi
10.1016/S0896-6273(00)81133-2
Catterall, W. A. (2011). Voltage-Gated Calcium Channels. Cold Spring Harbor perspectives in
biology, 3(8). doi:ARTNa00394710.1101/cshperspect.a003947
Caylor, R. C., Jin, Y., & Ackley, B. D. (2013). The Caenorhabditis elegans voltage-gated
calcium channel subunits UNC-2 and UNC-36 and the calcium-dependent kinase UNC43/CaMKII regulate neuromuscular junction morphology. Neural Development, 8(1), 10.
doi:10.1186/1749-8104-8-10
Ch'ng, Q., Williams, L., Lie, Y. S., Sym, M., Whangbo, J., & Kenyon, C. (2003). Identification
of genes that regulate a left-right asymmetric neuronal migration in Caenorhabditis
elegans. Genetics, 164(4), 1355-1367.
Chalfie, M., Hart, A. C., Rankin, C. H., & Goodman, M. B. (2014). Assaying mechanosensation.
WormBook. doi:doi/10.1895/wormbook.1.172.1, http://www.wormbook.org
Chalfie, M., Sulston, J. E., White, J. G., Southgate, E., Thomson, J. N., & Brenner, S. (1985).
The neural circuit for touch sensitivity in Caenorhabditis elegans. J Neurosci, 5(4), 956964.
Challacombe, J. F., Snow, D. M., & Letourneau, P. C. (1996). Role of the cytoskeleton in growth
cone motility and axonal elongation. Seminars in Neuroscience, 8(2), 67-80.
doi:10.1006/smns.1996.0010
Charron, F., & Tessier-Lavigne, M. The Hedgehog, TGF-β/BMP and Wnt Families of
Morphogens in Axon Guidance. In Advances in Experimental Medicine and Biology (pp.
116-133): Springer New York.
Chaste, P., Roeder, K., & Devlin, B. (2017). The Yin and Yang of Autism Genetics: How Rare
De Novo and Common Variations Affect Liability. Annu Rev Genomics Hum Genet, 18,
167-187. doi:10.1146/annurev-genom-083115-022647

127

Chen, L., Chetkovich, D. M., Petralia, R. S., Sweeney, N. T., Kawasaki, Y., Wenthold, R. J., . . .
Nicoll, R. A. (2000). Stargazin regulates synaptic targeting of AMPA receptors by two
distinct mechanisms. Nature, 408(6815), 936-943.
Chen, S., Fragoza, R., Klei, L., Liu, Y., Wang, J., Roeder, K., . . . Yu, H. (2018). An interactome
perturbation framework prioritizes damaging missense mutations for developmental
disorders. Nat Genet, 50(7), 1032-1040. doi:10.1038/s41588-018-0130-z
Chen, Y., Bharill, S., Altun, Z., O’Hagan, R., Coblitz, B., Isacoff, E. Y., & Chalfie, M. (2016).
Caenorhabditis elegans paraoxonase-like proteins control the functional expression of
DEG/ENaC mechanosensory proteins. Molecular Biology of the Cell, 27(8), 1272-1285.
doi:10.1091/mbc.e15-08-0561
Cheng, X.-T., Zhou, B., Lin, M.-Y., Cai, Q., & Sheng, Z.-H. (2015). Axonal autophagosomes
recruit dynein for retrograde transport through fusion with late endosomes. The Journal
of Cell Biology, 209(3), 377-386. doi:10.1083/jcb.201412046
Chevalier-Larsen, E., & Holzbaur, E. L. F. (2006). Axonal transport and neurodegenerative
disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1762(1112), 1094-1108. doi:10.1016/j.bbadis.2006.04.002
Chiang, H., Terlecky, Plant, C., & Dice, J. (1989). A role for a 70-kilodalton heat shock protein
in lysosomal degradation of intracellular proteins. Science, 246(4928), 382-385.
doi:10.1126/science.2799391
Clapham, D. E. (2007). Calcium signaling. Cell, 131(6), 1047-1058.
doi:10.1016/j.cell.2007.11.028
Clausen, T. H., Lamark, T., Isakson, P., Finley, K., Larsen, K. B., Brech, A., . . . Johansen, T.
(2010). p62/SQSTM1 and ALFY interact to facilitate the formation of p62 bodies/ALIS
and their degradation by autophagy. Autophagy, 6(3), 330-344.
Colvert, E., Tick, B., McEwen, F., Stewart, C., Curran, S. R., Woodhouse, E., . . . Bolton, P.
(2015). Heritability of Autism Spectrum Disorder in a UK Population-Based Twin
Sample. JAMA Psychiatry, 72(5), 415-423. doi:10.1001/jamapsychiatry.2014.3028
Courchesne, E., Mouton, P. R., Calhoun, M. E., Semendeferi, K., Ahrens-Barbeau, C., Hallet, M.
J., . . . Pierce, K. (2011). Neuron Number and Size in Prefrontal Cortex of Children With
Autism. JAMA, 306(18), 2001. doi:10.1001/jama.2011.1638
Craig, E. M., Van Goor, D., Forscher, P., & Mogilner, A. (2012). Membrane Tension, Myosin
Force, and Actin Turnover Maintain Actin Treadmill in the Nerve Growth Cone.
Biophysical Journal, 102(7), 1503-1513. doi:10.1016/j.bpj.2012.03.003
Cross-Disorder Group of the Psychiatric Genomics, C. (2013). Identification of risk loci with
shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet,
381(9875), 1371-1379. doi:10.1016/S0140-6736(12)62129-1

128

Cuervo, A. M. (2011). Chaperone-mediated autophagy: Dice's 'wild' idea about lysosomal
selectivity. Nature Reviews Molecular Cell Biology, 12(8), 535-541.
doi:10.1038/nrm3150
Cuervo, A. M., & Dice, J. F. (1996). A Receptor for the Selective Uptake and Degradation of
Proteins by Lysosomes. Science, 273(5274), 501-503. doi:10.1126/science.273.5274.501
Cuervo, A. M., & Dice, J. F. (2000). Regulation of Lamp2a Levels in the Lysosomal Membrane.
Traffic, 1(7), 570-583. doi:10.1034/j.1600-0854.2000.010707.x
Cushman, M., Johnson, B. S., King, O. D., Gitler, A. D., & Shorter, J. (2010). Prion-like
disorders: blurring the divide between transmissibility and infectivity. Journal of Cell
Science, 123(8), 1191-1201. doi:10.1242/jcs.051672
D'Arcangelo, G., G. Miao, G., Chen, S.-C., Scares, H. D., Morgan, J. I., & Curran, T. (1995). A
protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature,
374(6524), 719-723. doi:10.1038/374719a0
D'Gama, A. M., Pochareddy, S., Li, M., Jamuar, S. S., Reiff, R. E., Lam, A. N., . . . Walsh, C. A.
(2015). Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates
Multiple Genetic Mechanisms. Neuron, 88(5), 910-917.
doi:10.1016/j.neuron.2015.11.009
D'Souza, J., Hendricks, M., Le Guyader, S., Subburaju, S., Grunewald, B., Scholich, K., &
Jesuthasan, S. (2005). Formation of the retinotectal projection requires Esrom, an
ortholog of PAM (protein associated with Myc). Development, 132(2), 247-256.
doi:10.1242/dev.01578
Damaj, L., Lupien-Meilleur, A., Lortie, A., Riou, E., Ospina, L. H., Gagnon, L., . . . Rossignol,
E. (2015). CACNA1A haploinsufficiency causes cognitive impairment, autism and
epileptic encephalopathy with mild cerebellar symptoms. Eur J Hum Genet, 23(11),
1505-1512. doi:10.1038/ejhg.2015.21
Davies, A., Douglas, L., Hendrich, J., Wratten, J., Van Minh, A. T., Foucault, I., . . . Dolphin, A.
C. (2006). The calcium channel alpha(2)delta-2 subunit partitions with Ca(V)2.1 into
lipid rafts in cerebellum: Implications for localization and function. Journal of
Neuroscience, 26(34), 8748-8757. doi:10.1523/Jneurosci.2764-06.2006
Davies, A., Kadurin, I., Alvarez-Laviada, A., Douglas, L., Nieto-Rostro, M., Bauer, C. S., . . .
Dolphin, A. C. (2010). The alpha(2)delta subunits of voltage-gated calcium channels
form GPI-anchored proteins, a posttranslational modification essential for function.
Proceedings of the National Academy of Sciences of the United States of America,
107(4), 1654-1659. doi:10.1073/pnas.0908735107
De Rubeis, S., & Buxbaum, J. D. (2015). Genetics and genomics of autism spectrum disorder:
embracing complexity. Hum Mol Genet, 24(R1), R24-31. doi:10.1093/hmg/ddv273

129

De Rubeis, S., He, X., Goldberg, A. P., Poultney, C. S., Samocha, K., Cicek, A. E., . . .
Buxbaum, J. D. (2014). Synaptic, transcriptional and chromatin genes disrupted in
autism. Nature, 515(7526), 209-215. doi:10.1038/nature13772
Dedic, N., Pohlmann, M. L., Richter, J. S., Mehta, D., Czamara, D., Metzger, M. W., . . .
Deussing, J. M. (2018). Cross-disorder risk gene CACNA1C differentially modulates
susceptibility to psychiatric disorders during development and adulthood. Mol
Psychiatry, 23(3), 533-543. doi:10.1038/mp.2017.133
Delcroix, J.-D., Valletta, J. S., Wu, C., Hunt, S. J., Kowal, A. S., & Mobley, W. C. (2003). NGF
Signaling in Sensory Neurons. Neuron, 39(1), 69-84. doi:10.1016/s0896-6273(03)003970
Delorme-Axford, E., & Klionsky, D. J. (2015). A missing piece of the puzzle: Atg11 functions as
a scaffold to activate Atg1 for selective autophagy. Autophagy, 11(12), 2139-2141.
doi:10.1080/15548627.2015.1116672
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IVTR). (2000). In: American Psychiatric Association.
Dice, J. F. (2007). Chaperone-Mediated Autophagy. Autophagy, 3(4), 295-299.
doi:10.4161/auto.4144
Diep, V., & Seaver, L. H. (2015). Long QT syndrome with craniofacial, digital, and neurologic
features: Is it useful to distinguish between timothy syndrome types 1 and 2? American
Journal of Medical Genetics Part A, 167(11), 2780-2785. doi:10.1002/ajmg.a.37258
Dolphin, A. C. (2012). Calcium channel auxiliary alpha(2)delta and beta subunits: trafficking
and one step beyond. Nature Reviews Neuroscience, 13(8), 542-555.
doi:10.1038/nrn3311
Dolphin, A. C. (2013). The alpha(2)delta subunits of voltage-gated calcium channels. Biochimica
Et Biophysica Acta-Biomembranes, 1828(7), 1541-1549.
doi:10.1016/j.bbamem.2012.11.019
Dowdle, W. E., Nyfeler, B., Nagel, J., Elling, R. A., Liu, S., Triantafellow, E., . . . Murphy, L. O.
(2014). Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in
ferritin degradation and iron homeostasis in vivo. Nat Cell Biol, 16(11), 1069-1079.
doi:10.1038/ncb3053
Dragich, J. M., Kuwajima, T., Hirose-Ikeda, M., Yoon, M. S., Eenjes, E., Bosco, J. R., . . .
Yamamoto, A. (2016). Autophagy linked FYVE (Alfy/WDFY3) is required for
establishing neuronal connectivity in the mammalian brain. Elife, 5.
doi:10.7554/eLife.14810
Dudbridge, F. (2016). Polygenic Epidemiology. Genetic Epidemiology, 40(4), 268-272.
doi:10.1002/gepi.21966

130

Dunham, I., Kundaje, A., Aldred, S. F., Collins, P. J., Davis, C., Doyle, F., . . . Consortium, E. P.
(2012). An integrated encyclopedia of DNA elements in the human genome. Nature,
489(7414), 57-74. doi:10.1038/nature11247
Ebrahimi-Fakhari, D., Saffari, A., Wahlster, L., Lu, J., Byrne, S., Hoffmann, G. F., . . . Sahin, M.
(2016). Congenital disorders of autophagy: an emerging novel class of inborn errors of
neuro-metabolism. Brain, 139(Pt 2), 317-337. doi:10.1093/brain/awv371
Eroglu, C., Allen, N. J., Susman, M. W., O'Rourke, N. A., Park, C. Y., Ozkan, E., . . . Barres, B.
A. (2009). Gabapentin Receptor alpha 2 delta-1 Is a Neuronal Thrombospondin Receptor
Responsible for Excitatory CNS Synaptogenesis. Cell, 139(2), 380-392.
doi:10.1016/j.cell.2009.09.025
Falconer, D. S. (1951). Two new mutants, ‘trembler’ and ‘reeler’, with neurological actions in
the house mouse (Mus musculus L.). Journal of Genetics, 50(2), 192-205.
doi:10.1007/bf02996215
Farias, G. G., Guardia, C. M., De Pace, R., Britt, D. J., & Bonifacino, J. S. (2017).
BORC/kinesin-1 ensemble drives polarized transport of lysosomes into the axon. Proc
Natl Acad Sci U S A, 114(14), E2955-E2964. doi:10.1073/pnas.1616363114
Fatemi, S. H., Snow, A. V., Stary, J. M., Araghi-Niknam, M., Reutiman, T. J., Lee, S., . . .
Pearce, D. A. (2005). Reelin signaling is impaired in autism. Biological Psychiatry,
57(7), 777-787. doi:10.1016/j.biopsych.2004.12.018
Fatouros, C., Pir, G. J., Biernat, J., Koushika, S. P., Mandelkow, E., Mandelkow, E. M., . . .
Baumeister, R. (2012). Inhibition of tau aggregation in a novel Caenorhabditis elegans
model of tauopathy mitigates proteotoxicity. Human Molecular Genetics, 21(16), 35873603. doi:10.1093/hmg/dds190
Felix, R., Gurnett, C. A., DeWaard, M., & Campbell, K. P. (1997). Dissection of functional
domains of the voltage-dependent Ca2+ channel alpha(2)delta subunit. Journal of
Neuroscience, 17(18), 6884-6891.
Felizola, S. J. A., Maekawa, T., Nakamura, Y., Satoh, F., Oho, Y., Kikuchi, K., . . . Sasano, H.
(2014). Voltage-gated calcium channels in the human adrenal and primary aldosteronism.
Journal of Steroid Biochemistry and Molecular Biology, 144, 410-416.
doi:10.1016/j.jsbmb.2014.08.012
Ferreira, M. A., O'Donovan, M. C., Meng, Y. A., Jones, I. R., Ruderfer, D. M., Jones, L., . . .
Wellcome Trust Case Control, C. (2008). Collaborative genome-wide association
analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet, 40(9),
1056-1058. doi:10.1038/ng.209
Filimonenko, M., Isakson, P., Finley, K. D., Anderson, M., Jeong, H., Melia, T. J., . . .
Yamamoto, A. (2010). The selective macroautophagic degradation of aggregated proteins
requires the PI3P-binding protein Alfy. Mol Cell, 38(2), 265-279.
doi:10.1016/j.molcel.2010.04.007
131

Fombonne, E. (2009). Epidemiology of Pervasive Developmental Disorders. Pediatric Research,
65(6), 591-598. doi:10.1203/pdr.0b013e31819e7203
Fred Dice, J. (1990). Peptide sequences that target cytosolic proteins for lysosomal proteolysis.
Trends in Biochemical Sciences, 15(8), 305-309. doi:10.1016/0968-0004(90)90019-8
Frokjaer-Jensen, C., Kindt, K. S., Kerr, R. A., Suzuki, H., Melnik-Martinez, K., Gerstbreih, B., .
. . Schafer, W. R. (2006). Effects of voltage-gated calcium channel subunit genes on
calcium influx in cultured C. elegans mechanosensory neurons. J Neurobiol, 66(10),
1125-1139. doi:10.1002/neu.20261
Gallaud, E., Pham, T., & Cabernard, C. (2017). Drosophila melanogaster Neuroblasts: A Model
for Asymmetric Stem Cell Divisions. In Results and Problems in Cell Differentiation (pp.
183-210): Springer International Publishing.
Gao, Z., Lee, P., Stafford, J. M., von Schimmelmann, M., Schaefer, A., & Reinberg, D. (2014).
An AUTS2–Polycomb complex activates gene expression in the CNS. Nature,
516(7531), 349-354. doi:10.1038/nature13921
Gaugler, T., Klei, L., Sanders, S. J., Bodea, C. A., Goldberg, A. P., Lee, A. B., . . . Buxbaum, J.
D. (2014). Most genetic risk for autism resides with common variation. Nature Genetics,
46(8), 881-885. doi:10.1038/ng.3039
Geisheker, M. R., Heymann, G., Wang, T., Coe, B. P., Turner, T. N., Stessman, H. A. F., . . .
Eichler, E. E. (2017). Hotspots of missense mutation identify neurodevelopmental
disorder genes and functional domains. Nat Neurosci, 20(8), 1043-1051.
doi:10.1038/nn.4589
Giles, A. C., Opperman, K. J., Rankin, C. H., & Grill, B. (2015). Developmental Function of the
PHR Protein RPM-1 Is Required for Learning in Caenorhabditis elegans. G3 (Bethesda),
5(12), 2745-2757. doi:10.1534/g3.115.021410
Gomez, T. M., & Spitzer, N. C. (1999). In vivo regulation of axon extension and pathfinding by
growth-cone calcium transients. Nature, 397(6717), 350-355. doi:10.1038/16927
Gong, X., & Wang, H. (2015). SHANK1 and autism spectrum disorders. Sci China Life Sci,
58(10), 985-990. doi:10.1007/s11427-015-4892-6
Grabrucker, A. M., Schmeisser, M. J., Schoen, M., & Boeckers, T. M. (2011). Postsynaptic
ProSAP/Shank scaffolds in the cross-hair of synaptopathies. Trends in Cell Biology,
21(10), 594-603. doi:10.1016/j.tcb.2011.07.003
Grice, S. J., Liu, J. L., & Webber, C. (2015). Synergistic interactions between Drosophila
orthologues of genes spanned by de novo human CNVs support multiple-hit models of
autism. PLoS Genet, 11(3), e1004998. doi:10.1371/journal.pgen.1004998
Grill, B., Bienvenut, W. V., Brown, H. M., Ackley, B. D., Quadroni, M., & Jin, Y. (2007). C.
elegans RPM-1 regulates axon termination and synaptogenesis through the Rab GEF
132

GLO-4 and the Rab GTPase GLO-1. Neuron, 55(4), 587-601.
doi:10.1016/j.neuron.2007.07.009
Grove, J., Ripke, S., Als, T. D., Mattheisen, M., Walters, R. K., Won, H., . . . Borglum, A. D.
(2019). Identification of common genetic risk variants for autism spectrum disorder. Nat
Genet, 51(3), 431-444. doi:10.1038/s41588-019-0344-8
Guo, H., Wang, T., Wu, H., Long, M., Coe, B. P., Li, H., . . . Xia, K. (2018). Inherited and
multiple de novo mutations in autism/developmental delay risk genes suggest a
multifactorial model. Molecular Autism, 9(1). doi:10.1186/s13229-018-0247-z
Han, S. M., Baig, H. S., & Hammarlund, M. (2016). Mitochondria Localize to Injured Axons to
Support Regeneration. Neuron, 92(6), 1308-1323. doi:10.1016/j.neuron.2016.11.025
Hannon, E., Schendel, D., Ladd-Acosta, C., Grove, J., i, P.-B. A. S. D. G., Hansen, C. S., . . .
Mill, J. (2018). Elevated polygenic burden for autism is associated with differential DNA
methylation at birth. Genome Med, 10(1), 19. doi:10.1186/s13073-018-0527-4
Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., . . .
Mizushima, N. (2006). Suppression of basal autophagy in neural cells causes
neurodegenerative disease in mice. Nature, 441(7095), 885-889.
doi:10.1038/nature04724
He, C., Baba, M., Cao, Y., & Klionsky, D. J. (2008). Self-Interaction Is Critical for Atg9
Transport and Function at the Phagophore Assembly Site during Autophagy. Molecular
Biology of the Cell, 19(12), 5506-5516. doi:10.1091/mbc.e08-05-0544
He, M., Ding, Y., Chu, C., Tang, J., Xiao, Q., & Luo, Z.-G. (2016). Autophagy induction
stabilizes microtubules and promotes axon regeneration after spinal cord injury.
Proceedings of the National Academy of Sciences, 113(40), 11324-11329.
doi:10.1073/pnas.1611282113
Henley, J., & Poo, M.-m. (2004). Guiding neuronal growth cones using Ca 2+ signals. Trends in
Cell Biology, 14(6), 320-330. doi:10.1016/j.tcb.2004.04.006
Hermann, G. J., Schroeder, L. K., Hieb, C. A., Kershner, A. M., Rabbitts, B. M., Fonarev, P., . . .
Priess, J. R. (2005). Genetic Analysis of Lysosomal Trafficking in Caenorhabditis
elegans. Molecular Biology of the Cell, 16(7), 3273-3288. doi:10.1091/mbc.e05-01-0060
Hersh, B. M., Hartwieg, E., & Horvitz, H. R. (2002). The Caenorhabditis elegans mucolipin-like
gene cup-5 is essential for viability and regulates lysosomes in multiple cell types. Proc
Natl Acad Sci U S A, 99(7), 4355-4360. doi:10.1073/pnas.062065399
Higgs, H. N., & Pollard, T. D. (2001). Regulation of Actin Filament Network Formation
Through ARP2/3 Complex: Activation by a Diverse Array of Proteins. Annual Review of
Biochemistry, 70(1), 649-676. doi:10.1146/annurev.biochem.70.1.649

133

Hill, S. E., & Colón-Ramos, D. A. (2018). Retrograde Transport and ATG-4.2-Mediated
Maturation Cooperate to Remove Autophagosomes from the Synapse. In: Cold Spring
Harbor Laboratory.
Hill, S. E., Kauffman, K. J., Krout, M., Richmond, J. E., Melia, T. J., & Colon-Ramos, D. A.
(2019). Maturation and Clearance of Autophagosomes in Neurons Depends on a Specific
Cysteine Protease Isoform, ATG-4.2. Dev Cell. doi:10.1016/j.devcel.2019.02.013
Hilliard, M. A., & Bargmann, C. I. (2006). Wnt signals and frizzled activity orient anteriorposterior axon outgrowth in C-elegans. Developmental Cell, 10(3), 379-390.
doi:10.1016/j.devcel.2006.01.013
Hirokawa, N., Niwa, S., & Tanaka, Y. (2010). Molecular Motors in Neurons: Transport
Mechanisms and Roles in Brain Function, Development, and Disease. Neuron, 68(4),
610-638. doi:10.1016/j.neuron.2010.09.039
Hobert, O., Moerman, D. G., Clark, K. A., Beckerle, M. C., & Ruvkun, G. (1999). A conserved
LIM protein that affects muscular adherens junction integrity and mechanosensory
function in Caenorhabditis elegans. J Cell Biol, 144(1), 45-57.
Hong, S. E., Shugart, Y. Y., Huang, D. T., Shahwan, S. A., Grant, P. E., Hourihane, J. O. B., . . .
Walsh, C. A. (2000). Autosomal recessive lissencephaly with cerebellar hypoplasia is
associated with human RELN mutations. Nature Genetics, 26(1), 93-96.
doi:10.1038/79246
Hoon, M., Soykan, T., Falkenburger, B., Hammer, M., Patrizi, A., Schmidt, K. F., . . .
Varoqueaux, F. (2011). Neuroligin-4 is localized to glycinergic postsynapses and
regulates inhibition in the retina. Proceedings of the National Academy of Sciences,
108(7), 3053-3058. doi:10.1073/pnas.1006946108
Hori, K., Nagai, T., Shan, W., Sakamoto, A., Taya, S., Hashimoto, R., . . . Hoshino, M. (2014).
Cytoskeletal Regulation by AUTS2 in Neuronal Migration and Neuritogenesis. Cell
Reports, 9(6), 2166-2179. doi:10.1016/j.celrep.2014.11.045
Huang, H. C., Chen, L., Zhang, H. X., Li, S. F., Liu, P., Zhao, T. Y., & Li, C. X. (2016).
Autophagy Promotes Peripheral Nerve Regeneration and Motor Recovery Following
Sciatic Nerve Crush Injury in Rats. J Mol Neurosci, 58(4), 416-423. doi:10.1007/s12031015-0672-9
Ichimura, Y., Kirisako, T., Takao, T., Satomi, Y., Shimonishi, Y., Ishihara, N., . . . Ohsumi, Y.
(2000). A ubiquitin-like system mediates protein lipidation. Nature, 408(6811), 488-492.
doi:10.1038/35044114
Iossifov, I., O'Roak, B. J., Sanders, S. J., Ronemus, M., Krumm, N., Levy, D., . . . Wigler, M.
(2014). The contribution of de novo coding mutations to autism spectrum disorder.
Nature, 515(7526), 216-221. doi:10.1038/nature13908

134

Iossifov, I., Ronemus, M., Levy, D., Wang, Z., Hakker, I., Rosenbaum, J., . . . Wigler, M. (2012).
De Novo Gene Disruptions in Children on the Autistic Spectrum. Neuron, 74(2), 285299. doi:10.1016/j.neuron.2012.04.009
Ishikawa, T., Kaneko, M., Shin, H. S., & Takahashi, T. (2005). Presynaptic N-type and P/Q-type
Ca2+ channels mediating synaptic transmission at the calyx of held of mice. Journal of
Physiology-London, 568(1), 199-209. doi:10.1113/jphysiol.2005.089912
Itakura, E., Kishi-Itakura, C., & Mizushima, N. (2012). The Hairpin-type Tail-Anchored SNARE
Syntaxin 17 Targets to Autophagosomes for Fusion with Endosomes/Lysosomes. Cell,
151(6), 1256-1269. doi:10.1016/j.cell.2012.11.001
Itakura, E., & Mizushima, N. (2010). Characterization of autophagosome formation site by a
hierarchical analysis of mammalian Atg proteins. Autophagy, 6(6), 764-776.
doi:10.4161/auto.6.6.12709
Jacquemont, S., Coe, Bradley P., Hersch, M., Duyzend, Michael H., Krumm, N., Bergmann, S., .
. . Eichler, Evan E. (2014). A Higher Mutational Burden in Females Supports a “Female
Protective Model” in Neurodevelopmental Disorders. The American Journal of Human
Genetics, 94(3), 415-425. doi:10.1016/j.ajhg.2014.02.001
Jiang, Y. H., Yuen, R. K., Jin, X., Wang, M., Chen, N., Wu, X., . . . Scherer, S. W. (2013).
Detection of clinically relevant genetic variants in autism spectrum disorder by wholegenome sequencing. Am J Hum Genet, 93(2), 249-263. doi:10.1016/j.ajhg.2013.06.012
Just, M. A., Cherkassky, V. L., Keller, T. A., Kana, R. K., & Minshew, N. J. (2007). Functional
and anatomical cortical underconnectivity in autism: evidence from an FMRI study of an
executive function task and corpus callosum morphometry. Cereb Cortex, 17(4), 951961. doi:10.1093/cercor/bhl006
Just, M. A., Cherkassky, V. L., Keller, T. A., & Minshew, N. J. (2004). Cortical activation and
synchronization during sentence comprehension in high-functioning autism: evidence of
underconnectivity. Brain, 127(Pt 8), 1811-1821. doi:10.1093/brain/awh199
Kadir, R., Harel, T., Markus, B., Perez, Y., Bakhrat, A., Cohen, I., . . . Birk, O. S. (2016). ALFYControlled DVL3 Autophagy Regulates Wnt Signaling, Determining Human Brain Size.
PLoS Genetics, 12(3). doi:ARTNe100591910.1371/journal.pgen.1005919
Kaletsky, R., Lakhina, V., Arey, R., Williams, A., Landis, J., Ashraf, J., & Murphy, C. T. (2016).
The C. elegans adult neuronal IIS/FOXO transcriptome reveals adult phenotype
regulators. Nature, 529(7584), 92-96. doi:10.1038/nature16483
Kamal, A., Stokin, G. B., Yang, Z., Xia, C.-H., & Goldstein, L. S. B. (2000). Axonal Transport
of Amyloid Precursor Protein Is Mediated by Direct Binding to the Kinesin Light Chain
Subunit of Kinesin-I. Neuron, 28(2), 449-459. doi:10.1016/s0896-6273(00)00124-0
Kamijo, S., Ishii, Y., Horigane, S. I., Suzuki, K., Ohkura, M., Nakai, J., . . . Bito, H. (2018). A
Critical Neurodevelopmental Role for L-Type Voltage-Gated Calcium Channels in
135

Neurite Extension and Radial Migration. J Neurosci, 38(24), 5551-5566.
doi:10.1523/JNEUROSCI.2357-17.2018
Kang, C., Riazuddin, S., Mundorff, J., Krasnewich, D., Friedman, P., Mullikin, J. C., & Drayna,
D. (2010). Mutations in the Lysosomal Enzyme–Targeting Pathway and Persistent
Stuttering. New England Journal of Medicine, 362(8), 677-685.
doi:10.1056/nejmoa0902630
Kanki, T., Wang, K., Cao, Y., Baba, M., & Klionsky, D. J. (2009). Atg32 Is a Mitochondrial
Protein that Confers Selectivity during Mitophagy. Developmental Cell, 17(1), 98-109.
doi:10.1016/j.devcel.2009.06.014
Kannan, M., Bayam, E., Wagner, C., Rinaldi, B., Kretz, P. F., Tilly, P., . . . Yalcin, B. (2017).
WD40-repeat 47, a microtubule-associated protein, is essential for brain development and
autophagy. Proceedings of the National Academy of Sciences, 114(44), E9308-E9317.
doi:10.1073/pnas.1713625114
Kaushik, S., & Cuervo, A. M. (2012). Chaperone-mediated autophagy: a unique way to enter the
lysosome world. Trends in Cell Biology, 22(8), 407-417. doi:10.1016/j.tcb.2012.05.006
Kerstein, P. C., Nichol, R. H., & Gomez, T. M. (2015). Mechanochemical regulation of growth
cone motility. Frontiers in Cellular Neuroscience, 9. doi:ARTN
24410.3389/fncel.2015.00244
Khaminets, A., Behl, C., & Dikic, I. (2016). Ubiquitin-Dependent And Independent Signals In
Selective Autophagy. Trends in Cell Biology, 26(1), 6-16. doi:10.1016/j.tcb.2015.08.010
Killian, D. J., & Hubbard, E. J. A. (2001). RNAi feeding to produce males. Worm Breeder's
Gazette, 17(1).
Kirisako, T., Ichimura, Y., Okada, H., Kabeya, Y., Mizushima, N., Yoshimori, T., . . . Ohsumi,
Y. (2000). The Reversible Modification Regulates the Membrane-Binding State of
Apg8/Aut7 Essential for Autophagy and the Cytoplasm to Vacuole Targeting Pathway.
The Journal of Cell Biology, 151(2), 263-276. doi:10.1083/jcb.151.2.263
Kirszenblat, L., Neumann, B., Coakley, S., & Hilliard, M. A. (2013). A dominant mutation in
mec-7/beta-tubulin affects axon development and regeneration in Caenorhabditis elegans
neurons. Molecular Biology of the Cell, 24(3), 285-296. doi:10.1091/mbc.E12-06-0441
Kiryu-Seo, S., & Kiyama, H. (2019). Mitochondrial behavior during axon
regeneration/degeneration in vivo. Neuroscience Research, 139, 42-47.
doi:10.1016/j.neures.2018.08.014
Klionsky, D. J., Cregg, J. M., Dunn, W. A., Emr, S. D., Sakai, Y., Sandoval, I. V., . . . Ohsumi,
Y. (2003). A Unified Nomenclature for Yeast Autophagy-Related Genes. Developmental
Cell, 5(4), 539-545. doi:10.1016/s1534-5807(03)00296-x

136

Knoll, B. (2004). Src Family Kinases Are Involved in EphA Receptor-Mediated Retinal Axon
Guidance. Journal of Neuroscience, 24(28), 6248-6257. doi:10.1523/jneurosci.098504.2004
Koldewyn, K., Yendiki, A., Weigelt, S., Gweon, H., Julian, J., Richardson, H., . . . Kanwisher,
N. (2014). Differences in the right inferior longitudinal fasciculus but no general
disruption of white matter tracts in children with autism spectrum disorder. Proc Natl
Acad Sci U S A, 111(5), 1981-1986. doi:10.1073/pnas.1324037111
Kolodkin, A. L., & Pasterkamp, R. J. (2013). SnapShot: Axon Guidance II. Cell, 153(3), 722722.e721. doi:10.1016/j.cell.2013.04.004
Kononenko, N. L., Claßen, G. A., Kuijpers, M., Puchkov, D., Maritzen, T., Tempes, A., . . .
Haucke, V. (2017). Retrograde transport of TrkB-containing autophagosomes via the
adaptor AP-2 mediates neuronal complexity and prevents neurodegeneration. Nature
Communications, 8(1). doi:10.1038/ncomms14819
Krey, J. F., Paşca, S. P., Shcheglovitov, A., Yazawa, M., Schwemberger, R., Rasmusson, R., &
Dolmetsch, R. E. (2013). Timothy syndrome is associated with activity-dependent
dendritic retraction in rodent and human neurons. Nature Neuroscience, 16(2), 201-209.
doi:10.1038/nn.3307
Kulkarni, A., Chen, J., & Maday, S. (2018). Neuronal autophagy and intercellular regulation of
homeostasis in the brain. Current Opinion in Neurobiology, 51, 29-36.
doi:10.1016/j.conb.2018.02.008
Kulkarni, V. V., & Maday, S. (2018). Compartment-specific dynamics and functions of
autophagy in neurons. Dev Neurobiol, 78(3), 298-310. doi:10.1002/dneu.22562
Kunz, J. B., Schwarz, H., & Mayer, A. (2004). Determination of four sequential stages during
microautophagy in vitro. J Biol Chem, 279(11), 9987-9996.
doi:10.1074/jbc.M307905200
Kurshan, P. T., Oztan, A., & Schwarz, T. L. (2009). Presynaptic alpha(2)delta-3 is required for
synaptic morphogenesis independent of its Ca2+-channel functions. Nature
Neuroscience, 12(11), 1415-1423. doi:10.1038/nn.2417
Kwok, T. C., Hui, K., Kostelecki, W., Ricker, N., Selman, G., Feng, Z. P., & Roy, P. J. (2008). A
genetic screen for dihydropyridine (DHP)-resistant worms reveals new residues required
for DHP-blockage of mammalian calcium channels. PLoS Genet, 4(5), e1000067.
doi:10.1371/journal.pgen.1000067
Laine, V., Frokjaer-Jensen, C., Couchoux, H., & Jospin, M. (2011). The alpha1 subunit EGL-19,
the alpha2/delta subunit UNC-36, and the beta subunit CCB-1 underlie voltagedependent calcium currents in Caenorhabditis elegans striated muscle. J Biol Chem,
286(42), 36180-36187. doi:10.1074/jbc.M111.256149

137

Laine, V., Segor, J. R., Zhan, H., Bessereau, J. L., & Jospin, M. (2014). Hyperactivation of Ltype voltage-gated Ca2+ channels in Caenorhabditis elegans striated muscle can result
from point mutations in the IS6 or the IIIS4 segment of the alpha 1 subunit. Journal of
Experimental Biology, 217(21), 3805-3814. doi:10.1242/jeb.106732
Lamark, T., Kirkin, V., Dikic, I., & Johansen, T. (2009). NBR1 and p62 as cargo receptors for
selective autophagy of ubiquitinated targets. Cell Cycle, 8(13), 1986-1990.
doi:10.4161/cc.8.13.8892
Lämmermann, T., & Sixt, M. (2009). Mechanical modes of ‘amoeboid’ cell migration. Current
Opinion in Cell Biology, 21(5), 636-644. doi:10.1016/j.ceb.2009.05.003
Lavelle, T. A., Weinstein, M. C., Newhouse, J. P., Munir, K., Kuhlthau, K. A., & Prosser, L. A.
(2014). Economic burden of childhood autism spectrum disorders. Pediatrics, 133(3),
e520-529. doi:10.1542/peds.2013-0763
Lazar, M., Miles, L. M., Babb, J. S., & Donaldson, J. B. (2014). Axonal deficits in young adults
with High Functioning Autism and their impact on processing speed. Neuroimage Clin,
4, 417-425. doi:10.1016/j.nicl.2014.01.014
Lee, A. S., Ra, S., Rajadhyaksha, A. M., Britt, J. K., De Jesus-Cortes, H., Gonzales, K. L., . . .
Rajadhyaksha, A. M. (2012). Forebrain elimination of cacna1c mediates anxiety-like
behavior in mice. Molecular Psychiatry, 17(11), 1054-1055. doi:10.1038/mp.2012.71
Lee, C. W., & Peng, H. B. (2008). The Function of Mitochondria in Presynaptic Development at
the Neuromuscular Junction. Molecular Biology of the Cell, 19(1), 150-158.
doi:10.1091/mbc.e07-05-0515
Lee, J.-A. (2012). Neuronal Autophagy: A Housekeeper or a Fighter in Neuronal Cell Survival?
Experimental Neurobiology, 21(1), 1. doi:10.5607/en.2012.21.1.1
Lee, K.-M., Hwang, S.-K., & Lee, J.-A. (2013). Neuronal Autophagy and Neurodevelopmental
Disorders. Experimental Neurobiology, 22(3), 133. doi:10.5607/en.2013.22.3.133
Lee, R. Y., Lobel, L., Hengartner, M., Horvitz, H. R., & Avery, L. (1997). Mutations in the
alpha1 subunit of an L-type voltage-activated Ca2+ channel cause myotonia in
Caenorhabditis elegans. EMBO J, 16(20), 6066-6076. doi:10.1093/emboj/16.20.6066
Lee, S. H., Ripke, S., Neale, B. M., Faraone, S. V., Purcell, S. M., Perlis, R. H., . . . Genetic, I. I.
B. D. (2013). Genetic relationship between five psychiatric disorders estimated from
genome-wide SNPs. Nature Genetics, 45(9), 984-+. doi:10.1038/ng.2711
Lelieveld, S. H., Reijnders, M. R., Pfundt, R., Yntema, H. G., Kamsteeg, E. J., de Vries, P., . . .
Gilissen, C. (2016). Meta-analysis of 2,104 trios provides support for 10 new genes for
intellectual disability. Nat Neurosci, 19(9), 1194-1196. doi:10.1038/nn.4352

138

Letourneau, P. C. (1979). Cell-substratum adhesion of neurite growth cones, and its role in
neurite elongation. Experimental Cell Research, 124(1), 127-138. doi:10.1016/00144827(79)90263-5
Letourneau, P. C. (1983). Differences in the organization of actin in the growth cones compared
with the neurites of cultured neurons from chick embryos. The Journal of Cell Biology,
97(4), 963-973. doi:10.1083/jcb.97.4.963
Levine, B., & Kroemer, G. (2008). Autophagy in the Pathogenesis of Disease. Cell, 132(1), 2742. doi:10.1016/j.cell.2007.12.018
Levine, B., & Kroemer, G. (2019). Biological Functions of Autophagy Genes: A Disease
Perspective. Cell, 176(1-2), 11-42. doi:10.1016/j.cell.2018.09.048
Levy, O. A., Malagelada, C., & Greene, L. A. (2009). Cell death pathways in Parkinson’s
disease: proximal triggers, distal effectors, and final steps. Apoptosis, 14(4), 478-500.
doi:10.1007/s10495-008-0309-3
Li, H., Kulkarni, G., & Wadsworth, W. G. (2008). RPM-1, a Caenorhabditis elegans Protein
That Functions in Presynaptic Differentiation, Negatively Regulates Axon Outgrowth by
Controlling SAX-3/robo and UNC-5/UNC5 Activity. Journal of Neuroscience, 28(14),
3595-3603. doi:10.1523/jneurosci.5536-07.2008
Li, J., Zhao, L., You, Y., Lu, T., Jia, M., Yu, H., . . . Wang, L. (2015). Schizophrenia Related
Variants in CACNA1C also Confer Risk of Autism. PLOS ONE, 10(7), e0133247.
doi:10.1371/journal.pone.0133247
Li, W., Kang, L. J., Piggott, B. J., Feng, Z. Y., & Xu, X. Z. S. (2011). The neural circuits and
sensory channels mediating harsh touch sensation in Caenorhabditis elegans. Nature
Communications, 2. doi:ARTN 31510.1038/ncomms1308
Liang, Y., & Sigrist, S. (2018). Autophagy and proteostasis in the control of synapse aging and
disease. Current Opinion in Neurobiology, 48, 113-121. doi:10.1016/j.conb.2017.12.006
Liao, E. H., Hung, W., Abrams, B., & Zhen, M. (2004). An SCF-like ubiquitin ligase complex
that controls presynaptic differentiation. Nature, 430(6997), 345-350.
doi:10.1038/nature02647
Limpitikul, W. B., Dick, I. E., Ben-Johny, M., & Yue, D. T. (2016). An autism-associated
mutation in CaV1.3 channels has opposing effects on voltage- and Ca(2+)-dependent
regulation. Sci Rep, 6, 27235. doi:10.1038/srep27235
Lin, L., Yang, P., Huang, X., Zhang, H., Lu, Q., & Zhang, H. (2013). The scaffold protein EPG7 links cargo-receptor complexes with the autophagic assembly machinery. J Cell Biol,
201(1), 113-129. doi:10.1083/jcb.201209098
Liu, Y., Zhao, D., Dong, R., Yang, X., Zhang, Y., Tammimies, K., . . . Gai, Z. (2015). De novo
exon 1 deletion of AUTS2 gene in a patient with autism spectrum disorder and
139

developmental delay: a case report and a brief literature review. Am J Med Genet A,
167(6), 1381-1385. doi:10.1002/ajmg.a.37050
Long, J., Garner, T. P., Pandya, M. J., Craven, C. J., Chen, P., Shaw, B., . . . Searle, M. S.
(2010). Dimerisation of the UBA domain of p62 inhibits ubiquitin binding and regulates
NF-kappaB signalling. J Mol Biol, 396(1), 178-194. doi:10.1016/j.jmb.2009.11.032
Lord, C., Risi, S., DiLavore, P. S., Shulman, C., Thurm, A., & Pickles, A. (2006). Autism from 2
to 9 years of age. Arch Gen Psychiatry, 63(6), 694-701. doi:10.1001/archpsyc.63.6.694
Lu, A. T.-H., Dai, X., Martinez-Agosto, J. A., & Cantor, R. M. (2012). Support for calcium
channel gene defects in autism spectrum disorders. Molecular Autism, 3(1), 18.
doi:10.1186/2040-2392-3-18
Lynch-Day, M. A., Mao, K., Wang, K., Zhao, M., & Klionsky, D. J. (2012). The role of
autophagy in Parkinson's disease. Cold Spring Harb Perspect Med, 2(4), a009357.
doi:10.1101/cshperspect.a009357
Lystad, A. H., Ichimura, Y., Takagi, K., Yang, Y., Pankiv, S., Kanegae, Y., . . . Simonsen, A.
(2014). Structural determinants in GABARAP required for the selective binding and
recruitment of ALFY to LC3B-positive structures. EMBO Rep, 15(5), 557-565.
doi:10.1002/embr.201338003
Maday, S., & Holzbaur, E. L. (2016). Compartment-Specific Regulation of Autophagy in
Primary Neurons. J Neurosci, 36(22), 5933-5945. doi:10.1523/JNEUROSCI.440115.2016
Maday, S., Twelvetrees, A. E., Moughamian, A. J., & Holzbaur, E. L. (2014). Axonal transport:
cargo-specific mechanisms of motility and regulation. Neuron, 84(2), 292-309.
doi:10.1016/j.neuron.2014.10.019
Maday, S., Wallace, K. E., & Holzbaur, E. L. (2012). Autophagosomes initiate distally and
mature during transport toward the cell soma in primary neurons. J Cell Biol, 196(4),
407-417. doi:10.1083/jcb.201106120
Madeo, F., Tavernarakis, N., & Kroemer, G. (2010). Can autophagy promote longevity? Nat Cell
Biol, 12(9), 842-846. doi:10.1038/ncb0910-842
Mancias, J. D., Pontano Vaites, L., Nissim, S., Biancur, D. E., Kim, A. J., Wang, X., . . . Harper,
J. W. (2015). Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated
by iron dependent HERC2-mediated proteolysis. eLife, 4. doi:10.7554/eLife.10308
Mao, K., Wang, K., Liu, X., & Klionsky, D. J. (2013). The scaffold protein Atg11 recruits
fission machinery to drive selective mitochondria degradation by autophagy. Dev Cell,
26(1), 9-18. doi:10.1016/j.devcel.2013.05.024

140

Marcette, J. D., Chen, J. J., & Nonet, M. L. (2014). The Caenorhabditis elegans microtubule
minus-end binding homolog PTRN-1 stabilizes synapses and neurites. Elife, 3, e01637.
doi:10.7554/eLife.01637
Marcos, S., Nieto-Lopez, F., Sandonis, A., Cardozo, M. J., Di Marco, F., Esteve, P., &
Bovolenta, P. (2015). Secreted frizzled related proteins modulate pathfinding and
fasciculation of mouse retina ganglion cell axons by direct and indirect mechanisms. J
Neurosci, 35(11), 4729-4740. doi:10.1523/JNEUROSCI.3304-13.2015
Massey, A. C., Zhang, C., & Cuervo, A. M. (2006). Chaperone-mediated autophagy in aging and
disease. Curr Top Dev Biol, 73, 205-235. doi:10.1016/S0070-2153(05)73007-6
Mattson, M. P., & Partin, J. (1999). Evidence for mitochondrial control of neuronal polarity. J
Neurosci Res, 56(1), 8-20. doi:10.1002/(SICI)1097-4547(19990401)56:1<8::AIDJNR2>3.0.CO;2-G
Melentijevic, I., Toth, M. L., Arnold, M. L., Guasp, R. J., Harinath, G., Nguyen, K. C., . . .
Driscoll, M. (2017). C. elegans neurons jettison protein aggregates and mitochondria
under neurotoxic stress. Nature, 542(7641), 367-371. doi:10.1038/nature21362
Meng, L., Chen, C. H., & Yan, D. (2016). Regulation of Gap Junction Dynamics by UNC44/ankyrin and UNC-33/CRMP through VAB-8 in C. elegans Neurons. PLoS Genet,
12(3), e1005948. doi:10.1371/journal.pgen.1005948
Misgeld, T., Kerschensteiner, M., Bareyre, F. M., Burgess, R. W., & Lichtman, J. W. (2007).
Imaging axonal transport of mitochondria in vivo. Nat Methods, 4(7), 559-561.
doi:10.1038/nmeth1055
Mizushima, N., & Komatsu, M. (2011). Autophagy: renovation of cells and tissues. Cell, 147(4),
728-741. doi:10.1016/j.cell.2011.10.026
Mizushima, N., Noda, T., Yoshimori, T., Tanaka, Y., Ishii, T., George, M. D., . . . Ohsumi, Y.
(1998). A protein conjugation system essential for autophagy. Nature, 395(6700), 395398. doi:10.1038/26506
Monnier, P. P., Sierra, A., Macchi, P., Deitinghoff, L., Andersen, J. S., Mann, M., . . . Mueller,
B. K. (2002). RGM is a repulsive guidance molecule for retinal axons. Nature,
419(6905), 392-395. doi:10.1038/nature01041
Morris, R. L., & Hollenbeck, P. J. (1993). The regulation of bidirectional mitochondrial transport
is coordinated with axonal outgrowth. J Cell Sci, 104 ( Pt 3), 917-927.
Mukherjee, A., Patel, B., Koga, H., Cuervo, A. M., & Jenny, A. (2016). Selective endosomal
microautophagy is starvation-inducible in Drosophila. Autophagy, 12(11), 1984-1999.
doi:10.1080/15548627.2016.1208887
Murdoch, J. D., Rostosky, C. M., Gowrisankaran, S., Arora, A. S., Soukup, S. F., Vidal, R., . . .
Milosevic, I. (2016). Endophilin-A Deficiency Induces the Foxo3a-Fbxo32 Network in
141

the Brain and Causes Dysregulation of Autophagy and the Ubiquitin-Proteasome System.
Cell Rep, 17(4), 1071-1086. doi:10.1016/j.celrep.2016.09.058
Nair, U., Cao, Y., Xie, Z., & Klionsky, D. J. (2010). Roles of the lipid-binding motifs of Atg18
and Atg21 in the cytoplasm to vacuole targeting pathway and autophagy. J Biol Chem,
285(15), 11476-11488. doi:10.1074/jbc.M109.080374
Naisbitt, S., Kim, E., Tu, J. C., Xiao, B., Sala, C., Valtschanoff, J., . . . Sheng, M. (1999). Shank,
a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD95/GKAP complex and cortactin. Neuron, 23(3), 569-582.
Nakata, K., Abrams, B., Grill, B., Goncharov, A., Huang, X., Chisholm, A. D., & Jin, Y. (2005).
Regulation of a DLK-1 and p38 MAP Kinase Pathway by the Ubiquitin Ligase RPM-1 Is
Required for Presynaptic Development. Cell, 120(3), 407-420.
doi:10.1016/j.cell.2004.12.017
Napoli, E., Song, G., Panoutsopoulos, A., Riyadh, M. A., Kaushik, G., Halmai, J., . . . Giulivi, C.
(2018). Beyond autophagy: a novel role for autism-linked Wdfy3 in brain mitophagy. Sci
Rep, 8(1), 11348. doi:10.1038/s41598-018-29421-7
Napolitano, C., & Antzelevitch, C. (2011). Phenotypical manifestations of mutations in the genes
encoding subunits of the cardiac voltage-dependent L-type calcium channel. Circ Res,
108(5), 607-618. doi:10.1161/CIRCRESAHA.110.224279
Niemi, M. E. K., Martin, H. C., Rice, D. L., Gallone, G., Gordon, S., Kelemen, M., . . . Barrett, J.
C. (2018). Common genetic variants contribute to risk of rare severe neurodevelopmental
disorders. Nature, 562(7726), 268-271. doi:10.1038/s41586-018-0566-4
Nixon, R. A. (2013). The role of autophagy in neurodegenerative disease. Nat Med, 19(8), 983997. doi:10.1038/nm.3232
Okada, Y., Yamazaki, H., Sekine-Aizawa, Y., & Hirokawa, N. (1995). The neuron-specific
kinesin superfamily protein KIF1A is a unique monomeric motor for anterograde axonal
transport of synaptic vesicle precursors. Cell, 81(5), 769-780. doi:10.1016/00928674(95)90538-3
Okerlund, N. D., Schneider, K., Leal-Ortiz, S., Montenegro-Venegas, C., Kim, S. A., Garner, L.
C., . . . Garner, C. C. (2017). Bassoon Controls Presynaptic Autophagy through Atg5.
Neuron, 93(4), 897-913 e897. doi:10.1016/j.neuron.2017.01.026
Orloff, M. S., He, X., Peterson, C., Chen, F., Chen, J. L., Mester, J. L., & Eng, C. (2013).
Germline PIK3CA and AKT1 mutations in Cowden and Cowden-like syndromes. Am J
Hum Genet, 92(1), 76-80. doi:10.1016/j.ajhg.2012.10.021
Orosco, L. A., Ross, A. P., Cates, S. L., Scott, S. E., Wu, D., Sohn, J., . . . Zarbalis, K. S. (2014).
Loss of Wdfy3 in mice alters cerebral cortical neurogenesis reflecting aspects of the
autism pathology. Nat Commun, 5, 4692. doi:10.1038/ncomms5692

142

Palmisano, N. J., Melendez, A., & Grant, B. (2016). The GTPase, RAB-10, regulates the
dynamics of autophagy. Molecular Biology of the Cell, 27.
Pankiv, S., Clausen, T. H., Lamark, T., Brech, A., Bruun, J. A., Outzen, H., . . . Johansen, T.
(2007). p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of
ubiquitinated protein aggregates by autophagy. J Biol Chem, 282(33), 24131-24145.
doi:10.1074/jbc.M702824200
Parajuli, L. K., Nakajima, C., Kulik, A., Matsui, K., Schneider, T., Shigemoto, R., & Fukazawa,
Y. (2012). Quantitative Regional and Ultrastructural Localization of the Ca(v)2.3 Subunit
of R-type Calcium Channel in Mouse Brain. Journal of Neuroscience, 32(39), 1355513567. doi:10.1523/Jneurosci.1142-12.2012
Persico, A. M., D'Agruma, L., Maiorano, N., Totaro, A., Militerni, R., Bravaccio, C., . . .
Collaborative Linkage Study of, A. (2001). Reelin gene alleles and haplotypes as a factor
predisposing to autistic disorder. Mol Psychiatry, 6(2), 150-159.
doi:10.1038/sj.mp.4000850
Pilling, A. D., Horiuchi, D., Lively, C. M., & Saxton, W. M. (2006). Kinesin-1 and Dynein are
the primary motors for fast transport of mitochondria in Drosophila motor axons. Mol
Biol Cell, 17(4), 2057-2068. doi:10.1091/mbc.e05-06-0526
Pohl, C., & Jentsch, S. (2009). Midbody ring disposal by autophagy is a post-abscission event of
cytokinesis. Nat Cell Biol, 11(1), 65-70. doi:10.1038/ncb1813
Polimanti, R., & Gelernter, J. (2017). Widespread signatures of positive selection in common
risk alleles associated to autism spectrum disorder. PLoS Genet, 13(2), e1006618.
doi:10.1371/journal.pgen.1006618
Polleux, F., & Snider, W. (2010). Initiating and growing an axon. Cold Spring Harbor
perspectives in biology, 2(4), a001925. doi:10.1101/cshperspect.a001925
Pragnell, M., Dewaard, M., Mori, Y., Tanabe, T., Snutch, T. P., & Campbell, K. P. (1994).
Calcium-Channel Beta-Subunit Binds to a Conserved Motif in the I-Ii Cytoplasmic
Linker of the Alpha(1)-Subunit. Nature, 368(6466), 67-70. doi:DOI 10.1038/368067a0
Prehoda, K. E. (2009). Polarization of Drosophila neuroblasts during asymmetric division. Cold
Spring Harbor perspectives in biology, 1(2), a001388-a001388.
doi:10.1101/cshperspect.a001388
Purcell, S. M., Moran, J. L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P., . . . Sklar, P.
(2014). A polygenic burden of rare disruptive mutations in schizophrenia. Nature,
506(7487), 185-+. doi:10.1038/nature12975
Qin, N., Olcese, R., Stefani, E., & Birnbaumer, L. (1998). Modulation of human neuronal
alpha(1E)-type calcium channel by alpha(2)delta-subunit. American Journal of
Physiology-Cell Physiology, 274(5), C1324-C1331.

143

Rankin, C. H., Beck, C. D., & Chiba, C. M. (1990). Caenorhabditis elegans: a new model system
for the study of learning and memory. Behav Brain Res, 37(1), 89-92.
Rawson, R. L., Yam, L., Weimer, R. M., Bend, E. G., Hartwieg, E., Horvitz, H. R., . . .
Jorgensen, E. M. (2014). Axons degenerate in the absence of mitochondria in C. elegans.
Curr Biol, 24(7), 760-765. doi:10.1016/j.cub.2014.02.025
Ripke, S., Sanders, A. R., Kendler, K. S., Levinson, D. F., Sklar, P., Holmans, P. A., . . .
Genome-Wide, S. P. (2011). Genome-wide association study identifies five new
schizophrenia loci. Nature Genetics, 43(10), 969-976. doi:10.1038/ng.940
RK, C. Y., Merico, D., Bookman, M., J, L. H., Thiruvahindrapuram, B., Patel, R. V., . . .
Scherer, S. W. (2017). Whole genome sequencing resource identifies 18 new candidate
genes for autism spectrum disorder. Nat Neurosci, 20(4), 602-611. doi:10.1038/nn.4524
Robinson, E. B., St Pourcain, B., Anttila, V., Kosmicki, J. A., Bulik-Sullivan, B., Grove, J., . . .
Daly, M. J. (2016). Genetic risk for autism spectrum disorders and neuropsychiatric
variation in the general population. Nat Genet, 48(5), 552-555. doi:10.1038/ng.3529
Roussos, P., Mitchell, A. C., Voloudakis, G., Fullard, J. F., Pothula, V. M., Tsang, J., . . . Sklar,
P. (2014). A role for noncoding variation in schizophrenia. Cell Rep, 9(4), 1417-1429.
doi:10.1016/j.celrep.2014.10.015
Saheki, Y., & Bargmann, C. I. (2009). Presynaptic CaV2 calcium channel traffic requires CALF1 and the alpha(2)delta subunit UNC-36. Nat Neurosci, 12(10), 1257-1265.
doi:10.1038/nn.2383
Sahu, R., Kaushik, S., Clement, C. C., Cannizzo, E. S., Scharf, B., Follenzi, A., . . .
Santambrogio, L. (2011). Microautophagy of cytosolic proteins by late endosomes. Dev
Cell, 20(1), 131-139. doi:10.1016/j.devcel.2010.12.003
Salinas, P. C. (2012). Wnt signaling in the vertebrate central nervous system: from axon
guidance to synaptic function. Cold Spring Harbor perspectives in biology, 4(2).
doi:10.1101/cshperspect.a008003
Sanders, S. J., He, X., Willsey, A. J., Ercan-Sencicek, A. G., Samocha, K. E., Cicek, A. E., . . .
State, M. W. (2015). Insights into Autism Spectrum Disorder Genomic Architecture and
Biology from 71 Risk Loci. Neuron, 87(6), 1215-1233. doi:10.1016/j.neuron.2015.09.016
Sandin, S., Lichtenstein, P., Kuja-Halkola, R., Hultman, C., Larsson, H., & Reichenberg, A.
(2017). The Heritability of Autism Spectrum Disorder. JAMA, 318(12), 1182.
doi:10.1001/jama.2017.12141
Sato, D., Lionel, A. C., Leblond, C. S., Prasad, A., Pinto, D., Walker, S., . . . Scherer, S. W.
(2012). SHANK1 Deletions in Males with Autism Spectrum Disorder. Am J Hum Genet,
90(5), 879-887. doi:10.1016/j.ajhg.2012.03.017

144

Sawa-Makarska, J., Abert, C., Romanov, J., Zens, B., Ibiricu, I., & Martens, S. (2014). Cargo
binding to Atg19 unmasks additional Atg8 binding sites to mediate membrane-cargo
apposition during selective autophagy. Nat Cell Biol, 16(5), 425-433.
doi:10.1038/ncb2935
Schaaf, C. P., Sabo, A., Sakai, Y., Crosby, J., Muzny, D., Hawes, A., . . . Zoghbi, H. Y. (2011).
Oligogenic heterozygosity in individuals with high-functioning autism spectrum
disorders. Human Molecular Genetics, 20(17), 3366-3375. doi:10.1093/hmg/ddr243
Schaefer, A. M., Hadwiger, G. D., & Nonet, M. L. (2000). rpm-1, a conserved neuronal gene that
regulates targeting and synaptogenesis in C. elegans. Neuron, 26(2), 345-356.
Schafer, W. R., & Kenyon, C. J. (1995). A calcium-channel homologue required for adaptation
to dopamine and serotonin in Caenorhabditis elegans. Nature, 375(6526), 73-78.
doi:10.1038/375073a0
Schipul, S. E., Keller, T. A., & Just, M. A. (2011). Inter-Regional Brain Communication and Its
Disturbance in Autism. Frontiers in Systems Neuroscience, 5.
doi:10.3389/fnsys.2011.00010
Scott, R. C., Schuldiner, O., & Neufeld, T. P. (2004). Role and regulation of starvation-induced
autophagy in the Drosophila fat body. Dev Cell, 7(2), 167-178.
doi:10.1016/j.devcel.2004.07.009
Seto, S., Tsujimura, K., Horii, T., & Koide, Y. (2013). Autophagy adaptor protein p62/SQSTM1
and autophagy-related gene Atg5 mediate autophagosome formation in response to
Mycobacterium tuberculosis infection in dendritic cells. PLOS ONE, 8(12), e86017.
doi:10.1371/journal.pone.0086017
Shang, L., & Wang, X. (2011). AMPK and mTOR coordinate the regulation of Ulk1 and
mammalian autophagy initiation. Autophagy, 7(8), 924-926. doi:10.4161/auto.7.8.15860
Shen, D. N., Zhang, L. H., Wei, E. Q., & Yang, Y. (2015). Autophagy in synaptic development,
function, and pathology. Neurosci Bull, 31(4), 416-426. doi:10.1007/s12264-015-1536-6
Shen, W., & Ganetzky, B. (2009). Autophagy promotes synapse development inDrosophila. The
Journal of Cell Biology, 187(1), 71-79. doi:10.1083/jcb.200907109
Shintani, T., Huang, W. P., Stromhaug, P. E., & Klionsky, D. J. (2002). Mechanism of cargo
selection in the cytoplasm to vacuole targeting pathway. Dev Cell, 3(6), 825-837.
Shirasaki, R., Lewcock, J. W., Lettieri, K., & Pfaff, S. L. (2006). FGF as a target-derived
chemoattractant for developing motor axons genetically programmed by the LIM code.
Neuron, 50(6), 841-853. doi:10.1016/j.neuron.2006.04.030
Simonsen, A., Birkeland, H. C., Gillooly, D. J., Mizushima, N., Kuma, A., Yoshimori, T., . . .
Stenmark, H. (2004). Alfy, a novel FYVE-domain-containing protein associated with

145

protein granules and autophagic membranes. J Cell Sci, 117(Pt 18), 4239-4251.
doi:10.1242/jcs.01287
Sipos, I., Pika-Hartlaub, U., Hofmann, F., Flucher, B. E., & Melzer, W. (2000). Effects of the
dihydropyridine receptor subunits gamma and alpha(2)delta on the kinetics of
heterologously expressed L-type Ca2+ channels. Pflugers Archiv-European Journal of
Physiology, 439(6), 691-699. doi:DOI 10.1007/s004240050994
Siu, M. T., & Weksberg, R. (2017). Epigenetics of Autism Spectrum Disorder. Adv Exp Med
Biol, 978, 63-90. doi:10.1007/978-3-319-53889-1_4
Small, J. V., Stradal, T., Vignal, E., & Rottner, K. (2002). The lamellipodium: where motility
begins. Trends Cell Biol, 12(3), 112-120.
Smith, G. M., & Gallo, G. (2018). The role of mitochondria in axon development and
regeneration. Dev Neurobiol, 78(3), 221-237. doi:10.1002/dneu.22546
Soong, T. W., Stea, A., Hodson, C. D., Dubel, S. J., Vincent, S. R., & Snutch, T. P. (1993).
Structure and Functional Expression of a Member of the Low-Voltage Activated
Calcium-Channel Family. Science, 260(5111), 1133-1136. doi:DOI
10.1126/science.8388125
Soukup, S. F., Kuenen, S., Vanhauwaert, R., Manetsberger, J., Hernandez-Diaz, S., Swerts, J., . .
. Verstreken, P. (2016). A LRRK2-Dependent EndophilinA Phosphoswitch Is Critical for
Macroautophagy at Presynaptic Terminals. Neuron, 92(4), 829-844.
doi:10.1016/j.neuron.2016.09.037
Splawski, I., Timothy, K. W., Decher, N., Kumar, P., Sachse, F. B., Beggs, A. H., . . . Keating,
M. T. (2005). Severe arrhythmia disorder caused by cardiac L-type calcium channel
mutations. Proc Natl Acad Sci U S A, 102(23), 8089-8096; discussion 8086-8088.
doi:10.1073/pnas.0502506102
Splawski, I., Timothy, K. W., Sharpe, L. M., Decher, N., Kumar, P., Bloise, R., . . . Keating, M.
T. (2004). CaV1.2 Calcium Channel Dysfunction Causes a Multisystem Disorder
Including Arrhythmia and Autism. Cell, 119(1), 19-31. doi:10.1016/j.cell.2004.09.011
Sragovich, S., Merenlender-Wagner, A., & Gozes, I. (2017). ADNP Plays a Key Role in
Autophagy: From Autism to Schizophrenia and Alzheimer's Disease. Bioessays, 39(11).
doi:10.1002/bies.201700054
Stavoe, A. K., Hill, S. E., Hall, D. H., & Colon-Ramos, D. A. (2016). KIF1A/UNC-104
Transports ATG-9 to Regulate Neurodevelopment and Autophagy at Synapses. Dev Cell,
38(2), 171-185. doi:10.1016/j.devcel.2016.06.012
Steffenburg, S., Gillberg, C., Hellgren, L., Andersson, L., Gillberg, I. C., Jakobsson, G., &
Bohman, M. (1989). A twin study of autism in Denmark, Finland, Iceland, Norway and
Sweden. J Child Psychol Psychiatry, 30(3), 405-416.

146

Stein, J. L., Parikshak, N. N., & Geschwind, D. H. (2013). Rare inherited variation in autism:
beginning to see the forest and a few trees. Neuron, 77(2), 209-211.
doi:10.1016/j.neuron.2013.01.010
Stessman, H. A., Xiong, B., Coe, B. P., Wang, T., Hoekzema, K., Fenckova, M., . . . Eichler, E.
E. (2017). Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes
with autism and developmental-disability biases. Nat Genet, 49(4), 515-526.
doi:10.1038/ng.3792
Stoeckli, E. T. (2018). Understanding axon guidance: are we nearly there yet? Development,
145(10). doi:10.1242/dev.151415
Stoner, R., Chow, M. L., Boyle, M. P., Sunkin, S. M., Mouton, P. R., Roy, S., . . . Courchesne, E.
(2014). Patches of disorganization in the neocortex of children with autism. N Engl J
Med, 370(13), 1209-1219. doi:10.1056/NEJMoa1307491
Strasser, G. A., Rahim, N. A., VanderWaal, K. E., Gertler, F. B., & Lanier, L. M. (2004). Arp2/3
is a negative regulator of growth cone translocation. Neuron, 43(1), 81-94.
doi:10.1016/j.neuron.2004.05.015
Strauss, K. A., Puffenberger, E. G., Huentelman, M. J., Gottlieb, S., Dobrin, S. E., Parod, J. M., .
. . Morton, D. H. (2006). Recessive symptomatic focal epilepsy and mutant contactinassociated protein-like 2. N Engl J Med, 354(13), 1370-1377.
doi:10.1056/NEJMoa052773
Strom, S. P., Stone, J. L., Ten Bosch, J. R., Merriman, B., Cantor, R. M., Geschwind, D. H., &
Nelson, S. F. (2010). High-density SNP association study of the 17q21 chromosomal
region linked to autism identifies CACNA1G as a novel candidate gene. Mol Psychiatry,
15(10), 996-1005. doi:10.1038/mp.2009.41
Stromme, P., Mangelsdorf, M. E., Scheffer, I. E., & Gecz, J. (2002). Infantile spasms, dystonia,
and other X-linked phenotypes caused by mutations in Aristaless related homeobox gene,
ARX. Brain Dev, 24(5), 266-268.
Suetterlin, P., & Drescher, U. (2014). Target-independent ephrina/EphA-mediated axon-axon
repulsion as a novel element in retinocollicular mapping. Neuron, 84(4), 740-752.
doi:10.1016/j.neuron.2014.09.023
Sun, K. L. W., Correia, J. P., & Kennedy, T. E. (2011). Netrins: versatile extracellular cues with
diverse functions. Development, 138(11), 2153-2169. doi:10.1242/dev.044529
Suzuki, K., Kirisako, T., Kamada, Y., Mizushima, N., Noda, T., & Ohsumi, Y. (2001). The preautophagosomal structure organized by concerted functions of APG genes is essential for
autophagosome formation. EMBO J, 20(21), 5971-5981. doi:10.1093/emboj/20.21.5971
Svitkina, T. M., & Borisy, G. G. (1999). Arp2/3 complex and actin depolymerizing factor/cofilin
in dendritic organization and treadmilling of actin filament array in lamellipodia. J Cell
Biol, 145(5), 1009-1026. doi:10.1083/jcb.145.5.1009
147

Symons, M. H., & Mitchison, T. J. (1991). Control of Actin Polymerization in Live and
Permeabilized Fibroblasts. Journal of Cell Biology, 114(3), 503-513. doi:DOI
10.1083/jcb.114.3.503
Takemoto-Kimura, S., Suzuki, K., Kamijo, S., Ageta-Ishihara, N., Fujii, H., Okuno, H., & Bito,
H. (2010). Differential roles for CaM kinases in mediating excitation-morphogenesis
coupling during formation and maturation of neuronal circuits. Eur J Neurosci, 32(2),
224-230. doi:10.1111/j.1460-9568.2010.07353.x
Tang, F. J., Dent, E. W., & Kalil, K. (2003). Spontaneous calcium transients in developing
cortical neurons regulate axon outgrowth. Journal of Neuroscience, 23(3), 927-936.
Tang, G., Gudsnuk, K., Kuo, S. H., Cotrina, M. L., Rosoklija, G., Sosunov, A., . . . Sulzer, D.
(2014). Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning
deficits. Neuron, 83(5), 1131-1143. doi:10.1016/j.neuron.2014.07.040
Templin, C., Ghadri, J. R., Rougier, J. S., Baumer, A., Kaplan, V., Albesa, M., . . . Duru, F.
(2011). Identification of a novel loss-of-function calcium channel gene mutation in short
QT syndrome (SQTS6). European Heart Journal, 32(9), 1077-1088.
doi:10.1093/eurheartj/ehr076
Tian, X., Gala, U., Zhang, Y., Shang, W., Nagarkar Jaiswal, S., di Ronza, A., . . . Tong, C.
(2015). A voltage-gated calcium channel regulates lysosomal fusion with endosomes and
autophagosomes and is required for neuronal homeostasis. PLoS Biol, 13(3), e1002103.
doi:10.1371/journal.pbio.1002103
Tian, Y., Ren, H., Zhao, Y., Lu, Q., Huang, X., Yang, P., & Zhang, H. (2010). Four metazoan
autophagy genes regulate cargo recognition, autophagosome formation and
autolysosomal degradation. Autophagy, 6(7), 984-985. doi:10.4161/auto.6.7.13156
Travers, B. G., Adluru, N., Ennis, C., Tromp do, P. M., Destiche, D., Doran, S., . . . Alexander,
A. L. (2012). Diffusion tensor imaging in autism spectrum disorder: a review. Autism
Res, 5(5), 289-313. doi:10.1002/aur.1243
Treusch, S., Knuth, S., Slaugenhaupt, S. A., Goldin, E., Grant, B. D., & Fares, H. (2004).
Caenorhabditis elegans functional orthologue of human protein h-mucolipin-1 is required
for lysosome biogenesis. Proc Natl Acad Sci U S A, 101(13), 4483-4488.
doi:10.1073/pnas.0400709101
Tulgren, E. D., Baker, S. T., Rapp, L., Gurney, A. M., & Grill, B. (2011). PPM-1, a
PP2Calpha/beta phosphatase, regulates axon termination and synapse formation in
Caenorhabditis elegans. Genetics, 189(4), 1297-1307. doi:10.1534/genetics.111.134791
Tulgren, E. D., Turgeon, S. M., Opperman, K. J., & Grill, B. (2014). The Nesprin Family
Member ANC-1 Regulates Synapse Formation and Axon Termination by Functioning in
a Pathway with RPM-1 and β-Catenin. PLoS Genetics, 10(7), e1004481.
doi:10.1371/journal.pgen.1004481
148

Turner, G., Partington, M., Kerr, B., Mangelsdorf, M., & Gecz, J. (2002). Variable expression of
mental retardation, autism, seizures, and dystonic hand movements in two families with
an identical ARX gene mutation. Am J Med Genet, 112(4), 405-411.
doi:10.1002/ajmg.10714
Turner, T. N., Coe, B. P., Dickel, D. E., Hoekzema, K., Nelson, B. J., Zody, M. C., . . . Eichler,
E. E. (2017). Genomic Patterns of De Novo Mutation in Simplex Autism. Cell, 171(3),
710-722 e712. doi:10.1016/j.cell.2017.08.047
Uttenweiler, A., & Mayer, A. (2008). Microautophagy in the yeast Saccharomyces cerevisiae.
Methods Mol Biol, 445, 245-259. doi:10.1007/978-1-59745-157-4_16
Uytterhoeven, V., Lauwers, E., Maes, I., Miskiewicz, K., Melo, M. N., Swerts, J., . . .
Verstreken, P. (2015). Hsc70-4 Deforms Membranes to Promote Synaptic Protein
Turnover by Endosomal Microautophagy. Neuron, 88(4), 735-748.
doi:10.1016/j.neuron.2015.10.012
van Ham, T. J., Thijssen, K. L., Breitling, R., Hofstra, R. M., Plasterk, R. H., & Nollen, E. A.
(2008). C. elegans model identifies genetic modifiers of alpha-synuclein inclusion
formation during aging. PLoS Genet, 4(3), e1000027. doi:10.1371/journal.pgen.1000027
Vanhauwaert, R., Kuenen, S., Masius, R., Bademosi, A., Manetsberger, J., Schoovaerts, N., . . .
Verstreken, P. (2017). The SAC1 domain in synaptojanin is required for autophagosome
maturation at presynaptic terminals. EMBO J, 36(10), 1392-1411.
doi:10.15252/embj.201695773
Varoqueaux, F., Aramuni, G., Rawson, R. L., Mohrmann, R., Missler, M., Gottmann, K., . . .
Brose, N. (2006). Neuroligins determine synapse maturation and function. Neuron, 51(6),
741-754. doi:10.1016/j.neuron.2006.09.003
Vehlow, A., Soong, D., Vizcay-Barrena, G., Bodo, C., Law, A. L., Perera, U., & Krause, M.
(2013). Endophilin, Lamellipodin, and Mena cooperate to regulate F-actin-dependent
EGF-receptor endocytosis. EMBO J, 32(20), 2722-2734. doi:10.1038/emboj.2013.212
Verstreken, P., Ly, C. V., Venken, K. J., Koh, T. W., Zhou, Y., & Bellen, H. J. (2005). Synaptic
mitochondria are critical for mobilization of reserve pool vesicles at Drosophila
neuromuscular junctions. Neuron, 47(3), 365-378. doi:10.1016/j.neuron.2005.06.018
Wadel, K., Neher, E., & Sakaba, T. (2007). The coupling between synaptic vesicles and Ca2+
channels determines fast neurotransmitter release. Neuron, 53(4), 563-575.
doi:10.1016/j.neuron.2007.01.021
Waithe, D., Ferron, L., Page, K. M., Chaggar, K., & Dolphin, A. C. (2011). beta-Subunits
Promote the Expression of Ca(V)2.2 Channels by Reducing Their Proteasomal
Degradation. Journal of Biological Chemistry, 286(11), 9598-9611.
doi:10.1074/jbc.M110.195909

149

Wan, H. I., DiAntonio, A., Fetter, R. D., Bergstrom, K., Strauss, R., & Goodman, C. S. (2000).
Highwire regulates synaptic growth in Drosophila. Neuron, 26(2), 313-329.
Wang, D. W., Peng, Z. J., Ren, G. F., & Wang, G. X. (2015). The different roles of selective
autophagic protein degradation in mammalian cells. Oncotarget, 6(35), 37098-37116.
doi:10.18632/oncotarget.5776
Wang, L., Pang, K., Han, K., Adamski, C. J., Wang, W., He, L., . . . Zoghbi, H. Y. (2019). An
autism-linked missense mutation in SHANK3 reveals the modularity of Shank3 function.
Mol Psychiatry. doi:10.1038/s41380-018-0324-x
Wang, T., Guo, H., Xiong, B., Stessman, H. A., Wu, H., Coe, B. P., . . . Eichler, E. E. (2016). De
novo genic mutations among a Chinese autism spectrum disorder cohort. Nat Commun, 7,
13316. doi:10.1038/ncomms13316
Wang, Y., Li, L., Hou, C., Lai, Y., Long, J., Liu, J., . . . Diao, J. (2016). SNARE-mediated
membrane fusion in autophagy. Semin Cell Dev Biol, 60, 97-104.
doi:10.1016/j.semcdb.2016.07.009
Wang, Y. C., Lauwers, E., & Verstreken, P. (2017). Presynaptic protein homeostasis and
neuronal function. Curr Opin Genet Dev, 44, 38-46. doi:10.1016/j.gde.2017.01.015
Wayman, G. A., Lee, Y. S., Tokumitsu, H., Silva, A. J., & Soderling, T. R. (2008). Calmodulinkinases: modulators of neuronal development and plasticity. Neuron, 59(6), 914-931.
doi:10.1016/j.neuron.2008.08.021
Wegiel, J., Flory, M., Kuchna, I., Nowicki, K., Ma, S. Y., Imaki, H., . . . Wisniewski, T. (2014).
Brain-region-specific alterations of the trajectories of neuronal volume growth
throughout the lifespan in autism. Acta Neuropathol Commun, 2, 28. doi:10.1186/20515960-2-28
Wei, X. Y., Perezreyes, E., Lacerda, A. E., Schuster, G., Brown, A. M., & Birnbaumer, L.
(1991). Heterologous Regulation of the Cardiac Ca2+ Channel-Alpha-1 Subunit by
Skeletal-Muscle Beta-Subunit and Gamma-Subunits - Implications for the Structure of
Cardiac L-Type Ca2+ Channels. Journal of Biological Chemistry, 266(32), 21943-21947.
Weston, M. C., Chen, H., & Swann, J. W. (2014). Loss of mTOR repressors Tsc1 or Pten has
divergent effects on excitatory and inhibitory synaptic transmission in single
hippocampal neuron cultures. Front Mol Neurosci, 7, 1. doi:10.3389/fnmol.2014.00001
Wheeler, D. B., Sather, W. A., Randall, A., & Tsien, R. W. (1994). Distinctive Properties of a
Neuronal Calcium-Channel and Its Contribution to Excitatory Synaptic Transmission in
the Central-Nervous-System. Molecular and Cellular Mechanisms of Neurotransmitter
Release, 29, 155-171.
Wheeler, D. G., Barrett, C. F., Groth, R. D., Safa, P., & Tsien, R. W. (2008). CaMKII locally
encodes L-type channel activity to signal to nuclear CREB in excitation-transcription
coupling. Journal of Cell Biology, 183(5), 849-863. doi:10.1083/jcb.200805048
150

Wheeler, D. G., Groth, R. D., Ma, H., Barrett, C. F., Owen, S. F., Safa, P., & Tsien, R. W.
(2012). Ca(v)1 and Ca(v)2 Channels Engage Distinct Modes of Ca2+ Signaling to
Control CREB-Dependent Gene Expression. Cell, 149(5), 1112-1124.
doi:10.1016/j.cell.2012.03.041
White, J. G., Southgate, E., Thomson, J. N., & Brenner, S. (1986). The structure of the nervous
system of the nematode Caenorhabditis elegans. Phil. Trans. R. Soc. Lond. B, 314(1165).
doi:https://doi.org/10.1098/rstb.1986.0056
Wileman, T. (2013). Autophagy as a defence against intracellular pathogens. Essays Biochem,
55, 153-163. doi:10.1042/bse0550153
Williams, M. E., Brust, P. F., Feldman, D. H., Patthi, S., Simerson, S., Maroufi, A., . . . Harpold,
M. M. (1992). Structure and Functional Expression of an Omega-Conotoxin Sensitive
Human N-Type Calcium-Channel. Science, 257(5068), 389-395. doi:DOI
10.1126/science.1321501
Wilson, C. A., Tsuchida, M. A., Allen, G. M., Barnhart, E. L., Applegate, K. T., Yam, P. T., . . .
Theriot, J. A. (2010). Myosin II contributes to cell-scale actin network treadmilling
through network disassembly. Nature, 465(7296), 373-U137. doi:10.1038/nature08994
Wolff, J. J., Gu, H., Gerig, G., Elison, J. T., Styner, M., Gouttard, S., . . . Network, I. (2012).
Differences in white matter fiber tract development present from 6 to 24 months in
infants with autism. Am J Psychiatry, 169(6), 589-600.
doi:10.1176/appi.ajp.2011.11091447
Wu, C., Wairkar, Y. P., Collins, C. A., & DiAntonio, A. (2005). Highwire function at the
Drosophila neuromuscular junction: spatial, structural, and temporal requirements. J
Neurosci, 25(42), 9557-9566. doi:10.1523/JNEUROSCI.2532-05.2005
Wurzer, B., Zaffagnini, G., Fracchiolla, D., Turco, E., Abert, C., Romanov, J., & Martens, S.
(2015). Oligomerization of p62 allows for selection of ubiquitinated cargo and isolation
membrane during selective autophagy. eLife, 4, e08941. doi:10.7554/eLife.08941
Xu, Y., & Quinn, C. C. (2012). MIG-10 functions with ABI-1 to mediate the UNC-6 and SLT-1
axon guidance signaling pathways. PLoS Genet, 8(11), e1003054.
doi:10.1371/journal.pgen.1003054
Xu, Y., & Quinn, C. C. (2016). Transition between synaptic branch formation and
synaptogenesis is regulated by the lin-4 microRNA. Dev Biol, 420(1), 60-66.
doi:10.1016/j.ydbio.2016.10.010
Yamamoto, A., & Yue, Z. (2014). Autophagy and its normal and pathogenic states in the brain.
Annu Rev Neurosci, 37, 55-78. doi:10.1146/annurev-neuro-071013-014149
Yook, K. J., Proulx, S. R., & Jorgensen, E. M. (2001). Rules of nonallelic noncomplementation
at the synapse in Caenorhabditis elegans. Genetics, 158(1), 209-220.

151

Yoshimizu, T., Pan, J. Q., Mungenast, A. E., Madison, J. M., Su, S., Ketterman, J., . . . Tsai, L.
H. (2015). Functional implications of a psychiatric risk variant within CACNA1C in
induced human neurons. Mol Psychiatry, 20(2), 284. doi:10.1038/mp.2014.181
Ypsilanti, A. R., Zagar, Y., & Chedotal, A. (2010). Moving away from the midline: new
developments for Slit and Robo. Development, 137(12), 1939-1952.
doi:10.1242/dev.044511
Yuen, R. K., Thiruvahindrapuram, B., Merico, D., Walker, S., Tammimies, K., Hoang, N., . . .
Scherer, S. W. (2015). Whole-genome sequencing of quartet families with autism
spectrum disorder. Nat Med, 21(2), 185-191. doi:10.1038/nm.3792
Zaffagnini, G., & Martens, S. (2016). Mechanisms of Selective Autophagy. J Mol Biol, 428(9 Pt
A), 1714-1724. doi:10.1016/j.jmb.2016.02.004
Zhang, C., Milunsky, J. M., Newton, S., Ko, J., Zhao, G., Maher, T. A., . . . Sudhof, T. C. (2009).
A neuroligin-4 missense mutation associated with autism impairs neuroligin-4 folding
and endoplasmic reticulum export. J Neurosci, 29(35), 10843-10854.
doi:10.1523/JNEUROSCI.1248-09.2009
Zhang, J. Y., Li, X., Jevince, A. R., Guan, L. Y., Wang, J. M., Hall, D. H., . . . Ding, M. (2013).
Neuronal Target Identification Requires AHA-1-Mediated Fine-Tuning of Wnt Signaling
in C. elegans. PLoS Genetics, 9(6).
Zhang, Y., & Chalfie, M. (2002). MTD-1, a touch-cell-specific membrane protein with a subtle
effect on touch sensitivity. Mech Dev, 119(1), 3-7.
Zhen, M., Huang, X., Bamber, B., & Jin, Y. (2000). Regulation of presynaptic terminal
organization by C. elegans RPM-1, a putative guanine nucleotide exchanger with a
RING-H2 finger domain. Neuron, 26(2), 331-343.
Zheng, J. Q. (2000). Turning of nerve growth cones induced by localized increases in
intracellular calcium ions. Nature, 403(6765), 89-93. doi:10.1038/47501
Zheng, Y. T., Shahnazari, S., Brech, A., Lamark, T., Johansen, T., & Brumell, J. H. (2009). The
adaptor protein p62/SQSTM1 targets invading bacteria to the autophagy pathway. J
Immunol, 183(9), 5909-5916. doi:10.4049/jimmunol.0900441

152

CURRICULUM VITAE

Tyler Buddell
EDUCATION
University of Wisconsin-Milwaukee, Milwaukee, WI
Doctorate of Philosophy (Ph.D.), Biology, December 2019
Areas of Concentration: Molecular Neuroscience and Genetics
Knox College, Galesburg, IL
Bachelor of Arts (B.A.) in Biology, June 2014
Areas of Concentration: Molecular Biology, Cell and Developmental Biology
Minors: Chemistry and History

RESEARCH EXPERIENCE
Dissertation: An Autism-Causing Variant Misregulates Selective Autophagy to Alter Axon
Targeting and Behavior August 2014 – August 2019
University of Wisconsin-Milwaukee, Milwaukee, WI
PI: Dr. Christopher C. Quinn
Senior Research: Localization of Intersectin1 in Xenopus laevis September 2013 – June 2014
Knox College, Galesburg, IL
Mentor: Dr. Judith Thorn
Research Assistant: C2C12 myogenic cells as a model for studying cell pathways of Duchenne
muscular dystrophy in mammals June 2013 – August 2013
Rosalind Franklin University, North Chicago, IL
Mentor: Dr. Joseph X. DiMario
Independent Research: Characterization and localization of a novel gene in Drosophila
melanogaster September 2012 – May 2013
Knox College, Galesburg, IL
Mentor: Dr. Judith Thorn
Research Assistant: Isolating quail myoblast cell line June 2012 – August 2012
Rosalind Franklin University, North Chicago, IL
Mentor: Dr. Joseph X. DiMario
Research Intern June 2010 – August 2010
Rosalind Franklin University, North Chicago, IL
Mentor: Dr. Joseph X. DiMario

153

TEACHING EXPERIENCE
Teaching Assistant – Laboratory Cell Biology and Genetics, University of WisconsinMilwaukee August 2014 – May 2019
Average Evaluation Score: 4.7 out of 5
Teaching Assistant – Laboratory Anatomy & Physiology, University of Wisconsin-Milwaukee
August 2019 – December 2019

PUBLICATIONS
PLOS Genetics, doi: 10.1371/journal.pgen.1008488
Buddell, T., Friedman, V., Drozd, C., Quinn, C.C. “An autism-causing calcium channel variant
functions with selective autophagy to alter axon targeting and behavior”

NOTABLE PRESENTATIONS
“An autism-causing variant misregulates selective autophagy to alter axon targeting and
behavior” UWM, Dissertation Defense, August 21st 2019
“An autism-causing variant misregulates selective autophagy to alter axon targeting and
behavior”
University of Illinois-Chicago, 2nd Chicago Are Worm Meeting, May 23rdth 2019
“An autism-causing mutation disrupts axon termination by misregulating selective
autophagy”
UWM, Colloquium, March 8th 2019
“An autism-causing mutation disrupts axon termination by misregulating selective
autophagy”
UW-Madison, Ce NEURO International Conference, Oral Presentation, June 26th 2018
“Autism Spectrum Disorder: How Calcium Channel Mutations Can Change the Brain”
UWM, Inaugural 3MT Competition Finalist, April 4th 2018
“The role of lamellipodin in regulating axon outgrowth”
UWM, Qualification Exam Defense, January 10th 2017
“The role of voltage gated calcium channels in mediating axon termination”
UWM, Dissertation Proposal Defense, September 23rd 2016
“The role of voltage gated calcium channels in mediating axon termination”
UWM, Biological Sciences Research Symposium, Poster April 22nd 2016 + CMB Talk April 21st
2017 + April 14th 2018

154

“The role of voltage gated calcium channels in mediating axon termination”
UWM, Neurosymposium Micro-talk & Poster Presentation, March 11th 2016 + March 3rd
2017 + March 16th 2018
“Investigation of how the unc-2 and unc-36 calcium channel genes regulate axon outgrowth”
UWM, Cell and Molecular Biology Seminar Presentation, April 1st 2015 + February 17th 2016

ADDITIONAL CONFERENCES ATTENDED
1st Chicago Area Worm Meeting (published abstract), University of Illinois-Chicago, May 24th
2018
Milwaukee Worm Meeting, Marquette University, Milwaukee, WI, October 23 rd 2015
C. Elegans 20th International Meeting, University of California, Los Angeles, CA, June 24th-28th
2015

AWARDS AND HONORS
Chancellor’s Graduate School Award 2014-2019
Clifford H. Mortimer Award 2017
UWM Inaugural 3MT Finalist 2018
Ruth I Walker – Graduate Grant-in-Aid Award 2018
James J Magnino, MD Scholarship 2019

155

